phv00025995.v1 ::: phs000086.v2.p1 ::: pht000214.v1 ::: DCCT_f0034 ::: OCDM3LUS ::: Diabetes monitoring (three or more daily injections or infusion pump): blood test(s) should have done before lunch ::: int ::: BLOOD GLUCOSE TESTS ::: NONE ::: NONE ::: diabetes monitoring  three or more daily injections or infusion pump   blood test s  should have done before lunch ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetes monitoring check done;injection of therapeutic agent;injection procedure;hematologic tests;blood analysis (lab test) ::: C0422587;C0021485;C1533685;C0018941;C2121789 ::: fndg;topp;topp;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00084527.v2 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: volu11c ::: SCAN 1: TOTAL CALCIUM VOLUME, UNADJUSTED ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: scan 1  total calcium volume, unadjusted ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;calcium volume ::: C2700258;C1562777 ::: lbpr;clna ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00079514.v3 ::: phs000200.v8.p2 ::: pht001013.v3 ::: f45_rel1 ::: F45FOLIC ::: Supplemental Folic Acid, mcg ::: decimal ::: mcg ::: 0 ::: 20400 ::: supplemental folic acid, mcg ::: NULL ::: NULL ::: NULL ::: NULL ::: folic acid;folic acid measurement ::: C0016410;C0523631 ::: orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00126946.v1 ::: phs000286.v3.p1 ::: pht001953.v1 ::: DPASS_DIET1_ES ::: ravg_glut ::: RECALL: glutamic acid ::: decimal ::: NONE ::: 4.0375 ::: 33.9375 ::: recall  glutamic acid ::: NULL ::: NULL ::: NULL ::: NULL ::: mental recall;recall:-:point in time:^patient:-;glutamic acid;glutamate measurement ::: C0034770;C2361119;C0061472;C0523665 ::: menp;clna;aapp,bacs,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Mental or Emotional Finding
phv00002226.v1 ::: phs000007.v18.p7 ::: pht000016.v3 ::: ex0_14s ::: FG91 ::: INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS ::: NONE ::: NONE ::: NONE ::: NONE ::: interim history of medicine used  anti cholesterol agents ::: NULL ::: NULL ::: NULL ::: NULL ::: medical history;history of previous events;pharmaceutical preparations;used by;anti-anxiety agents;serum total cholesterol measurement ::: C0262926;C2004062;C0013227;C1273517;C0040616;C1445957 ::: fndg;fndg;phsu;fndg;phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Medical History
phv00032899.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL26B11 ::: Post-breakfast blood glucose at OD 340 (quarterly visit 11) ::: float ::: OD 340 ::: NONE ::: NONE ::: post breakfast blood glucose at od 340   quarterly visit 11 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033295.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL26B29 ::: Post-breakfast blood glucose at OD 340 (quarterly visit 29) ::: float ::: OD 340 ::: NONE ::: NONE ::: post breakfast blood glucose at od 340   quarterly visit 29 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00162223.v2 ::: phs000007.v18.p7 ::: pht002350.v2 ::: vr_ffreq_ex08_1_0615s ::: TUNA ::: FFQ: CANNED TUNA FISH ::: encoded ::: 3 - 4 oz ::: NONE ::: NONE ::: food frequency questionnaire  canned tuna fluorescent in situ hybridization ::: NULL ::: NULL ::: NULL ::: NULL ::: food;tuna - dietary;tuna allergenic extract;in situ hybridization ::: C0016452;C0453048;C2702350;C0162788 ::: food;food;imft,phsu;lbpr,mbrt ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00147741.v2 ::: phs000209.v10.p2 ::: pht002102.v2 ::: MESA_AncilMesaLungExam3CT ::: RMP_air_v ::: RIGHT LUNG, MIDDLE PEEL: TOTAL VOLUME OF AIR IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, middle peel  total volume of air in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;localized desquamation ::: C2700258;C0520893 ::: lbpr;patf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00077363.v3 ::: phs000200.v8.p2 ::: pht000986.v3 ::: cbc_rel1 ::: CBCDAYS ::: CBC Days since randomization/enrollment ::: integer ::: days ::: -1023 ::: 2479 ::: complete blood count days since randomization enrollment ::: NULL ::: NULL ::: NULL ::: NULL ::: complete blood count;randomization;enrollment ::: C0009555;C0034656;C1516879 ::: lbpr;resa;hlca ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Healthcare Activity Finding;Research Attributes
phv00100281.v1 ::: phs000287.v2.p1 ::: pht001451.v1 ::: BASE2 ::: BRADYC ::: CALCULATED PERSISTENT BRADYCARDIA <40 BE ::: encoded ::: NONE ::: NONE ::: NONE ::: calculated persistent bradycardia <40 be ::: NULL ::: NULL ::: NULL ::: NULL ::: bradycardia;calculated (procedure) ::: C0428977;C1443182 ::: patf;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00143678.v3 ::: phs000209.v10.p2 ::: pht002100.v3 ::: MESA_AncilMesaLungExam1CT ::: RLP_tot_v ::: RIGHT LUNG, LOWER PEEL: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, lower peel  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;localized desquamation ::: C2700258;C0520893 ::: lbpr;patf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00058592.v2 ::: phs000128.v3.p3 ::: pht000413.v2 ::: simphen014 ::: rx3 ::: 1:Rx for high LDL, 0:No Rx, visit 3 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 3 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00027672.v1 ::: phs000086.v2.p1 ::: pht000231.v1 ::: DCCT_ms5exprt ::: DRINKS24 ::: Patient reports using alcohol: quarterly visit 24 ::: byte ::: NONE ::: NONE ::: NONE ::: patient reports using alcohol  quarterly visit 24 ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement;health care visit ::: C0001975;C0202304;C1512346 ::: orch,phsu;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History
phv00085241.v2 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: chlageu1 ::: CHOLESTEROL MEDS, AGE STARTED UNKNOWN ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: cholesterol meds, age started unknown ::: Age ::: age ::: C0001779 ::: orga ::: serum total cholesterol measurement ::: C1445957 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Demographics;Lab Tests Patient
phv00111796.v3 ::: phs000200.v8.p2 ::: pht001517.v3 ::: f60_item_rel1 ::: FRYFISH ::: Item #53: Fried fish/fish sandwich/fried shellfish, med serv/day ::: decimal ::: servings ::: 0 ::: 3 ::: item  number 53  fried fluorescent in situ hybridization fluorescent in situ hybridization sandwich fried shellfish, med serv day ::: NULL ::: NULL ::: NULL ::: NULL ::: french fries;in situ hybridization;shellfish - dietary ::: C1510451;C0162788;C0036950 ::: food;lbpr,mbrt;food ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Eating or Nutritional Finding
phv00062969.v2 ::: phs000128.v3.p3 ::: pht000550.v2 ::: simphen151 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00032798.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL31A06 ::: Bedtime blood glucose mg/dl (quarterly visit 06) ::: int ::: MG/DL ::: NONE ::: NONE ::: bedtime blood glucose magnesium distolingual  quarterly visit 06 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00163823.v2 ::: phs000159.v4.p2 ::: pht000817.v4 ::: AML_Subject_Phenotypes ::: Immunophenotype & Cytochemistry: CD13 % Positive ::: Immunophenotype & Cytochemistry: CD13 % Positive ::: NONE ::: NONE ::: NONE ::: NONE ::: immunophenotype & cytochemistry  cd13  % positive ::: NULL ::: NULL ::: NULL ::: NULL ::: immunophenotyping;positive finding ::: C0079611;C1514241 ::: lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00023742.v1 ::: phs000007.v18.p7 ::: pht000158.v2 ::: heard0_22s ::: MCR_R_10 ::: SSI-ICM TEST - +10 MCR SCORE - RIGHT EAR ::: NONE ::: NONE ::: NONE ::: NONE ::: ssi icm test +10 mcr score right ear ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00018445.v1 ::: phs000017.v3.p1 ::: pht000058.v1 ::: EA_DIGS4_Data ::: V1417 ::: J44. Opiates.  (Participants with European ancestry). DIGS4 ::: NONE ::: NONE ::: NONE ::: NONE ::: j44   opiates   participants with european ancestry   diagnostic interview for genetic studies ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: opioid abuse;opiate assay;opiates;diagnosis;genetic study ::: C0029095;C0242401;C0376196;C0011900;C2827447 ::: mobd;lbpr;hops,phsu;fndg;resa ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Substance Use History;Research Attributes;Medical History
phv00172766.v1 ::: phs000007.v18.p7 ::: pht002900.v1 ::: vr_ffreq_ex02_3_0713s ::: nut_nia_wo ::: Derived field: Nutrient value - Niacin without supplements ::: decimal, encoded ::: mg ::: 1.13 ::: 163.09 ::: derived field  nutrient value niacin without supplements ::: NULL ::: NULL ::: NULL ::: NULL ::: nutrients;niacin;vitamin b3 assay;dietary supplements ::: C0678695;C0027996;C1142562;C0242295 ::: food;orch,phsu,vita;lbpr;food ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00142505.v1 ::: phs000308.v1.p1 ::: pht002086.v1 ::: GLAUGEN_Subject_Phenotypes ::: GENEVA_ID ::: NHS/HPFS/GEP: Unique GENEVA ID ::: integer ::: NONE ::: NONE ::: NONE ::: national health service health professionals follow-up study the genetic etiologies of primary-open angle glaucoma study  unique gene-environment association studies identification ::: NULL ::: NULL ::: NULL ::: NULL ::: health services, national;follow-up studies;primary open angle glaucoma;clinical trials;study;mental association;scientific study;identification (psychology) ::: C0027462;C0016441;C0339573;C0008976;C2603343;C0004083;C0947630;C0020792 ::: hlca;resa;dsyn;resa;resa;menp;lbpr;menp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Research Attributes;Medical History
phv00059858.v2 ::: phs000128.v3.p3 ::: pht000453.v2 ::: simphen054 ::: rx1 ::: 1:Rx for high LDL,0:No Rx, visit 1 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0 no rx, visit 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00031767.v1 ::: phs000086.v2.p1 ::: pht000269.v1 ::: DCCT_cbl5 ::: BCNLD24 ::: CBL5: Lipid test - 24: collection date ::: str6 ::: NONE ::: NONE ::: NONE ::: cbl5  lipid test 24  collection date ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00050429.v1 ::: phs000086.v2.p1 ::: pht000338.v1 ::: EDIC_f0702 ::: GOB8E1 ::: B8e1. Health care delivery. During the past 6 months have you had laboratory test: stress test, how many times ::: byte ::: Times ::: NONE ::: NONE ::: b8e1   health candidate gene association resource delivery  during the past 6 months have you had laboratory test  stress test, how many times ::: NULL ::: NULL ::: NULL ::: NULL ::: mental association;obstetric delivery;delivery finding;laboratory procedures;exercise stress test ::: C0004083;C0011209;C0559563;C0022885;C0015260 ::: menp;topp;fndg;lbpr;diap ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Therapeutic or Preventive Procedure;Diagnostic Procedure;Medical History
phv00010841.v1 ::: phs000007.v18.p7 ::: pht000042.v3 ::: mm0_28s ::: COGSCR18 ::: Total score for cognitive function test ::: integer, encoded ::: points ::: 0 ::: 30 ::: total score for cognitive function test ::: NULL ::: NULL ::: NULL ::: NULL ::: cognitive functions;laboratory procedures ::: C0392335;C0022885 ::: menp;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00033379.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: NLD25_33 ::: Blood glucose profile analysis date (quarterly visit 33) ::: str6 ::: NONE ::: NONE ::: NONE ::: blood glucose profile analysis date  quarterly visit 33 ::: NULL ::: NULL ::: NULL ::: NULL ::: profile (lab procedure);analysis of substances;date fruit;analysis;blood glucose measurement;health care visit ::: C1979963;C0002778;C2348077;C0936012;C0392201;C1512346 ::: lbpr;lbpr;food;resa;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00064611.v2 ::: phs000007.v18.p7 ::: pht000606.v3 ::: cmrefat1_2006s ::: CHMID ::: 4CH VIEW ED MID RV ::: NONE ::: MM ::: NONE ::: NONE ::: 4ch view ed mid residual volume ::: NULL ::: NULL ::: NULL ::: NULL ::: erectile dysfunction;residual volume;lung residual volume measurement;volume.residual:volume:point in time:respiratory system:quantitative ::: C0242350;C0035190;C0429713;C0802961 ::: dsyn;clna;lbpr;clna ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00149277.v1 ::: phs000209.v10.p2 ::: pht002103.v1 ::: MESA_AncilMesaLungExam4CT ::: R_tot_v ::: RIGHT LUNG: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142180.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: CACNB2_Run3_Plate ::: RNA LEVELS: CACNB2, Run3, Platelet (TaqmanAssayID : Hs00167861_m1) ::: decimal, encoded ::: cycle threshold ::: 14.5603805305001 ::: 26.9963095600494 ::: ribonucleic acid levels  cacnb2, run3, platelet  taqmanassayid   hs00167861_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00033357.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: NLD25_32 ::: Blood glucose profile analysis date (quarterly visit 32) ::: str6 ::: NONE ::: NONE ::: NONE ::: blood glucose profile analysis date  quarterly visit 32 ::: NULL ::: NULL ::: NULL ::: NULL ::: profile (lab procedure);analysis of substances;date fruit;analysis;blood glucose measurement;health care visit ::: C1979963;C0002778;C2348077;C0936012;C0392201;C1512346 ::: lbpr;lbpr;food;resa;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00171683.v1 ::: phs000462.v1.p1 ::: pht002844.v1 ::: T2D_GENES_Subject_Phenotypes ::: CHOL_YR ::: Year of the most recent study visit for which we have Total cholesterol ::: integer ::: Year ::: 1992 ::: 2012 ::: year of the most recent study visit for which we have total cholesterol ::: NULL ::: NULL ::: NULL ::: NULL ::: clinical trials;health care visit;study;serum total cholesterol measurement ::: C0008976;C1512346;C2603343;C1445957 ::: resa;inbe;resa;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00162609.v2 ::: phs000007.v18.p7 ::: pht002350.v2 ::: vr_ffreq_ex08_1_0615s ::: FFD85 ::: DERIVED FIELD:OTHER FISH ::: decimal, encoded ::: servings/week ::: 0 ::: 5.5 ::: derived field other fluorescent in situ hybridization ::: NULL ::: NULL ::: NULL ::: NULL ::: others;in situ hybridization ::: C1955473;C0162788 ::: fndg;lbpr,mbrt ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00062002.v2 ::: phs000128.v3.p3 ::: pht000520.v2 ::: simphen121 ::: rx1 ::: 1:Rx for high LDL,0:No Rx, visit 1 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0 no rx, visit 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00061568.v2 ::: phs000128.v3.p3 ::: pht000506.v2 ::: simphen107 ::: rx3 ::: 1:Rx for high LDL, 0:No Rx, visit 3 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 3 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00059264.v2 ::: phs000128.v3.p3 ::: pht000434.v2 ::: simphen035 ::: rx3 ::: 1:Rx for high LDL, 0:No Rx, visit 3 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 3 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00151530.v3 ::: phs000209.v10.p2 ::: pht002108.v3 ::: MESA_MesaAirNR_LungCT ::: RLP_air_v ::: RIGHT LUNG, LOWER PEEL: TOTAL VOLUME OF AIR IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, lower peel  total volume of air in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;localized desquamation ::: C2700258;C0520893 ::: lbpr;patf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00060025.v2 ::: phs000128.v3.p3 ::: pht000458.v2 ::: simphen059 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00076122.v1 ::: phs000203.v1.p1 ::: pht000881.v1 ::: eMERGE_PAD_Phenotype ::: dyslipidemia ::: Total cholesterol >= 200 OR Triglycerides >= 150 OR HDL cholesterol <= 40 OR 'C49488=Yes' (taking) lipid lowering medications ::: Encoded value ::: NONE ::: NONE ::: NONE ::: total cholesterol >= 200  or triglycerides >= 150  or high-density lipoprotein cholesterol <= 40 or  c49488=yes   taking  lipid lowering medications ::: NULL ::: NULL ::: NULL ::: NULL ::: serum total cholesterol measurement;pharmaceutical preparations;medications:presence or identity:duration of the study:^patient:nominal;medications:-:point in time:^patient:- ::: C1445957;C0013227;C0802604;C2598133 ::: lbpr;phsu;clna;clna ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00105799.v1 ::: phs000287.v2.p1 ::: pht001490.v1 ::: YR5NEW ::: TANDEM27 ::: CAN PTT DO A TANDEM STAND ::: encoded ::: NONE ::: NONE ::: NONE ::: can ptt do a tandem stand ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement;tandem;does stand ::: C0030605;C0075804;C0596013 ::: lbpr;orch,phsu;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Daily or Recreational Activity
phv00166823.v2 ::: phs000007.v18.p7 ::: pht002566.v2 ::: l_mtbli2_ex05_1_0660s ::: thyroxine ::: Thyroxine ::: decimal, encoded ::: NONE ::: 0.1199 ::: 2.6348 ::: thyroxine ::: NULL ::: NULL ::: NULL ::: NULL ::: thyroxine;total thyroxine measurement ::: C0040165;C1281902 ::: aapp,horm,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00170076.v1 ::: phs000200.v8.p2 ::: pht002761.v1 ::: outc_cardio_cad_rel2 ::: CKMNORMP ::: CK-MB within norm % or index ::: encoded value ::: NONE ::: NONE ::: NONE ::: ckmb within norm % or index ::: NULL ::: NULL ::: NULL ::: NULL ::: creatine kinase mb measurement ::: C0523584 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00092995.v1 ::: phs000280.v1.p1 ::: pht001310.v1 ::: ARIC_CARE_DERV4C1 ::: LCOMPS41 ::: Plaque/shadowing in the left common ::: encoded ::: NONE ::: NONE ::: NONE ::: plaque shadowing in the left common ::: NULL ::: NULL ::: NULL ::: NULL ::: dental plaque;plaque (lesion);senile plaques;shadowing (histology);therapeutic shadowing ::: C0011389;C0332461;C0333463;C0085195;C0600111 ::: dsyn;fndg;acab;lbpr;topp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00050685.v1 ::: phs000086.v2.p1 ::: pht000339.v1 ::: EDIC_f0703 ::: GOB8IB2 ::: B6ib2. Health care delivery. Other major tests: paid by insurance ::: byte ::: Times ::: NONE ::: NONE ::: b6ib2   health candidate gene association resource delivery  other major tests  paid by insurance ::: NULL ::: NULL ::: NULL ::: NULL ::: mental association;obstetric delivery;others;laboratory procedures;delivery finding ::: C0004083;C0011209;C1955473;C0022885;C0559563 ::: menp;topp;fndg;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Therapeutic or Preventive Procedure;Medical History
phv00027393.v1 ::: phs000086.v2.p1 ::: pht000230.v1 ::: DCCT_cbl2 ::: BCVAL22 ::: CBL2: Lipid test - 22: triglyceride (serum) value  (mg/dl) ::: int ::: MG/DL ::: NONE ::: NONE ::: cbl2  lipid test 22  triglyceride  serum  value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: measurement of serum lipid level;serum magnesium finding ::: C0428462;C1826990 ::: lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163981.v1 ::: phs000398.v1.p1 ::: pht002467.v1 ::: HeartGO_ARIC_LDLandEOMI_PhenotypeDataFile ::: ESP_AGE_AT_FIBRINOGEN ::: Age in years at Fibrinogen measurement ::: Numeric ::: Years ::: NONE ::: NONE ::: age in years at fibrinogen measurement ::: Age ::: age ::: C0001779 ::: orga ::: fibrinogen assay ::: C0337428 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Demographics;Lab Tests Patient
phv00088077.v1 ::: phs000094.v1.p1 ::: pht001138.v1 ::: Oral_Clefts_Sample ::: SUBJID ::: GENEVA ID ::: integer ::: NONE ::: NONE ::: NONE ::: gene-environment association studies identification ::: NULL ::: NULL ::: NULL ::: NULL ::: mental association;scientific study;identification (psychology) ::: C0004083;C0947630;C0020792 ::: menp;lbpr;menp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00032680.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL27B99 ::: Pre-lunch blood glucose at OD 340 (close-out) ::: float ::: OD 340 ::: NONE ::: NONE ::: pre lunch blood glucose at od 340   close out ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans ::: C0392201;C0029421 ::: lbpr;dsyn ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00124418.v1 ::: phs000304.v1.p1 ::: pht001907.v1 ::: GABC_Subject_Phenotypes ::: RDW (%) ::: Red blood cell width distribution, variance in percentage ::: decimal ::: % ::: 11.15 ::: 19.1 ::: red blood cell width distribution, variance in percentage ::: NULL ::: NULL ::: NULL ::: NULL ::: red cell distribution width determination ::: C0427460 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00143478.v3 ::: phs000209.v10.p2 ::: pht002100.v3 ::: MESA_AncilMesaLungExam1CT ::: R_tot_v ::: RIGHT LUNG: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00115697.v2 ::: phs000285.v2.p2 ::: pht001667.v2 ::: C1F12PF ::: C12RPFE1 ::: REPRODUCIBILITY OF MAX FEV1 (VOLUME DIF) ::: decimal ::: NONE ::: 0 ::: 2.92 ::: reproducibility of max fev1  volume dif ::: NULL ::: NULL ::: NULL ::: NULL ::: forced expiratory volume in 1 second finding;volume measurement;volume^at 1.0 s post forced expiration:volume:point in time:respiratory system:quantitative;pulmonary function test/forced expiratory volume 1 ::: C0429706;C2700258;C0802965;C0849974 ::: fndg;lbpr;clna;diap ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure;Medical History
phv00030723.v1 ::: phs000086.v2.p1 ::: pht000253.v1 ::: DCCT_baseline ::: SCR ::: Serum creatinine value (mg/dl, form 23b) ::: float ::: MG/DL ::: NONE ::: NONE ::: serum creatinine value  magnesium dl, form 23 b ::: NULL ::: NULL ::: NULL ::: NULL ::: serum magnesium finding;creatinine finding;creatinine measurement, serum (procedure) ::: C1826990;C1561535;C0201976 ::: fndg;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00024789.v3 ::: phs000007.v18.p7 ::: pht000209.v4 ::: ton1_7s ::: erd ::: EFFECTIVE REFLECTION DISTANCE (MM)  CALCULATED: CFPWV C0TI/2 ::: NONE ::: MM ::: NONE ::: NONE ::: effective reflection distance  millimeter  calculated  cfpwv c0ti 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: calculated (procedure) ::: C1443182 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00056561.v3 ::: phs000007.v18.p7 ::: pht000395.v6 ::: sleep1_1998s ::: TSTMN51 ::: From recorder: Start test - minute ::: NONE ::: NONE ::: NONE ::: NONE ::: from recorder  start test minute ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00063737.v2 ::: phs000128.v3.p3 ::: pht000574.v2 ::: simphen175 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00171665.v1 ::: phs000462.v1.p1 ::: pht002844.v1 ::: T2D_GENES_Subject_Phenotypes ::: LEPTIN_YR ::: Year of the most recent study visit for which we have Leptin concentration ::: integer ::: Year ::: 1992 ::: 2012 ::: year of the most recent study visit for which we have leptin concentration ::: NULL ::: NULL ::: NULL ::: NULL ::: clinical trials;health care visit;study;mental concentration;leptin measurement ::: C0008976;C1512346;C2603343;C0086045;C1295176 ::: resa;inbe;resa;menp;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Research Attributes
phv00146009.v1 ::: phs000209.v10.p2 ::: pht002101.v1 ::: MESA_AncilMesaLungExam2CT ::: RUC_tot_v ::: RIGHT LUNG, UPPER CORE: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, upper core  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00061433.v2 ::: phs000128.v3.p3 ::: pht000502.v2 ::: simphen103 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00051755.v1 ::: phs000128.v3.p3 ::: pht000362.v1 ::: cohort ::: alc2 ::: EQUIVALENT ALCOHOL OZ (PER WEEK), EXAM2 ::: integer ::: ounces ::: 0 ::: 33 ::: equivalent alcohol oz  per week , exam2 ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement ::: C0001975;C0202304 ::: orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History
phv00165226.v1 ::: phs000400.v1.p1 ::: pht002536.v1 ::: HeartGO_CHS_LDL_PhenotypeDataFile ::: ESP_MONOCYTES ::: Monocytes in absolute numbers at designated visit (may not be baseline). ::: Numeric ::: NONE ::: NONE ::: NONE ::: monocytes in absolute numbers at designated visit  may not be baseline ::: NULL ::: NULL ::: NULL ::: NULL ::: monocyte count procedure;health care visit ::: C0200637;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163886.v2 ::: phs000159.v4.p2 ::: pht000817.v4 ::: AML_Subject_Phenotypes ::: TEL-AML1: For FISH tested indicate % ::: :TEL-AML1: For FISH tested indicate % ::: :NONE ::: % ::: NONE ::: NONE ::: tel aml1  for fluorescent in situ hybridization tested indicate % ::: NULL ::: NULL ::: NULL ::: NULL ::: in situ hybridization;indicated ::: C0162788;C1444656 ::: lbpr,mbrt;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00162386.v2 ::: phs000007.v18.p7 ::: pht002350.v2 ::: vr_ffreq_ex08_1_0615s ::: NUT_GLUT ::: Derived field: Nutrient value - Glutamate ::: decimal, encoded ::: gm ::: 3.7 ::: 45.34 ::: derived field  nutrient value glutamate ::: NULL ::: NULL ::: NULL ::: NULL ::: nutrients;glutamate measurement ::: C0678695;C0523665 ::: food;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Eating or Nutritional Finding
phv00143977.v3 ::: phs000209.v10.p2 ::: pht002100.v3 ::: MESA_AncilMesaLungExam1CT ::: RUC_tis_v ::: RIGHT LUNG, UPPER CORE: TOTAL VOLUME OF TISSUE IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, upper core  total volume of tissue in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142178.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: B2M_Run3_Plate ::: RNA LEVELS: B2M, Run3, Platelet (TaqmanAssayID : Hs99999907_m1) ::: decimal, encoded ::: cycle threshold ::: 2.5 ::: 26.7836629202224 ::: ribonucleic acid levels  b2 m, run3, platelet  taqmanassayid   hs99999907_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00156427.v2 ::: phs000200.v8.p2 ::: pht002125.v2 ::: f60_nutr_rel1 ::: F60VITB6 ::: Dietary Vitamin B6 (mg) ::: decimal ::: mg ::: 0 ::: 21.47606 ::: dietary vitamin b6  magnesium ::: NULL ::: NULL ::: NULL ::: NULL ::: vitamin b6;blood vitamin b6 analysis ::: C0087162;C0696232 ::: orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00050676.v1 ::: phs000086.v2.p1 ::: pht000339.v1 ::: EDIC_f0703 ::: GOB8H3 ::: B8h3. Health care delivery. Urine tests: paid by other insurance ::: byte ::: Times ::: NONE ::: NONE ::: b8h3   health candidate gene association resource delivery  urine tests  paid by other insurance ::: NULL ::: NULL ::: NULL ::: NULL ::: mental association;obstetric delivery;urinalysis;delivery finding ::: C0004083;C0011209;C0042014;C0559563 ::: menp;topp;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Therapeutic or Preventive Procedure;Medical History
phv00128717.v1 ::: phs000209.v10.p2 ::: pht001984.v1 ::: MESA_AncilMesaInflammation ::: epccd8lm ::: REASON FOR MISSING DATA: ESTIMATED %CD8, AS A PERCENT OF LYMPHOCYTES ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: reason for missing data  estimated %cd8, as a percent of lymphocytes ::: NULL ::: NULL ::: NULL ::: NULL ::: lymphocyte count measurement ::: C0200635 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163552.v1 ::: phs000433.v1.p1 ::: pht002436.v1 ::: SIGNET_Subject_Phenotypes ::: FST ::: Fasting glucose ::: integer, encoded value ::: NONE ::: NONE ::: NONE ::: fasting glucose ::: NULL ::: NULL ::: NULL ::: NULL ::: fasting;glucose;plasma glucose measurement ::: C0015663;C0017725;C0202042 ::: fndg;bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Medical History
phv00063904.v2 ::: phs000128.v3.p3 ::: pht000579.v2 ::: simphen180 ::: rx3 ::: 1:Rx for high LDL, 0:No Rx, visit 3 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 3 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00113708.v2 ::: phs000285.v2.p2 ::: pht001588.v2 ::: A4LIP ::: AL1CHLDT ::: CHOLESTEROL ANALYSIS DATE ::: encoded ::: NONE ::: NONE ::: NONE ::: cholesterol analysis date ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;date fruit;analysis;serum total cholesterol measurement ::: C0002778;C2348077;C0936012;C1445957 ::: lbpr;food;resa;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00012019.v1 ::: phs000017.v3.p1 ::: pht000056.v1 ::: EA_DIGS2_Data ::: I17686 ::: E8a. Please tell me more about these periods we've just discussed. DURATION (WEEKS). (Participants with European ancestry). DIGS2 ::: NONE ::: Weeks ::: NONE ::: NONE ::: e8 a  please tell medical examiner more about these periods we expired volume just discussed  duration  weeks    participants with european ancestry   digs2 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: duration;volume measurement ::: C2926735;C2700258 ::: phsu;lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Lab Tests Patient
phv00030729.v1 ::: phs000086.v2.p1 ::: pht000253.v1 ::: DCCT_baseline ::: WPMEAN ::: Within-profile mean blood glucose value (mg/dl) ::: float ::: MG/DL ::: NONE ::: NONE ::: within profile mean blood glucose value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: profile (lab procedure);glucose;plasma glucose measurement;blood glucose measurement ::: C1979963;C0017725;C0202042;C0392201 ::: lbpr;bacs,carb,phsu;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00121977.v1 ::: phs000188.v1.p1 ::: pht001895.v1 ::: QRS_Sample ::: CHIPGENOTYPED ::: The chip a sample was genotyped on (Platform) ::: string ::: NONE ::: NONE ::: NONE ::: the chip a sample was genotyped on  platform ::: NULL ::: NULL ::: NULL ::: NULL ::: genotype determination ::: C1285573 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00172254.v1 ::: phs000007.v18.p7 ::: pht002894.v1 ::: l_mtblcmhi2_ex05_1_0708s ::: cmh_fruc_gluc_galac ::: Fructose + glucose + galactose ::: NONE ::: NONE ::: 0.5318 ::: 1.2882 ::: fructose + glucose + galactose ::: NULL ::: NULL ::: NULL ::: NULL ::: fructose;glucose;plasma glucose measurement ::: C0016745;C0017725;C0202042 ::: carb,phsu;bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00031007.v1 ::: phs000086.v2.p1 ::: pht000260.v1 ::: DCCT_cbl9 ::: BCURCR ::: CBL9: 24-hr urine: creatinine/urine: value (mg/dl) ::: int ::: MG/DL ::: NONE ::: NONE ::: cbl9  24 heart rate urine  creatinine urine  value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine;creatinine finding;urine creatinine measurement ::: C0428308;C1561535;C1318439 ::: lbpr;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00124417.v1 ::: phs000304.v1.p1 ::: pht001907.v1 ::: GABC_Subject_Phenotypes ::: MCHC (g/dL) ::: Mean corpuscular hemoglobin concentration in grams per deciliter ::: decimal ::: grams per deciliter ::: 27.3 ::: 48.8 ::: mean corpuscular hemoglobin concentration in grams per deciliter ::: NULL ::: NULL ::: NULL ::: NULL ::: mean corpuscular hemoglobin concentration determination ::: C0474535 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00167746.v1 ::: phs000454.v1.p1 ::: pht002650.v1 ::: HIV_Susceptibility_Subject_Phenotypes ::: lca_group ::: Latent Class Analysis (LCA) assigned HIV risk group used in frequency matching ::: integer ::: NONE ::: 1 ::: 3 ::: latent class analysis  left carotid artery  assigned human immunodeficiency virus risk group used in frequency matching ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;hiv infections;used by;matching ::: C0002778;C0936012;C0019693;C1273517;C0150103 ::: lbpr;resa;dsyn;fndg;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00032836.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL28A08 ::: Post-lunch blood glucose mg/dl (quarterly visit 08) ::: int ::: MG/DL ::: NONE ::: NONE ::: post lunch blood glucose magnesium distolingual  quarterly visit 08 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00048507.v1 ::: phs000086.v2.p1 ::: pht000324.v1 ::: EDIC_cbldata ::: BOVOLT1 ::: GFR (glomerular filtration rate) urine-volume: t-1 ::: int ::: NONE ::: NONE ::: NONE ::: glomerular filtration rate  glomerular filtration rate  urine volume  t1 ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;urine volume function;urine sample volume measurement;urine volume finding;glomerular filtration rate finding ::: C0017654;C0232856;C1278293;C1287298;C1561549 ::: diap,ortf;clna;lbpr;fndg;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure;Medical History
phv00025651.v1 ::: phs000086.v2.p1 ::: pht000213.v1 ::: DCCT_f0033 ::: OCDM3LUD ::: Diabetes monitoring (three or more daily injections or infusion pump): blood test(s) done before lunch ::: int ::: BLOOD TESTS ::: NONE ::: NONE ::: diabetes monitoring  three or more daily injections or infusion pump   blood test s  done before lunch ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetes monitoring check done;injection of therapeutic agent;injection procedure;hematologic tests;blood analysis (lab test) ::: C0422587;C0021485;C1533685;C0018941;C2121789 ::: fndg;topp;topp;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00163486.v1 ::: phs000007.v18.p7 ::: pht002429.v1 ::: t_pwaved_1975_m_0644s ::: lead_aVR_3 ::: Lead aVR measurement 3 ::: integer ::: ms ::: 57 ::: 124 ::: lead avr measurement 3 ::: NULL ::: NULL ::: NULL ::: NULL ::: lead measurement ::: C0524167 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00012162.v1 ::: phs000017.v3.p1 ::: pht000056.v1 ::: EA_DIGS2_Data ::: I4890 ::: F35. Did this episode follow increased use of alcohol? IF YES: specify. MOST SEVERE EPISODE. (Participants with European ancestry). DIGS2 ::: NONE ::: NONE ::: NONE ::: NONE ::: f35   did this episode follow increased use of alcohol  if yes  specify  most severe episode   participants with european ancestry   digs2 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: alcohols;alcohol measurement ::: C0001975;C0202304 ::: orch,phsu;lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Drinking History
phv00073544.v2 ::: phs000091.v2.p1 ::: pht000800.v2 ::: Type2Diabetes_NHS_HPFS_Sample ::: SAMPID ::: Sample genotyping instance ID ::: string, integer ::: NONE ::: NONE ::: NONE ::: sample genotyping instance identification ::: NULL ::: NULL ::: NULL ::: NULL ::: genotype determination;identification (psychology) ::: C1285573;C0020792 ::: lbpr;menp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00126354.v1 ::: phs000286.v3.p1 ::: pht001952.v1 ::: DPASS_DIET1 ::: lffq_nia ::: LFFQ: niacin (mg) ::: decimal ::: mg ::: 4.970579 ::: 93.91473 ::: lffq  niacin  magnesium ::: NULL ::: NULL ::: NULL ::: NULL ::: niacin;vitamin b3 assay ::: C0027996;C1142562 ::: orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033162.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL26A23 ::: Post-breakfast blood glucose mg/dl (quarterly visit 23) ::: int ::: MG/DL ::: NONE ::: NONE ::: post breakfast blood glucose magnesium distolingual  quarterly visit 23 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00032886.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL31A10 ::: Bedtime blood glucose mg/dl (quarterly visit 10) ::: int ::: MG/DL ::: NONE ::: NONE ::: bedtime blood glucose magnesium distolingual  quarterly visit 10 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00054359.v1 ::: phs000017.v3.p1 ::: pht000383.v1 ::: AA_GAIN_phenotype_controls_main_subset ::: previously_genotyped_+well ::: SNP genotyping success rate: Y = at least 95% SNP genotyping success rate. (African American participants) ::: string ::: NONE ::: NONE ::: NONE ::: single nucleotide polymorphism genotyping success rate  y = at least 95% single nucleotide polymorphism genotyping success rate   african american participants ::: Marital Status;Race ::: single nucleotide polymorphism;african american ::: C0752046;C0085756 ::: nusq;popg ::: genotype determination ::: C1285573 ::: lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Lab Tests Patient
phv00051127.v1 ::: phs000086.v2.p1 ::: pht000343.v1 ::: EDIC_f0913 ::: IAC5RES1 ::: C5. Diagnostic tests performed. Result of test 1 ::: byte ::: NONE ::: NONE ::: NONE ::: c5  diagnostic tests performed  result of test 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: diagnostic tests;laboratory procedures;experimental result ::: C0086143;C0022885;C2825142 ::: diap;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure
phv00032771.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL28B05 ::: Post-lunch blood glucose at OD 340 (quarterly visit 05) ::: float ::: OD 340 ::: NONE ::: NONE ::: post lunch blood glucose at od 340   quarterly visit 05 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00129480.v2 ::: phs000309.v2.p2 ::: pht001998.v2 ::: CARDIA_Sample ::: SUBJID ::: GENEVA ID ::: integer ::: NONE ::: NONE ::: NONE ::: gene-environment association studies identification ::: NULL ::: NULL ::: NULL ::: NULL ::: mental association;scientific study;identification (psychology) ::: C0004083;C0947630;C0020792 ::: menp;lbpr;menp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00013757.v1 ::: phs000017.v3.p1 ::: pht000056.v1 ::: EA_DIGS2_Data ::: I13650 ::: K70. Did the current/most recent episode follow increased or excessive use of alcohol? If yes, specify. (Participants with European ancestry). DIGS2 ::: NONE ::: NONE ::: NONE ::: NONE ::: k70   did the current most recent episode follow increased or excessive use of alcohol  if yes, specify   participants with european ancestry   digs2 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: alcohols;alcohol measurement ::: C0001975;C0202304 ::: orch,phsu;lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Drinking History
phv00122552.v1 ::: phs000284.v1.p1 ::: pht001902.v1 ::: CFS_CARe_Subject_Phenotypes ::: DRKALC ::: Drinks alcohol (C) ::: encoded ::: NONE ::: NONE ::: NONE ::: drinks alcohol  c ::: NULL ::: NULL ::: NULL ::: NULL ::: drink (dietary substance);alcohols;alcohol measurement ::: C0452428;C0001975;C0202304 ::: food;orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History;Eating or Nutritional Finding
phv00126484.v1 ::: phs000286.v3.p1 ::: pht001952.v1 ::: DPASS_DIET1 ::: ravg_pant ::: RECALL: pantothenic acid ::: decimal ::: NONE ::: 1.25 ::: 80.22437 ::: recall  pantothenic acid ::: NULL ::: NULL ::: NULL ::: NULL ::: mental recall;recall:-:point in time:^patient:-;pantothenic acid;blood pantothenic acid analysis;vitamin b5 measurement ::: C0034770;C2361119;C0030342;C0696237;C2700255 ::: menp;clna;orch,phsu,vita;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Mental or Emotional Finding
phv00020973.v4 ::: phs000007.v18.p7 ::: pht000074.v6 ::: ex3_1s ::: G3A118 ::: IF EVER CONSUMED ALCOHOL: DO YOU DRINK WHITE WINE AT LEAST ONCE A MONTH? ::: NONE ::: NONE ::: NONE ::: NONE ::: if ever consumed alcohol  do you drink white wine at least once a month ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement;drink (dietary substance);white wine ::: C0001975;C0202304;C0452428;C0349372 ::: orch,phsu;lbpr;food;food ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History;Eating or Nutritional Finding
phv00033264.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL33A27 ::: Blood glucose profile 8 - mg/dl (quarterly visit 27) ::: int ::: MG/DL ::: NONE ::: NONE ::: blood glucose profile 8 magnesium distolingual  quarterly visit 27 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;profile (lab procedure);plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C1979963;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00094435.v1 ::: phs000280.v1.p1 ::: pht001331.v1 ::: ARIC_CARE_HMTBV2C1 ::: HMTB13 ::: MEAN CORPUSCULAR VOLUME (MCV)     Q13 ::: integer ::: NONE ::: 53 ::: 140 ::: mean corpuscular volume  mean corpuscular volume  q13 ::: NULL ::: NULL ::: NULL ::: NULL ::: mean corpuscular volume analyses;erythrocyte mean corpuscular volume measurement ::: C0863148;C1948043 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00098327.v1 ::: phs000280.v1.p1 ::: pht001414.v1 ::: ARIC_CARE_VITV3C1 ::: RETINOL ::: Retinol IU ::: decimal ::: NONE ::: 0 ::: 50000 ::: retinol international unit ::: NULL ::: NULL ::: NULL ::: NULL ::: vitamin a;all-trans-retinol;vitamin a measurement ::: C0042839;C0087161;C0373745 ::: orch,phsu,vita;orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00066356.v1 ::: phs000140.v1.p1 ::: pht000631.v1 ::: T2D_Control_Data ::: FBS ::: Fasting Blood Sugar ::: continuous integer ::: mg/dL ::: NONE ::: NONE ::: fasting blood sugar ::: NULL ::: NULL ::: NULL ::: NULL ::: fasting blood sugar measurement ::: C2825162 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00001401.v1 ::: phs000007.v18.p7 ::: pht000012.v3 ::: ex0_10s ::: FC45 ::: BLOOD ANALYSIS, FASTING: BETA CHOLESTEROL (MG/100 ML) ::: NONE ::: MG/100 ML ::: NONE ::: NONE ::: blood analysis, fasting  beta cholesterol  magnesium 100 mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;fasting;serum total cholesterol measurement ::: C0002778;C0936012;C0015663;C1445957 ::: lbpr;resa;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00055889.v3 ::: phs000007.v18.p7 ::: pht000395.v6 ::: sleep1_1998s ::: RestAn3 ::: Restricted analysis: scoring ended before lights on/awake? ::: NONE ::: NONE ::: NONE ::: NONE ::: restricted analysis  scoring ended before lights on awake ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;awake ::: C0002778;C0936012;C0234422 ::: lbpr;resa;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00081028.v1 ::: phs000007.v18.p7 ::: pht001045.v2 ::: laba0_20s ::: A_G ::: Albumin/Globulin Ratio ::: decimal, encoded ::: NONE ::: 0.5 ::: 3.5 ::: albumin globulin ratio ::: NULL ::: NULL ::: NULL ::: NULL ::: albumin/globulin ratio ::: C0201837 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00147543.v2 ::: phs000209.v10.p2 ::: pht002102.v2 ::: MESA_AncilMesaLungExam3CT ::: RLC_tot_v ::: RIGHT LUNG, LOWER CORE: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, lower core  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00144859.v1 ::: phs000209.v10.p2 ::: pht002101.v1 ::: MESA_AncilMesaLungExam2CT ::: BP_tot_v ::: BOTH LUNGS, PEEL: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: both lungs, peel  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;localized desquamation ::: C2700258;C0520893 ::: lbpr;patf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00002702.v1 ::: phs000007.v18.p7 ::: pht000018.v4 ::: ex0_16s ::: FI50 ::: INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS ::: NONE ::: NONE ::: NONE ::: NONE ::: interim history of medicine used  anti cholesterol agents ::: NULL ::: NULL ::: NULL ::: NULL ::: medical history;history of previous events;pharmaceutical preparations;used by;anti-anxiety agents;serum total cholesterol measurement ::: C0262926;C2004062;C0013227;C1273517;C0040616;C1445957 ::: fndg;fndg;phsu;fndg;phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Medical History
phv00001587.v1 ::: phs000007.v18.p7 ::: pht000013.v3 ::: ex0_11s ::: FD42 ::: BLOOD ANALYSIS: FASTING LIPIDS, CHOLESTEROL - BOTTOM FRACTION (ALPHA + BETA) (SEE VARIABLE #47 FOR DECK 141 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.) ::: NONE ::: MG/100 ML ::: NONE ::: NONE ::: blood analysis  fasting lipids, cholesterol bottom fraction  alpha + beta   see variable  number 47 for deck 141  cholesterol values recorded in serum or plasma units ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;fasting;analysis;serum total cholesterol measurement;vision ::: C0002778;C0015663;C0936012;C1445957;C0042789 ::: lbpr;fndg;resa;lbpr;orgf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00109264.v1 ::: phs000287.v2.p1 ::: pht001494.v1 ::: YR8 ::: DEVICE27 ::: DOES PTT USE AN ASSISTIVE DEVICE ::: encoded ::: NONE ::: NONE ::: NONE ::: does ptt use an assistive device ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00124099.v1 ::: phs000284.v1.p1 ::: pht001902.v1 ::: CFS_CARe_Subject_Phenotypes ::: adiponectin ::: Adiponectin am (pg/mL) ::: decimal ::: NONE ::: 15.45222 ::: 1545.497 ::: adiponectin am pg m l ::: NULL ::: NULL ::: NULL ::: NULL ::: adiponectin measurement ::: C2700366 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00031219.v1 ::: phs000086.v2.p1 ::: pht000263.v1 ::: DCCT_f0217 ::: BADM1BBS ::: Diabetes monitoring - one or two daily injection(s): blood test(s) should have done before breakfast ::: int ::: BLOOD TEST(S) ::: NONE ::: NONE ::: diabetes monitoring one or two daily injection s   blood test s  should have done before breakfast ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetes monitoring check done;injection of therapeutic agent;hematologic tests;blood analysis (lab test);injection procedure ::: C0422587;C0021485;C0018941;C2121789;C1533685 ::: fndg;topp;lbpr;lbpr;topp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00032641.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL29B00 ::: Pre-supper blood glucose at OD 340 (quarterly visit 00) ::: float ::: OD 340 ::: NONE ::: NONE ::: pre supper blood glucose at od 340   quarterly visit 00 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00158290.v1 ::: phs000007.v18.p7 ::: pht002153.v1 ::: ffreq0_22s ::: TUNA ::: FFQ: CANNED TUNA FISH (3-4 OZ) ::: NONE ::: NONE ::: NONE ::: NONE ::: food frequency questionnaire  canned tuna fluorescent in situ hybridization  34 oz ::: NULL ::: NULL ::: NULL ::: NULL ::: food;tuna - dietary;tuna allergenic extract;in situ hybridization ::: C0016452;C0453048;C2702350;C0162788 ::: food;food;imft,phsu;lbpr,mbrt ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00032774.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL30A05 ::: Post-supper blood glucose mg/dl (quarterly visit 05) ::: int ::: MG/DL ::: NONE ::: NONE ::: post supper blood glucose magnesium distolingual  quarterly visit 05 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00027382.v1 ::: phs000086.v2.p1 ::: pht000230.v1 ::: DCCT_cbl2 ::: BCVAL16 ::: CBL2: Renal test - 16: creatinine (urine) value  (mg/dl) ::: float ::: MG/DL ::: NONE ::: NONE ::: cbl2  renal test 16  creatinine  urine  value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine ::: C0428308 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00050651.v1 ::: phs000086.v2.p1 ::: pht000339.v1 ::: EDIC_f0703 ::: GOB8C3 ::: B8c3. Health care delivery. Other blood tests: paid other insurance ::: byte ::: Times ::: NONE ::: NONE ::: b8c3   health candidate gene association resource delivery  other blood tests  paid other insurance ::: NULL ::: NULL ::: NULL ::: NULL ::: health insurance;mental association;obstetric delivery;others;hematologic tests;delivery finding ::: C0021682;C0004083;C0011209;C1955473;C0018941;C0559563 ::: hlca;menp;topp;fndg;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Therapeutic or Preventive Procedure;Medical History
phv00052757.v1 ::: phs000017.v3.p1 ::: pht000367.v1 ::: GAIN_AA_DIGS4 ::: V1397 ::: J41.0 Select opiates, (African American participants). DIGS4 ::: NONE ::: NONE ::: NONE ::: NONE ::: j41 0  select opiates,  african american participants   diagnostic interview for genetic studies ::: Race ::: african american ::: C0085756 ::: popg ::: opioid abuse;opiate assay;opiates;diagnosis;genetic study ::: C0029095;C0242401;C0376196;C0011900;C2827447 ::: mobd;lbpr;hops,phsu;fndg;resa ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Substance Use History;Research Attributes;Medical History
phv00033033.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL27B17 ::: Pre-lunch blood glucose at OD 340 (quarterly visit 17) ::: float ::: OD 340 ::: NONE ::: NONE ::: pre lunch blood glucose at od 340   quarterly visit 17 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00088326.v1 ::: phs000222.v1.p1 ::: pht001157.v1 ::: Predict_HD_cas ::: cas9b ::: HVLT - R (Hopkins Verbal Learning Test - Revised) learning trail #2 ::: integer ::: NONE ::: NONE ::: NONE ::: hopkins verbal learning test r  hopkins verbal learning test revised  learning trail  number 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: verbal learning;laboratory procedures;r prime;revision procedure;learning ::: C0042531;C0022885;C2603358;C1527075;C0023185 ::: menp;lbpr;clna;topp;menp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Therapeutic or Preventive Procedure
phv00025665.v1 ::: phs000086.v2.p1 ::: pht000213.v1 ::: DCCT_f0033 ::: OCDM1BLD ::: Diabetes monitoring (one or two daily injection[s]): blood test(s) done before lunch ::: int ::: BLOOD TESTS ::: NONE ::: NONE ::: diabetes monitoring  one or two daily injection s    blood test s  done before lunch ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetes monitoring check done;injection of therapeutic agent;hematologic tests;blood analysis (lab test);injection procedure ::: C0422587;C0021485;C0018941;C2121789;C1533685 ::: fndg;topp;lbpr;lbpr;topp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00161369.v3 ::: phs000200.v8.p2 ::: pht002246.v3 ::: WHISP_Subject_Phenotypes ::: esp_phenotype ::: PHENOTYPE SAMPLE WAS SEQUENCED FOR ::: STRING ::: NONE ::: NONE ::: NONE ::: phenotype sample was sequenced for ::: NULL ::: NULL ::: NULL ::: NULL ::: phenotype determination ::: C1285572 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00090101.v1 ::: phs000209.v10.p2 ::: pht001205.v1 ::: MESA_AncilMesaExam4AbdominalAorticCT ::: nph3mn4 ::: NEW PHANTOM: MEAN 3 (CALCULATED) ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: new phantom  mean 3  calculated ::: NULL ::: NULL ::: NULL ::: NULL ::: calculated (procedure) ::: C1443182 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00126331.v1 ::: phs000286.v3.p1 ::: pht001952.v1 ::: DPASS_DIET1 ::: lffq_gluc ::: LFFQ: glucose (gm) ::: decimal ::: gm ::: 1.21229 ::: 172.3593 ::: lffq  glucose  gm ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement ::: C0017725;C0202042 ::: bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033789.v1 ::: phs000086.v2.p1 ::: pht000279.v1 ::: DCCT_ms2exprt ::: REYSEVIS ::: Quarterly visit number of recovery from soft exudate (se) and/or intra-retinal microvascular abnormalities (irma) ::: byte ::: QUARTERLY VISIT ::: NONE ::: NONE ::: quarterly visit number of recovery from soft exudate  se  and or intra retinal microvascular abnormalities  irma ::: NULL ::: NULL ::: NULL ::: NULL ::: health care visit;recovery - healing process;retinal abnormality;immunoradiometric assays ::: C1512346;C2004454;C0035300;C0021073 ::: inbe;orgf;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00123982.v1 ::: phs000284.v1.p1 ::: pht001902.v1 ::: CFS_CARe_Subject_Phenotypes ::: isi0120 ::: ISI (0,120) = Metabolic clearance rate / log (Mean Serum Insulin) ::: decimal ::: NONE ::: 3.717317 ::: 53.61561 ::: isi  0,120  = metabolic clearance rate   logarithm  mean serum insulin ::: NULL ::: NULL ::: NULL ::: NULL ::: metabolic clearance rate;serum insulin measurement ::: C0025515;C0428357 ::: clna;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00063090.v2 ::: phs000128.v3.p3 ::: pht000554.v2 ::: simphen155 ::: rx1 ::: 1:Rx for high LDL,0:No Rx, visit 1 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0 no rx, visit 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00033744.v1 ::: phs000086.v2.p1 ::: pht000279.v1 ::: DCCT_ms2exprt ::: REYSEFLG ::: Recovery from soft exudate (se) and/or intraretinal microvascular abnormalities (irma) ::: byte ::: NONE ::: NONE ::: NONE ::: recovery from soft exudate  se  and or intraretinal microvascular abnormalities  irma ::: NULL ::: NULL ::: NULL ::: NULL ::: recovery - healing process;diabetic intraretinal microvascular anomalies;immunoradiometric assays ::: C2004454;C1306674;C0021073 ::: orgf;dsyn;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00055169.v2 ::: phs000007.v18.p7 ::: pht000394.v5 ::: wktest1_7s ::: WT002 ::: IF TEST NOT DONE, REASON FOR EXCLUSION ::: NONE ::: NONE ::: NONE ::: NONE ::: if test not done, reason for exclusion ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00073598.v1 ::: phs000170.v1.p1 ::: pht000737.v1 ::: Marshfield_Data_Phenotype ::: Adjusted_Total_Cholesterol_Measurement ::: Adjusted baseline total cholesterol (age 59, BMI 29, no estrogen) ::: decimal ::: Mg/dL ::: 120.2 ::: 401.7 ::: adjusted baseline total cholesterol  age 59, body mass index 29, no estrogen ::: Age ::: age ::: C0001779 ::: orga ::: serum total cholesterol measurement;body mass index procedure;body mass index;estrogens ::: C1445957;C0005893;C1305855;C0014939 ::: lbpr;diap;clna;horm,phsu,strd ::: study subject ::: C0681850 ::: grup ::: Demographics;Medication Patient;Lab Tests Patient;Clinical Attributes
phv00062034.v2 ::: phs000128.v3.p3 ::: pht000521.v2 ::: simphen122 ::: rx1 ::: 1:Rx for high LDL,0:No Rx, visit 1 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0 no rx, visit 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00173553.v1 ::: phs000536.v1.p1 ::: pht002951.v1 ::: Retrotransposition_Colorectal_Tumors_Sample_Attributes ::: HISTOLOGICAL_TYPE ::: Cell or tissue type or subtype of sample ::: string ::: NONE ::: NONE ::: NONE ::: cell or tissue type or subtype of sample ::: NULL ::: NULL ::: NULL ::: NULL ::: histocompatibility testing ::: C0019633 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00018470.v1 ::: phs000017.v3.p1 ::: pht000058.v1 ::: EA_DIGS4_Data ::: V1442 ::: J48. Opiates.  (Participants with European ancestry). DIGS4 ::: NONE ::: NONE ::: NONE ::: NONE ::: j48   opiates   participants with european ancestry   diagnostic interview for genetic studies ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: opioid abuse;opiate assay;opiates;diagnosis;genetic study ::: C0029095;C0242401;C0376196;C0011900;C2827447 ::: mobd;lbpr;hops,phsu;fndg;resa ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Substance Use History;Research Attributes;Medical History
phv00084974.v2 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: chol1 ::: TOTAL CHOLESTEROL (mg/dl) ::: NUMERIC ::: mg/dl ::: NONE ::: NONE ::: total cholesterol  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: serum total cholesterol measurement ::: C1445957 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032926.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL29A12 ::: Pre-supper blood glucose mg/dl (quarterly visit 12) ::: int ::: MG/DL ::: NONE ::: NONE ::: pre supper blood glucose magnesium distolingual  quarterly visit 12 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00031103.v1 ::: phs000086.v2.p1 ::: pht000261.v1 ::: DCCT_cbl8 ::: BCNLD24 ::: CBL8: Lipid test - 24: collection date ::: str6 ::: NONE ::: NONE ::: NONE ::: cbl8  lipid test 24  collection date ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00033297.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL27B29 ::: Pre-lunch blood glucose at OD 340 (quarterly visit 29) ::: float ::: OD 340 ::: NONE ::: NONE ::: pre lunch blood glucose at od 340   quarterly visit 29 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00147442.v2 ::: phs000209.v10.p2 ::: pht002102.v2 ::: MESA_AncilMesaLungExam3CT ::: RC_tis_v ::: RIGHT LUNG, CORE: TOTAL VOLUME OF TISSUE IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, core  total volume of tissue in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142341.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: FLJ36031_Run4_Plate ::: RNA LEVELS: FLJ36031, Run4, Platelet (TaqmanAssayID : Hs00703139_s1) ::: decimal, encoded ::: cycle threshold ::: 10.6392504099344 ::: 26.9964780561442 ::: ribonucleic acid levels  flj36031 , run4, platelet  taqmanassayid   hs00703139_s1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00084975.v2 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: chlcat1c ::: TOTAL CHOLESTEROL, NCEP CATEGORIES ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: total cholesterol, nucleic acid testing categories ::: NULL ::: NULL ::: NULL ::: NULL ::: serum total cholesterol measurement;nucleic acid amplification tests ::: C1445957;C0200932 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00169353.v1 ::: phs000179.v2.p2 ::: pht002239.v2 ::: COPDGene_Subject_Phenotypes ::: pctEmph_vida ::: Percent emph (-950 Hu) total lung CT VIDA ::: numeric ::: NONE ::: NONE ::: NONE ::: percent emph  950 hounsfield unit  total lung computed tomographic vida ::: NULL ::: NULL ::: NULL ::: NULL ::: x-ray computed tomography;lung tomograms;computed (procedure) ::: C0040405;C0580161;C1441526 ::: diap;diap;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure
phv00026497.v1 ::: phs000086.v2.p1 ::: pht000215.v1 ::: DCCT_cbl00 ::: BCSGLUCB ::: CBL00: GFR serum glucose - pre-injection (mg/dl) ::: NONE ::: NONE ::: NONE ::: NONE ::: cbl00   glomerular filtration rate serum glucose pre injection  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum magnesium finding;glucose;injection of therapeutic agent;injection procedure;plasma glucose measurement;glucose measurement, serum;glomerular filtration rate finding ::: C0017654;C1826990;C0017725;C0021485;C1533685;C0202042;C0202041;C1561549 ::: diap,ortf;fndg;bacs,carb,phsu;topp;topp;lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Therapeutic or Preventive Procedure;Diagnostic Procedure
phv00142177.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: ATP2B1_Run3_Plate ::: RNA LEVELS: ATP2B1, Run3, Platelet (TaqmanAssayID : Hs00155949_m1) ::: decimal, encoded ::: cycle threshold ::: 3.5 ::: 26.9786959326994 ::: ribonucleic acid levels  atp2b1 , run3, platelet  taqmanassayid   hs00155949_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00033259.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL30B27 ::: Post-supper blood glucose at OD 340 (quarterly visit 27) ::: float ::: OD 340 ::: NONE ::: NONE ::: post supper blood glucose at od 340   quarterly visit 27 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00117755.v2 ::: phs000285.v2.p2 ::: pht001746.v2 ::: D2F06V ::: DV6RETIN ::: RETINOL (MCG) ::: decimal ::: MCG ::: 2.92 ::: 101168.4 ::: retinol  mcg ::: NULL ::: NULL ::: NULL ::: NULL ::: vitamin a;all-trans-retinol;vitamin a measurement ::: C0042839;C0087161;C0373745 ::: orch,phsu,vita;orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00145009.v1 ::: phs000209.v10.p2 ::: pht002101.v1 ::: MESA_AncilMesaLungExam2CT ::: LL_tot_v ::: LEFT LUNG, LOWER: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: left lung, lower  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00064578.v1 ::: phs000007.v18.p7 ::: pht000602.v3 ::: echo0_20s ::: lvfs20 ::: FRACTIONAL SHORTENING, CALCULATED: (LVDD20 - LVDS20)/LVDD20 ::: NONE ::: NONE ::: NONE ::: NONE ::: fractional shortening, calculated   lvdd20 lvds20  lvdd20 ::: NULL ::: NULL ::: NULL ::: NULL ::: fractional shortening;calculated (procedure) ::: C2599768;C1443182 ::: fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00151781.v3 ::: phs000209.v10.p2 ::: pht002108.v3 ::: MESA_MesaAirNR_LungCT ::: RU_tis_v ::: RIGHT LUNG, UPPER: TOTAL VOLUME OF TISSUE IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, upper  total volume of tissue in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00027809.v1 ::: phs000086.v2.p1 ::: pht000231.v1 ::: DCCT_ms5exprt ::: OBESE_24 ::: Weight > 120% calculated ideal: quarterly visit 24 ::: byte ::: NONE ::: NONE ::: NONE ::: weight > 120 % calculated ideal  quarterly visit 24 ::: NULL ::: NULL ::: NULL ::: NULL ::: weighing patient;calculated (procedure);health care visit ::: C1305866;C1443182;C1512346 ::: diap;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00032707.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL29B02 ::: Pre-supper blood glucose at OD 340 (quarterly visit 02) ::: float ::: OD 340 ::: NONE ::: NONE ::: pre supper blood glucose at od 340   quarterly visit 02 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00104712.v1 ::: phs000287.v2.p1 ::: pht001489.v1 ::: YR4 ::: PRARM27 ::: DOES PTT USE A RIGHT ARM PROTHESIS ::: encoded ::: NONE ::: NONE ::: NONE ::: does ptt use a right arm prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00147743.v2 ::: phs000209.v10.p2 ::: pht002102.v2 ::: MESA_AncilMesaLungExam3CT ::: RMP_tot_v ::: RIGHT LUNG, MIDDLE PEEL: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, middle peel  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;localized desquamation ::: C2700258;C0520893 ::: lbpr;patf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00086778.v2 ::: phs000209.v10.p2 ::: pht001120.v7 ::: MESA_Exam4Main ::: VOLSU24C ::: SCAN 2:  TOTAL VOLUME SCORE, UNADJUSTED ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: scan 2  total volume score, unadjusted ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;radionuclide imaging;scanning;related to cancer ::: C2700258;C0034606;C0441633;C2826292 ::: lbpr;diap;diap;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure
phv00011963.v1 ::: phs000017.v3.p1 ::: pht000056.v1 ::: EA_DIGS2_Data ::: I3270 ::: E4. Have you ever taken medications for your nerves or any emotional or mental problems? Antidepressants: Wellbutrin. (Participants with European ancestry). DIGS2 ::: NONE ::: NONE ::: NONE ::: NONE ::: e4  have you ever taken medications for your nerves or any emotional or mental problems  antidepressants  wellbutrin   participants with european ancestry   digs2 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: pharmaceutical preparations;medications:presence or identity:duration of the study:^patient:nominal;medications:-:point in time:^patient:-;emotions;emotional;mental problem;antidepressive agents;wellbutrin;antidepressant measurement ::: C0013227;C0802604;C2598133;C0013987;C0849912;C0848067;C0003289;C0085934;C2698157 ::: phsu;clna;clna;menp;fndg;fndg;phsu;orch,phsu;lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Mental or Emotional Finding;Medical History
phv00022581.v1 ::: phs000007.v18.p7 ::: pht000103.v3 ::: pft0_19s ::: STAND ::: TEST POSITION ::: NONE ::: NONE ::: NONE ::: NONE ::: test position ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00118226.v2 ::: phs000285.v2.p2 ::: pht001756.v2 ::: E1ECHY10 ::: EDVTI ::: DIASTOLIC VTI ::: decimal ::: NONE ::: 0.09 ::: 0.4 ::: diastolic volume thickness index ::: NULL ::: NULL ::: NULL ::: NULL ::: diastole;volume measurement ::: C0012000;C2700258 ::: clna;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00161936.v2 ::: phs000007.v18.p7 ::: pht002344.v2 ::: l_rnatrans2_ex08_1_0619s ::: actb_Run3_Plate ::: RNA levels (cycle threshold): ACTB, run3, Platelet (TaqmanAssayID: Hs99999903_m1) ::: NONE ::: cycle threshold ::: 3.9097103 ::: 26.9302209 ::: ribonucleic acid levels  cycle threshold   actb, run3, platelet  taqmanassayid  hs99999903_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00094454.v1 ::: phs000280.v1.p1 ::: pht001333.v1 ::: ARIC_CARE_HMTCV4C1 ::: HMTC5 ::: HEMATOCRIT                           Q5 ::: decimal ::: NONE ::: 23.89999 ::: 55 ::: hematocrit q5 ::: NULL ::: NULL ::: NULL ::: NULL ::: hematocrit procedure ::: C0018935 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00078569.v3 ::: phs000200.v8.p2 ::: pht000999.v3 ::: f30_rel1 ::: HEMOCCUL ::: Hemoccult test ever ::: encoded value ::: NONE ::: NONE ::: NONE ::: hemoccult test ever ::: NULL ::: NULL ::: NULL ::: NULL ::: fecal occult blood test;laboratory procedures ::: C0201811;C0022885 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00033329.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL32B30 ::: 3:00 a.m. blood glucose at OD 340 (quarterly visit 30) ::: byte ::: OD 340 ::: NONE ::: NONE ::: 3 00 a m  blood glucose at od 340   quarterly visit 30 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00013032.v1 ::: phs000017.v3.p1 ::: pht000056.v1 ::: EA_DIGS2_Data ::: I14570 ::: N3. Have your (mood/psychotic) episodes ever continued after you stopped using (alcohol/drugs) heavily? (Participants with European ancestry). DIGS2 ::: NONE ::: NONE ::: NONE ::: NONE ::: n3  have your  mood psychotic  episodes ever continued after you stopped using  alcohol drugs  heavily   participants with european ancestry   digs2 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: n3 category;mood (psychological function);psychotic episodes;mood:-:point in time:^patient:-;pharmaceutical preparations;alcohols;alcohol measurement ::: C0441961;C0026516;C0338614;C2713234;C0013227;C0001975;C0202304 ::: fndg;menp;mobd;clna;phsu;orch,phsu;lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Mental or Emotional Finding;Drinking History
phv00111135.v2 ::: phs000200.v8.p2 ::: pht001502.v2 ::: outc_bc_rel1 ::: ERTYPE ::: F130 Type of Estrogen Assay ::: encoded value ::: NONE ::: NONE ::: NONE ::: f130  type of estrogen assay ::: NULL ::: NULL ::: NULL ::: NULL ::: estrogens;biological assay;assay ::: C0014939;C0005507;C1510438 ::: horm,phsu,strd;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00155526.v2 ::: phs000200.v8.p2 ::: pht002118.v2 ::: ecg_rel2 ::: STM_V3 ::: M (middle of ST segment) amplitude, lead stm_v3 ::: integer ::: NONE ::: -435 ::: 1391 ::: m  middle of subtalar segment  amplitude, lead stm_v3 ::: NULL ::: NULL ::: NULL ::: NULL ::: microscopy, scanning tunneling ::: C0079837 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00001381.v1 ::: phs000007.v18.p7 ::: pht000012.v3 ::: ex0_10s ::: FC23 ::: BLOOD ANALYSIS: BETA CHOLESTEROL (MG/100 ML) ::: NONE ::: MG/100ML ::: NONE ::: NONE ::: blood analysis  beta cholesterol  magnesium 100 mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;serum total cholesterol measurement;analysis;blood cholesterol ::: C0002778;C1445957;C0936012;C0518017 ::: lbpr;lbpr;resa;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00116366.v2 ::: phs000285.v2.p2 ::: pht001694.v2 ::: C1HEMO ::: CLEBTYPE ::: ABO BLOOD TYPE ::: string ::: NONE ::: NONE ::: NONE ::: abo blood type ::: NULL ::: NULL ::: NULL ::: NULL ::: abo typing ::: C0200499 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00085711.v2 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: pulsewp1 ::: PULSE RATE (FROM WAVEFORM ANALYSIS), (BEATS/MINUTE) ::: NUMERIC ::: beats/minute ::: NONE ::: NONE ::: pulse rate  from waveform analysis ,  beats minute ::: NULL ::: NULL ::: NULL ::: NULL ::: pulse rate;physiologic pulse;analysis of substances;analysis ::: C0232117;C0391850;C0002778;C0936012 ::: clna;phsf;lbpr;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes;Research Attributes;Medical History
phv00025268.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR20_46 ::: Test r46: difference between year 5  and baseline scores ::: byte ::: TEST R46 SCORE ::: NONE ::: NONE ::: test r46   difference between year 5 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00070362.v4 ::: phs000007.v18.p7 ::: pht000688.v5 ::: insulin3_1s ::: insulin ::: INSULIN, PMOL/L (ELISA RESULTS WERE MULTIPLIED BY A FACTOR OF 6 TO GET PMOL/L UNITS FOR INSULIN) ::: NONE ::: PMOL/L ::: NONE ::: NONE ::: insulin, pmol l  enzyme-linked immunosorbent assay results were multiplied by a factor of 6 to get pmol l units for insulin ::: NULL ::: NULL ::: NULL ::: NULL ::: insulin;recombinant insulin;enzyme-linked immunosorbent assay ::: C0021641;C1533581;C0014441 ::: aapp,horm,phsu;aapp,horm,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00081034.v1 ::: phs000007.v18.p7 ::: pht001045.v2 ::: laba0_20s ::: PLATELET ::: Platelet Count ::: integer, encoded ::: thou/uL (thousands per microliter) ::: 40 ::: 759 ::: platelet count ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00060601.v2 ::: phs000128.v3.p3 ::: pht000476.v2 ::: simphen077 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00025873.v1 ::: phs000086.v2.p1 ::: pht000213.v1 ::: DCCT_f0033 ::: OCDC4D2 ::: Diabetes control - severe hypoglycemia: how many times has patient received glucose i.v. ::: byte ::: I.V. GLUCOSE ADMINISTRATION ::: NONE ::: NONE ::: diabetes control severe hypoglycemia  how many times has patient received glucose i v ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetic hypoglycemia nos;glucose;plasma glucose measurement ::: C0865166;C0017725;C0202042 ::: dsyn;bacs,carb,phsu;lbpr ::: patients ::: C0030705 ::: podg ::: Medication Patient;Lab Tests Patient;Medical History
phv00027329.v1 ::: phs000086.v2.p1 ::: pht000229.v1 ::: DCCT_cbl1 ::: BCVAL24 ::: CBL1: Lipid test - 24: LDL cholesterol (serum) value  (mg/dl) ::: int ::: MG/DL ::: NONE ::: NONE ::: cbl1  lipid test 24  low-density lipoprotein cholesterol  serum  value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: measurement of serum lipid level;laboratory procedures;serum magnesium finding ::: C0428462;C0022885;C1826990 ::: lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00031596.v1 ::: phs000086.v2.p1 ::: pht000266.v1 ::: DCCT_cbl4 ::: BCVAL16 ::: CBL4: Renal test - 16: creatinine (urine) value  (mg/dl) ::: int ::: MG/DL ::: NONE ::: NONE ::: cbl4  renal test 16  creatinine  urine  value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine ::: C0428308 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00024467.v3 ::: phs000007.v18.p7 ::: pht000195.v4 ::: brach1_7s ::: EF40 ::: DISTANCE FROM THE ANTECUBITAL CREASE TO THE PROBE (MM)? ::: NONE ::: MM ::: NONE ::: NONE ::: distance from the antecubital crease to the probe  millimeter ::: NULL ::: NULL ::: NULL ::: NULL ::: dna probe method ::: C1442917 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00025281.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR20_59 ::: Test r59: difference between year 5  and baseline scores ::: byte ::: TEST R59 SCORE ::: NONE ::: NONE ::: test r59   difference between year 5 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032721.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL25B03 ::: Pre-breakfast blood glucose at OD 340 (quarterly visit 03) ::: float ::: OD 340 ::: NONE ::: NONE ::: pre breakfast blood glucose at od 340   quarterly visit 03 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00163819.v2 ::: phs000159.v4.p2 ::: pht000817.v4 ::: AML_Subject_Phenotypes ::: Immunophenotype & Cytochemistry: CD3 % Positive ::: Immunophenotype & Cytochemistry: CD3 % Positive ::: NONE ::: NONE ::: NONE ::: NONE ::: immunophenotype & cytochemistry  cd3 % positive ::: NULL ::: NULL ::: NULL ::: NULL ::: immunophenotyping;cd3 expressing t cell count;positive finding ::: C0079611;C2698592;C1514241 ::: lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00123012.v1 ::: phs000284.v1.p1 ::: pht001902.v1 ::: CFS_CARe_Subject_Phenotypes ::: END_dur_hr ::: Calculated sleep duration on weekends (hours) ::: decimal ::: NONE ::: -10 ::: 31 ::: calculated sleep duration on weekends  hours ::: NULL ::: NULL ::: NULL ::: NULL ::: duration of sleep;calculated (procedure) ::: C0424574;C1443182 ::: fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Daily or Recreational Activity
phv00066579.v1 ::: phs000092.v1.p1 ::: pht000116.v1 ::: AlcoholDepAdd_Data ::: oth_sx3 ::: Using drugs other than marijuana, cocaine or opiates in larger amounts or over longer period than intended ::: encoded value ::: NONE ::: 1 ::: 9 ::: using drugs other than marijuana, cocaine or opiates in larger amounts or over longer period than intended ::: NULL ::: NULL ::: NULL ::: NULL ::: pharmaceutical preparations;marihuana;cocaine;cocaine measurement;opioid abuse;opiate assay;opiates ::: C0013227;C0024808;C0009170;C0202362;C0029095;C0242401;C0376196 ::: phsu;orch,phsu;hops,orch,phsu;lbpr;mobd;lbpr;hops,phsu ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Substance Use History;Medical History
phv00032671.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL33B01 ::: Blood glucose profile 8 at OD 340 (quarterly visit 01) ::: float ::: OD 340 ::: NONE ::: NONE ::: blood glucose profile 8 at od 340   quarterly visit 01 ::: NULL ::: NULL ::: NULL ::: NULL ::: profile (lab procedure);blood glucose measurement;osteochondritis dissecans;health care visit ::: C1979963;C0392201;C0029421;C1512346 ::: lbpr;lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033411.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL29B34 ::: Pre-supper blood glucose at OD 340 (quarterly visit 34) ::: float ::: OD 340 ::: NONE ::: NONE ::: pre supper blood glucose at od 340   quarterly visit 34 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00112624.v2 ::: phs000285.v2.p2 ::: pht001562.v2 ::: A4F04 ::: A04ALCOH ::: HAD PROBLEMS FROM USE OF ALCOHOL ::: encoded ::: NONE ::: NONE ::: NONE ::: had problems from use of alcohol ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement ::: C0001975;C0202304 ::: orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History
phv00156763.v2 ::: phs000007.v18.p7 ::: pht002150.v2 ::: vr_ffreq_ex01_3_0587s ::: B6 ::: FFQ: TAKE VIT B6 SUPPLEMENT ::: encoded ::: NONE ::: NONE ::: NONE ::: food frequency questionnaire  take vit b6 supplement ::: NULL ::: NULL ::: NULL ::: NULL ::: food;vitamin b6;dietary supplements;vitamin b6 measurement ::: C0016452;C0087162;C0242295;C0202251 ::: food;orch,phsu,vita;food;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00061472.v2 ::: phs000128.v3.p3 ::: pht000503.v2 ::: simphen104 ::: rx3 ::: 1:Rx for high LDL, 0:No Rx, visit 3 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 3 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00028515.v1 ::: phs000086.v2.p1 ::: pht000239.v1 ::: DCCT_cbl7 ::: BCSGLUC4 ::: CBL7: GFR serum glucose - t4 value (mg/dl) ::: int ::: MG/DL ::: NONE ::: NONE ::: cbl7  glomerular filtration rate serum glucose t4 value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum thyroxine;glucose;plasma glucose measurement;glomerular filtration rate finding ::: C0017654;C0036833;C0017725;C0202042;C1561549 ::: diap,ortf;lbpr;bacs,carb,phsu;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Diagnostic Procedure
phv00025585.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR36_51 ::: Test r51: difference between year 9  and baseline scores ::: byte ::: TEST R51 score difference ::: NONE ::: NONE ::: test r51   difference between year 9 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00158127.v1 ::: phs000007.v18.p7 ::: pht002153.v1 ::: ffreq0_22s ::: SCORE37 ::: DERIVED FIELD: NUTRIENT VALUE - PANTOTHENIC ACID, (MG) ::: NONE ::: mg ::: NONE ::: NONE ::: derived field  nutrient value pantothenic acid,  magnesium ::: NULL ::: NULL ::: NULL ::: NULL ::: nutrients;pantothenic acid;blood pantothenic acid analysis;vitamin b5 measurement ::: C0678695;C0030342;C0696237;C2700255 ::: food;orch,phsu,vita;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00111880.v3 ::: phs000200.v8.p2 ::: pht001517.v3 ::: f60_item_rel1 ::: MILKS ::: Computed food group: Milks, med serv/day ::: decimal ::: servings ::: 0 ::: 10.5625 ::: computed food group  milks, med serv day ::: NULL ::: NULL ::: NULL ::: NULL ::: computed (procedure);food ::: C1441526;C0016452 ::: lbpr;food ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Eating or Nutritional Finding
phv00128704.v1 ::: phs000209.v10.p2 ::: pht001984.v1 ::: MESA_AncilMesaInflammation ::: ablympha ::: LYMPHOCYTE COUNT  x10^3/ul ::: NUMERIC ::: x10^3/ul ::: NONE ::: NONE ::: lymphocyte count x10^3  ul ::: NULL ::: NULL ::: NULL ::: NULL ::: lymphocyte count measurement ::: C0200635 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032740.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: LDT25_04 ::: Blood glucose profile collection date (quarterly visit 04) ::: str6 ::: NONE ::: NONE ::: NONE ::: blood glucose profile collection date  quarterly visit 04 ::: NULL ::: NULL ::: NULL ::: NULL ::: profile (lab procedure);blood glucose measurement;health care visit ::: C1979963;C0392201;C1512346 ::: lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00165196.v1 ::: phs000400.v1.p1 ::: pht002536.v1 ::: HeartGO_CHS_LDL_PhenotypeDataFile ::: ESP_FASTGLUCOSE_BASELINE ::: Blood fasting glucose at baseline in mg/dL ::: Numeric ::: mg/dL ::: NONE ::: NONE ::: blood fasting glucose at baseline inmg d l ::: NULL ::: NULL ::: NULL ::: NULL ::: fasting blood glucose measurement ::: C0428568 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032829.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: NLD25_08 ::: Blood glucose profile analysis date (quarterly visit 08) ::: str6 ::: NONE ::: NONE ::: NONE ::: blood glucose profile analysis date  quarterly visit 08 ::: NULL ::: NULL ::: NULL ::: NULL ::: profile (lab procedure);analysis of substances;date fruit;analysis;blood glucose measurement;health care visit ::: C1979963;C0002778;C2348077;C0936012;C0392201;C1512346 ::: lbpr;lbpr;food;resa;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00025286.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR20_64 ::: Test r64: difference between year 5  and baseline scores ::: byte ::: TEST R64 SCORE ::: NONE ::: NONE ::: test r64   difference between year 5 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142191.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: KLKB1_Run3_Plate ::: RNA LEVELS: KLKB1, Run3, Platelet (TaqmanAssayID : Hs00168478_m1) ::: decimal, encoded ::: cycle threshold ::: 12.3108672796174 ::: 26.9468630289169 ::: ribonucleic acid levels  klkb1, run3, platelet  taqmanassayid   hs00168478_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00115260.v2 ::: phs000285.v2.p2 ::: pht001651.v2 ::: C1ECHO ::: A4RVAD ::: 2D: RV AREA ::: decimal ::: NONE ::: 4.61 ::: 30.43 ::: 2 d  residual volume area ::: NULL ::: NULL ::: NULL ::: NULL ::: residual volume;lung residual volume measurement;volume.residual:volume:point in time:respiratory system:quantitative ::: C0035190;C0429713;C0802961 ::: clna;lbpr;clna ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00069882.v2 ::: phs000007.v18.p7 ::: pht000680.v3 ::: ffreq1_5s ::: FA ::: FFQ: TAKE FOLIC ACID SUPPLEMENT ::: NONE ::: NONE ::: NONE ::: NONE ::: food frequency questionnaire  take folic acid supplement ::: NULL ::: NULL ::: NULL ::: NULL ::: food;folic acid;dietary supplements;folic acid measurement ::: C0016452;C0016410;C0242295;C0523631 ::: food;orch,phsu,vita;food;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00077361.v3 ::: phs000200.v8.p2 ::: pht000986.v3 ::: cbc_rel1 ::: CBCVTYP ::: CBC Visit type ::: encoded value ::: NONE ::: NONE ::: NONE ::: complete blood count visit type ::: NULL ::: NULL ::: NULL ::: NULL ::: complete blood count;health care visit ::: C0009555;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00063602.v2 ::: phs000128.v3.p3 ::: pht000570.v2 ::: simphen171 ::: rx1 ::: 1:Rx for high LDL,0:No Rx, visit 1 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0 no rx, visit 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00178130.v1 ::: phs000562.v1.p1 ::: pht003107.v1 ::: Burkitt_Lymphoma_Sample_Attributes ::: HISTOLOGICAL_TYPE ::: Cell or tissue type or subtype of sample ::: string ::: NONE ::: NONE ::: NONE ::: cell or tissue type or subtype of sample ::: NULL ::: NULL ::: NULL ::: NULL ::: histocompatibility testing ::: C0019633 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00145259.v1 ::: phs000209.v10.p2 ::: pht002101.v1 ::: MESA_AncilMesaLungExam2CT ::: LMP_tot_v ::: LEFT LUNG, MIDDLE PEEL: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: left lung, middle peel  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;localized desquamation ::: C2700258;C0520893 ::: lbpr;patf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00076410.v2 ::: phs000007.v18.p7 ::: pht000910.v3 ::: pftdiff1_8s ::: vi3_8_1 ::: Inspired Volume - 3rd Acceptable Effort ::: decimal, encoded ::: L ::: 1.51 ::: 4.98 ::: inspired volume 3rd acceptable effort ::: NULL ::: NULL ::: NULL ::: NULL ::: inspiration function;exertion;volume measurement ::: C0004048;C0015264;C2700258 ::: orgf;orgf;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00111881.v3 ::: phs000200.v8.p2 ::: pht001517.v3 ::: f60_item_rel1 ::: DAIRY ::: Computed food group: Dairy, med serv/day ::: decimal ::: servings ::: 0 ::: 29.76798 ::: computed food group  dairy, med serv day ::: NULL ::: NULL ::: NULL ::: NULL ::: computed (procedure);food ::: C1441526;C0016452 ::: lbpr;food ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Eating or Nutritional Finding
phv00063890.v2 ::: phs000128.v3.p3 ::: pht000579.v2 ::: simphen180 ::: rx1 ::: 1:Rx for high LDL,0:No Rx, visit 1 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0 no rx, visit 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00034509.v1 ::: phs000086.v2.p1 ::: pht000284.v1 ::: EDIC_neph_8yr ::: COMBINED ::: SCR (serum creatinine rate) > 2, StdClr < 70, and AER (albumin excretion rate) > 300 simultaneously ::: NONE ::: mg/day ::: NONE ::: NONE ::: serum creatinine rate  serum creatinine rate  > 2, stdclr < 70, and albumin-excretion rate  albumin excretion rate  > 300  simultaneously ::: NULL ::: NULL ::: NULL ::: NULL ::: creatinine measurement, serum (procedure);albumin excretion rate measurement ::: C0201976;C0585937 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00025495.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: QV36_R17 ::: Category test - subtest 7 - errors (quarterly visit 36) ::: NONE ::: ERRORS/SUBTEST 7 ::: NONE ::: NONE ::: category test subtest 7 errors  quarterly visit 36 ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures;health care visit ::: C0022885;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00086328.v2 ::: phs000209.v10.p2 ::: pht001119.v5 ::: MESA_Exam3Main ::: VOLSP13C ::: SCAN 1:  TOTAL VOLUME SCORE, PHANTOM ADJUSTED ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: scan 1  total volume score, phantom adjusted ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00162883.v1 ::: phs000404.v1.p1 ::: pht002368.v1 ::: GENEVA_Smoking_Cessation_Subject_Phenotypes_COGEND ::: coc_sx_tot ::: Number of cocaine symptoms endorsed ::: integer, encoded string ::: NONE ::: 0 ::: 7 ::: number of cocaine symptoms endorsed ::: NULL ::: NULL ::: NULL ::: NULL ::: cocaine;symptoms;cocaine measurement ::: C0009170;C1457887;C0202362 ::: hops,orch,phsu;sosy;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Substance Use History;Medical History
phv00027395.v1 ::: phs000086.v2.p1 ::: pht000230.v1 ::: DCCT_cbl2 ::: BCNLD24 ::: CBL2: Lipid test - 24: collection date ::: str6 ::: NONE ::: NONE ::: NONE ::: cbl2  lipid test 24  collection date ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00157671.v1 ::: phs000007.v18.p7 ::: pht002151.v1 ::: ffreq0_20s ::: FFD84 ::: DERIVED FIELD: SERVINGS PER WEEK - DARK FISH ::: NONE ::: NONE ::: NONE ::: NONE ::: derived field  servings per week dark fluorescent in situ hybridization ::: NULL ::: NULL ::: NULL ::: NULL ::: in situ hybridization ::: C0162788 ::: lbpr,mbrt ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00062834.v2 ::: phs000128.v3.p3 ::: pht000546.v2 ::: simphen147 ::: rx1 ::: 1:Rx for high LDL,0:No Rx, visit 1 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0 no rx, visit 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00165219.v1 ::: phs000400.v1.p1 ::: pht002536.v1 ::: HeartGO_CHS_LDL_PhenotypeDataFile ::: ESP_PLATELET_COUNT ::: Platelet count at designated visit (may not be baseline) in x 1000/cubic mm ::: Numeric ::: x1000/cubic mm ::: NONE ::: NONE ::: platelet count at designated visit  may not be baseline  in kienbock s unit 1000  cubic millimeter ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement;health care visit ::: C0032181;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00171640.v1 ::: phs000462.v1.p1 ::: pht002844.v1 ::: T2D_GENES_Subject_Phenotypes ::: A2H_GLU_1 ::: 2-hour glucose concentration at the first study visit ::: decimal ::: mmol/L ::: 0.5 ::: 40 ::: 2hour glucose concentration at the first study visit ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose concentration, test strip measurement;clinical trials;health care visit;study ::: C0427743;C0008976;C1512346;C2603343 ::: lbpr;resa;inbe;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00025382.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR28_3 ::: Test r3: difference between year 7  and baseline scores ::: byte ::: TEST R3 SCORE DIFFERENCE ::: NONE ::: NONE ::: test r3  difference between year 7 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00061657.v2 ::: phs000128.v3.p3 ::: pht000509.v2 ::: simphen110 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00105809.v1 ::: phs000287.v2.p1 ::: pht001490.v1 ::: YR5NEW ::: PROTHE27 ::: DOES PTT USE A PROTHESIS ::: encoded ::: NONE ::: NONE ::: NONE ::: does ptt use a prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00073694.v4 ::: phs000159.v4.p2 ::: pht000817.v4 ::: AML_Subject_Phenotypes ::: Immunophenotype & Cytochemistry: CD15 ::: Immunophenotype & Cytochemistry: CD15 ::: NONE ::: NONE ::: NONE ::: NONE ::: immunophenotype & cytochemistry  cd15 ::: NULL ::: NULL ::: NULL ::: NULL ::: immunophenotyping ::: C0079611 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00153179.v2 ::: phs000209.v10.p2 ::: pht002109.v2 ::: MESA_MesaFamily_LungCT ::: LU_tis_v ::: LEFT LUNG UPPER: TOTAL VOLUME OF TISSUE IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: left lung upper  total volume of tissue in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00033175.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL32B23 ::: 3:00 a.m. blood glucose at OD 340 (quarterly visit 23) ::: byte ::: OD 340 ::: NONE ::: NONE ::: 3 00 a m  blood glucose at od 340   quarterly visit 23 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00052464.v1 ::: phs000017.v3.p1 ::: pht000367.v1 ::: GAIN_AA_DIGS4 ::: V898 ::: G30c Alcohol, increase, (African American participants). DIGS4 ::: NONE ::: NONE ::: NONE ::: NONE ::: g30 c alcohol, increase,  african american participants   diagnostic interview for genetic studies ::: Race ::: african american ::: C0085756 ::: popg ::: alcohols;alcohol measurement;diagnosis;genetic study ::: C0001975;C0202304;C0011900;C2827447 ::: orch,phsu;lbpr;fndg;resa ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Drinking History;Research Attributes
phv00115941.v2 ::: phs000285.v2.p2 ::: pht001674.v2 ::: C1F31B ::: C31B_DO3 ::: WHAT PTT WAS DOING WHEN INJURED -CODE3 ::: encoded ::: NONE ::: NONE ::: NONE ::: what ptt was doing when injured code3 ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00101322.v1 ::: phs000287.v2.p1 ::: pht001473.v1 ::: ULTRAYR5 ::: LDENS255 ::: BL REREAD LESION DENSITY, LFT SIDE ::: encoded ::: NONE ::: NONE ::: NONE ::: bleeding on probing reread lesion density, lft side ::: NULL ::: NULL ::: NULL ::: NULL ::: hemorrhage;exploration with a probe;lesion;liver function tests ::: C0019080;C0419358;C0221198;C0023901 ::: patf;diap;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure;Medical History
phv00086534.v2 ::: phs000209.v10.p2 ::: pht001119.v5 ::: MESA_Exam3Main ::: niac3c ::: NIACIN AND NICOTINIC ACID ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: niacin and nicotinic acid ::: NULL ::: NULL ::: NULL ::: NULL ::: niacin;vitamin b3 assay;nicotinic acids ::: C0027996;C1142562;C0028049 ::: orch,phsu,vita;lbpr;orch,phsu,vita ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00007979.v3 ::: phs000007.v18.p7 ::: pht000031.v5 ::: ex1_2s ::: B361 ::: BLOOD ANALYSIS-FASTING LIPIDS ORIGIN TOP FRACTION (1.006) ::: NONE ::: NONE ::: NONE ::: NONE ::: blood analysis fasting lipids origin top fraction  1 006 ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;fasting;national origin;analysis ::: C0002778;C0015663;C0079946;C0936012 ::: lbpr;fndg;clna;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00084390.v2 ::: phs000209.v10.p2 ::: pht001115.v3 ::: MESA_Exam1Diet ::: alcwine1c ::: TOTAL INTAKE OF ALCOHOL FROM WINE PER DAY (G) ::: NUMERIC ::: g ::: NONE ::: NONE ::: total intake of alcohol from wine per day  gram ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement;wine ::: C0001975;C0202304;C0043188 ::: orch,phsu;lbpr;food ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History;Eating or Nutritional Finding
phv00015436.v1 ::: phs000017.v3.p1 ::: pht000057.v1 ::: EA_DIGS3_Data ::: SEV_MANIA_COCAINE_SPEC ::: G30.a. Sev Mania Cocaine Spec, (Participants with European ancestry). DIGS3 ::: NONE ::: NONE ::: NONE ::: NONE ::: g30  a  sev mania cocaine spec,  participants with european ancestry   digs3 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: manic;cocaine;cocaine measurement;sev (substance) ::: C0338831;C0009170;C0202362;C0458216 ::: mobd;hops,orch,phsu;lbpr;food ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Substance Use History;Eating or Nutritional Finding
phv00162419.v2 ::: phs000007.v18.p7 ::: pht002350.v2 ::: vr_ffreq_ex08_1_0615s ::: NUT_NIAWO ::: Derived field: Nutrient value - Niacin without supplements ::: decimal, encoded ::: mg ::: 5.14 ::: 182.05 ::: derived field  nutrient value niacin without supplements ::: NULL ::: NULL ::: NULL ::: NULL ::: nutrients;niacin;vitamin b3 assay;dietary supplements ::: C0678695;C0027996;C1142562;C0242295 ::: food;orch,phsu,vita;lbpr;food ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00080994.v3 ::: phs000007.v18.p7 ::: pht001043.v4 ::: il63_1s ::: raw2 ::: Interleukin-6 raw OD reading for second well ::: decimal, encoded ::: NONE ::: 0.134 ::: 2.903 ::: interleukin 6 raw od reading for second well ::: NULL ::: NULL ::: NULL ::: NULL ::: osteochondritis dissecans;reading (activity);reading (datum presentation);interleukin 6 measurement;recombinant interleukin-6 ::: C0029421;C0034754;C1705179;C0919829;C1527132 ::: dsyn;dora;fndg;lbpr;aapp,imft,phsu ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Daily or Recreational Activity
phv00145257.v1 ::: phs000209.v10.p2 ::: pht002101.v1 ::: MESA_AncilMesaLungExam2CT ::: LMP_air_v ::: LEFT LUNG, MIDDLE PEEL: TOTAL VOLUME OF AIR IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: left lung, middle peel  total volume of air in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;localized desquamation ::: C2700258;C0520893 ::: lbpr;patf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00116110.v2 ::: phs000285.v2.p2 ::: pht001679.v2 ::: C1F39 ::: RAWCREA2 ::: URINARY CREATININE (UNADJUSTED):DAY 2 ::: decimal ::: NONE ::: 17.3 ::: 426.9 ::: urinary creatinine  unadjusted  day 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: urine creatinine measurement ::: C1318439 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00100433.v1 ::: phs000287.v2.p1 ::: pht001452.v1 ::: BASEBOTH ::: IHYPER ::: CALC ISO SYS HTN ::: encoded ::: NONE ::: NONE ::: NONE ::: calc iso sys hypertension ::: NULL ::: NULL ::: NULL ::: NULL ::: hypertensive disease;hypertension adverse event;calculated (procedure) ::: C0020538;C1963138;C1443182 ::: dsyn;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00048499.v1 ::: phs000086.v2.p1 ::: pht000324.v1 ::: EDIC_cbldata ::: BOSGLUC5 ::: Serum glucose-t 5 (mg/dl) ::: int ::: mg/dl ::: NONE ::: NONE ::: serum glucose t 5  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: serum magnesium finding;glucose;plasma glucose measurement;glucose measurement, serum ::: C1826990;C0017725;C0202042;C0202041 ::: fndg;bacs,carb,phsu;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00052792.v1 ::: phs000017.v3.p1 ::: pht000367.v1 ::: GAIN_AA_DIGS4 ::: V1432 ::: J47 Opiates, (African American participants). DIGS4 ::: NONE ::: NONE ::: NONE ::: NONE ::: j47  opiates,  african american participants   diagnostic interview for genetic studies ::: Race ::: african american ::: C0085756 ::: popg ::: opioid abuse;opiate assay;opiates;diagnosis;genetic study ::: C0029095;C0242401;C0376196;C0011900;C2827447 ::: mobd;lbpr;hops,phsu;fndg;resa ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Substance Use History;Research Attributes;Medical History
phv00049318.v1 ::: phs000086.v2.p1 ::: pht000326.v1 ::: EDIC_f0024 ::: OBO2E ::: O2e. Female/ reproductive: did test indicate pregnancy ::: byte ::: NONE ::: NONE ::: NONE ::: o2 e  female  reproductive  did test indicate pregnancy ::: NULL ::: NULL ::: NULL ::: NULL ::: oxygen;female;reproduction;laboratory procedures;indicated;pregnancy ::: C0030054;C0015780;C0035150;C0022885;C1444656;C0032961 ::: elii,phsu;fndg;orgf;lbpr;fndg;orgf ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Medical History
phv00027413.v1 ::: phs000086.v2.p1 ::: pht000231.v1 ::: DCCT_ms5exprt ::: BGPX_20 ::: Mean blood glucose value taken from BG profile: quarterly visit 20 ::: float ::: MG/DL ::: NONE ::: NONE ::: mean blood glucose value taken from blood glucose profile  quarterly visit 20 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;profile (lab procedure);health care visit ::: C0392201;C1979963;C1512346 ::: lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00156348.v1 ::: phs000200.v8.p2 ::: pht002124.v1 ::: outc_self_cad_rel2 ::: F33CHOLESPILLS ::: F33 Cholesterol Pills ::: encoded value ::: NONE ::: NONE ::: NONE ::: f33  cholesterol pills ::: NULL ::: NULL ::: NULL ::: NULL ::: serum total cholesterol measurement ::: C1445957 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00034216.v1 ::: phs000086.v2.p1 ::: pht000282.v1 ::: DCCT_f002cmb4 ::: OBABUSE ::: Patient has a history of drug, alcohol or substance abuse ::: byte ::: NONE ::: NONE ::: NONE ::: patient has a history of drug, alcohol or substance abuse ::: NULL ::: NULL ::: NULL ::: NULL ::: medical history;history of previous events;pharmaceutical preparations;pharmacologic substance;alcohols;alcohol measurement;substance abuse problem ::: C0262926;C2004062;C0013227;C1254351;C0001975;C0202304;C0740858 ::: fndg;fndg;phsu;phsu;orch,phsu;lbpr;mobd ::: patients ::: C0030705 ::: podg ::: Medication Patient;Lab Tests Patient;Drinking History
phv00087540.v1 ::: phs000209.v10.p2 ::: pht001121.v3 ::: MESA_FamilyExamMain ::: volsu1fc ::: SCAN 1: TOTAL ISOMETRIC VOLUME SCORE, UNADJUSTED ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: scan 1  total isometric volume score, unadjusted ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00120355.v2 ::: phs000285.v2.p2 ::: pht001825.v2 ::: F1F48 ::: F48VITBN ::: NUMBER TAKEN (VITAMIN B). Q 2 ::: integer ::: NONE ::: 1 ::: 40 ::: number taken  vitamin b   q 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: riboflavin;blood vitamin b-2 analysis ::: C0035527;C0696224 ::: orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00031331.v1 ::: phs000086.v2.p1 ::: pht000263.v1 ::: DCCT_f0217 ::: BAMDT2B ::: Experimental group: self blood glucose monitoring - less frequent daily schedule ::: byte ::: NONE ::: NONE ::: NONE ::: experimental group  self blood glucose monitoring less frequent daily schedule ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;preventive monitoring;clinical trials, monitoring ::: C0392201;C0150369;C1516647 ::: lbpr;hlca;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Healthcare Activity Finding;Research Attributes
phv00099558.v1 ::: phs000287.v2.p1 ::: pht001450.v1 ::: BASE1 ::: FSHOIL06 ::: CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS ::: encoded ::: NONE ::: NONE ::: NONE ::: codliver oil other fluorescent in situ hybridization oil supplements ::: NULL ::: NULL ::: NULL ::: NULL ::: cod liver oil;others;in situ hybridization;food oil;dietary supplements ::: C0009213;C1955473;C0162788;C1517288;C0242295 ::: lipd,phsu;fndg;lbpr,mbrt;food,lipd;food ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00068619.v2 ::: phs000007.v18.p7 ::: pht000681.v3 ::: ffreq1_6s ::: NUT_RETINOL ::: DERIVED FIELD: NUTRIENT VALUE - RETINOL, (IU) ::: NONE ::: IU ::: NONE ::: NONE ::: derived field  nutrient value retinol,  international unit ::: NULL ::: NULL ::: NULL ::: NULL ::: nutrients;vitamin a;all-trans-retinol;vitamin a measurement ::: C0678695;C0042839;C0087161;C0373745 ::: food;orch,phsu,vita;orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00160629.v1 ::: phs000209.v10.p2 ::: pht002298.v1 ::: MESA_AncilMesaRVFunction ::: rvedv1 ::: PHASE 1: RV END-DIASTOLIC VOLUME (mL) ::: NUMERIC ::: mL ::: NONE ::: NONE ::: phase 1  residual volume end diastolic volume m l ::: NULL ::: NULL ::: NULL ::: NULL ::: residual volume;end diastolic;lung residual volume measurement;volume.residual:volume:point in time:respiratory system:quantitative ::: C0035190;C0442709;C0429713;C0802961 ::: clna;clna;lbpr;clna ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00061945.v2 ::: phs000128.v3.p3 ::: pht000518.v2 ::: simphen119 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00173446.v1 ::: phs000007.v18.p7 ::: pht002942.v1 ::: SABRe_Project_2_Immunoassays_l_mpimn02_2005_m_0693s ::: GMP_140 ::: Granule membrane protein 140 (P-selectin) (sample type: plasma) ::: NONE ::: pg/mL ::: 116 ::: 60500 ::: granule membrane protein 140   pselectin   sample type  plasma ::: NULL ::: NULL ::: NULL ::: NULL ::: plasma protein assay ::: C1168405 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00124401.v1 ::: phs000304.v1.p1 ::: pht001907.v1 ::: GABC_Subject_Phenotypes ::: Favorite color ::: Of the following colors, which is your favorite color? ::: encoded integer ::: NONE ::: 1 ::: 10 ::: of the following colors, which is your favorite color ::: NULL ::: NULL ::: NULL ::: NULL ::: coloring excipient;color assessment ::: C1705245;C1880121 ::: phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00025020.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: QV08_R12 ::: Category test - subtest 2 - errors (quarterly visit 08) ::: byte ::: ERRORS/SUBTEST 2 ::: NONE ::: NONE ::: category test subtest 2 errors  quarterly visit 08 ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures;health care visit ::: C0022885;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00116369.v2 ::: phs000285.v2.p2 ::: pht001695.v2 ::: C1LIP ::: CL1CHOL ::: TOTAL CHOLESTEROL (MG/DL) ::: integer ::: MG/DL ::: 70 ::: 465 ::: total cholesterol  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: serum total cholesterol measurement ::: C1445957 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00023796.v3 ::: phs000007.v18.p7 ::: pht000161.v4 ::: il61_7s ::: il6 ::: INTERLEUKIN-6 FROM SERUM (PG/ML) ::: NONE ::: PG/ML ::: NONE ::: NONE ::: interleukin 6 from serum  pg mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: interleukin 6 measurement;recombinant interleukin-6 ::: C0919829;C1527132 ::: lbpr;aapp,imft,phsu ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00145459.v1 ::: phs000209.v10.p2 ::: pht002101.v1 ::: MESA_AncilMesaLungExam2CT ::: LUP_tot_v ::: LEFT LUNG UPPER PEEL: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: left lung upper peel  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;localized desquamation ::: C2700258;C0520893 ::: lbpr;patf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00119784.v2 ::: phs000285.v2.p2 ::: pht001809.v2 ::: F1F05 ::: F05TMSPN ::: TIME BLOOD WAS SPUN. Q 7 ::: integer ::: NONE ::: 26040 ::: 62580 ::: time blood was spun  q 7 ::: NULL ::: NULL ::: NULL ::: NULL ::: spun ::: C1446863 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00162225.v2 ::: phs000007.v18.p7 ::: pht002350.v2 ::: vr_ffreq_ex08_1_0615s ::: OTH_FISH ::: FFQ: OTHER FISH ::: encoded ::: 3 - 5 oz ::: NONE ::: NONE ::: food frequency questionnaire  other fluorescent in situ hybridization ::: NULL ::: NULL ::: NULL ::: NULL ::: food;others;in situ hybridization ::: C0016452;C1955473;C0162788 ::: food;fndg;lbpr,mbrt ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Eating or Nutritional Finding
phv00015277.v1 ::: phs000017.v3.p1 ::: pht000057.v1 ::: EA_DIGS3_Data ::: OTH_DFA_AT_LEAST_1_HOUR ::: F40.b. Oth DFA at Least 1 hour, (Participants with European ancestry). DIGS3 ::: NONE ::: NONE ::: NONE ::: NONE ::: f40  b  oth dfa at least 1 hour,  participants with european ancestry   digs3 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: direct fluorescent antibody test ::: C1707759 ::: lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Lab Tests Patient
phv00019976.v1 ::: phs000018.v1.p1 ::: pht000062.v1 ::: GOKIND_Phenotype_GAIN ::: CREATN ::: Serum creatinine (mg/dL) ::: NONE ::: mg/dL ::: NONE ::: NONE ::: serum creatinine magnesium d l ::: NULL ::: NULL ::: NULL ::: NULL ::: serum magnesium finding;creatinine finding;creatinine measurement, serum (procedure) ::: C1826990;C1561535;C0201976 ::: fndg;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00155524.v2 ::: phs000200.v8.p2 ::: pht002118.v2 ::: ecg_rel2 ::: STM_V1 ::: M (middle of ST segment) amplitude, lead stm_v1 ::: integer ::: NONE ::: -323 ::: 1201 ::: m  middle of subtalar segment  amplitude, lead stm_v1 ::: NULL ::: NULL ::: NULL ::: NULL ::: microscopy, scanning tunneling ::: C0079837 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00033232.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL28A26 ::: Post-lunch blood glucose mg/dl (quarterly visit 26) ::: int ::: MG/DL ::: NONE ::: NONE ::: post lunch blood glucose magnesium distolingual  quarterly visit 26 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00092896.v1 ::: phs000280.v1.p1 ::: pht001309.v1 ::: ARIC_CARE_DERV3C1 ::: TCHSIU31 ::: Total Cholesterol in SI units ::: decimal ::: NONE ::: 1.99122 ::: 14.42988 ::: total cholesterol in si units ::: NULL ::: NULL ::: NULL ::: NULL ::: serum total cholesterol measurement ::: C1445957 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00094459.v1 ::: phs000280.v1.p1 ::: pht001333.v1 ::: ARIC_CARE_HMTCV4C1 ::: HMTC10 ::: Platelet Count                       Q10 ::: integer ::: NONE ::: 19 ::: 890 ::: platelet count q10 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00162819.v1 ::: phs000404.v1.p1 ::: pht002368.v1 ::: GENEVA_Smoking_Cessation_Subject_Phenotypes_COGEND ::: alc_sx3 ::: Using alcohol in larger amounts or over longer period than intended ::: encoded integer ::: NONE ::: NONE ::: NONE ::: using alcohol in larger amounts or over longer period than intended ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement ::: C0001975;C0202304 ::: orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History
phv00153278.v2 ::: phs000209.v10.p2 ::: pht002109.v2 ::: MESA_MesaFamily_LungCT ::: LUP_air_v ::: LEFT LUNG UPPER PEEL: TOTAL VOLUME OF AIR IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: left lung upper peel  total volume of air in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;localized desquamation ::: C2700258;C0520893 ::: lbpr;patf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00161716.v1 ::: phs000385.v1.p1 ::: pht002342.v1 ::: Epigenetic_Colorectal_Cancer_Sample_Attributes ::: HISTOLOGICAL_TYPE ::: Cell or tissue type or subtype of sample ::: string ::: NONE ::: NONE ::: NONE ::: cell or tissue type or subtype of sample ::: NULL ::: NULL ::: NULL ::: NULL ::: histocompatibility testing ::: C0019633 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142315.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: C1orf58_Run4_Plate ::: RNA LEVELS: C1orf58, Run4, Platelet (TaqmanAssayID : Hs00329051_m1) ::: decimal, encoded ::: cycle threshold ::: 8.38262957310909 ::: 26.9992047595094 ::: ribonucleic acid levels  c1orf58 , run4, platelet  taqmanassayid   hs00329051_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00023230.v3 ::: phs000007.v18.p7 ::: pht000147.v4 ::: ebct1_7s ::: EBCT22 ::: CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.:  TOTAL ::: NONE ::: NONE ::: NONE ::: NONE ::: coronary artery calcium score volume w e   total ::: NULL ::: NULL ::: NULL ::: NULL ::: coronary calcium score;volume measurement ::: C2825178;C2700258 ::: fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00100517.v1 ::: phs000287.v2.p1 ::: pht001452.v1 ::: BASEBOTH ::: ADPI06 ::: Inhibitors of ADP-induced platelet aggre ::: encoded ::: NONE ::: NONE ::: NONE ::: inhibitors of adenosine diphosphate induced platelet aggre ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00151182.v3 ::: phs000209.v10.p2 ::: pht002108.v3 ::: MESA_MesaAirNR_LungCT ::: LU_tot_v ::: LEFT LUNG UPPER: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: left lung upper  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00160680.v1 ::: phs000209.v10.p2 ::: pht002298.v1 ::: MESA_AncilMesaRVFunction ::: rvedv2 ::: PHASE 2: RV END-DIASTOLIC VOLUME (mL) ::: NUMERIC ::: mL ::: NONE ::: NONE ::: phase 2  residual volume end diastolic volume m l ::: NULL ::: NULL ::: NULL ::: NULL ::: residual volume;end diastolic;lung residual volume measurement;volume.residual:volume:point in time:respiratory system:quantitative ::: C0035190;C0442709;C0429713;C0802961 ::: clna;clna;lbpr;clna ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00106920.v1 ::: phs000287.v2.p1 ::: pht001491.v1 ::: YR5OLD ::: HEMATO23 ::: HEMATOCRIT (%) ::: decimal ::: NONE ::: 10.9 ::: 54.9 ::: hematocrit  % ::: NULL ::: NULL ::: NULL ::: NULL ::: hematocrit procedure ::: C0018935 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00050691.v1 ::: phs000086.v2.p1 ::: pht000339.v1 ::: EDIC_f0703 ::: GOB8IC3 ::: B8ic3. Health care delivery. Other major tests: paid by other insurance ::: byte ::: Times ::: NONE ::: NONE ::: b8ic3   health candidate gene association resource delivery  other major tests  paid by other insurance ::: NULL ::: NULL ::: NULL ::: NULL ::: mental association;obstetric delivery;others;laboratory procedures;delivery finding ::: C0004083;C0011209;C1955473;C0022885;C0559563 ::: menp;topp;fndg;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Therapeutic or Preventive Procedure;Medical History
phv00027773.v1 ::: phs000086.v2.p1 ::: pht000231.v1 ::: DCCT_ms5exprt ::: STDCHL08 ::: Cholesterol (mg/1000 calories): quarterly visit 08 ::: float ::: MG/1000 CAL ::: NONE ::: NONE ::: cholesterol  magnesium 1000 calories   quarterly visit 08 ::: NULL ::: NULL ::: NULL ::: NULL ::: serum total cholesterol measurement;health care visit ::: C1445957;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00165100.v1 ::: phs000435.v1.p1 ::: pht002523.v1 ::: CLL_dbGaP_SubjectPhenotypesDS_v1 ::: Trisomy 12 ::: Trisomy 12 is measured by FISH cytogenetic analysis. Cutoff score is 2%. Trisomy 12 is a neutral prognosis marker. ::: NONE ::: NONE ::: NONE ::: NONE ::: trisomy 12 is measured by fluorescent in situ hybridization cytogenetic analysis  cutoff score is 2%  trisomy 12 is a neutral prognosis marker ::: NULL ::: NULL ::: NULL ::: NULL ::: trisomy 12;in situ hybridization;trisomy 2 ::: C0432408;C0162788;C0795801 ::: dsyn;lbpr,mbrt;dsyn ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00059090.v2 ::: phs000128.v3.p3 ::: pht000429.v2 ::: simphen030 ::: rx1 ::: 1:Rx for high LDL,0:No Rx, visit 1 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0 no rx, visit 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00025253.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR20_31 ::: Test r31: difference between year 5  and baseline scores ::: byte ::: TEST R31 SCORE ::: NONE ::: NONE ::: test r31   difference between year 5 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00107381.v1 ::: phs000287.v2.p1 ::: pht001491.v1 ::: YR5OLD ::: CCBSR06 ::: Slow-release CCBs = NIFSR or DIHSR or VE ::: encoded ::: NONE ::: NONE ::: NONE ::: slow release calcium channel blockers = nifsr or type of medication or expired volume ::: NULL ::: NULL ::: NULL ::: NULL ::: patient discharge;calcium channel blockers;discharge (release);release (procedure);pharmaceutical preparations;volume measurement ::: C0030685;C0006684;C0680255;C1963578;C0013227;C2700258 ::: hlca;phsu;hlca;topp;phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Healthcare Activity Finding;Therapeutic or Preventive Procedure
phv00013038.v1 ::: phs000017.v3.p1 ::: pht000056.v1 ::: EA_DIGS2_Data ::: I14630 ::: N4. Did you ever continue to use (alcohol/drugs) heavily after your (mood/psychotic) episode stopped? (Participants with European ancestry). DIGS2 ::: NONE ::: NONE ::: NONE ::: NONE ::: n4  did you ever continue to use  alcohol drugs  heavily after your  mood psychotic  episode stopped   participants with european ancestry   digs2 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: pharmaceutical preparations;alcohols;alcohol measurement;mood (psychological function);psychotic episodes;mood:-:point in time:^patient:- ::: C0013227;C0001975;C0202304;C0026516;C0338614;C2713234 ::: phsu;orch,phsu;lbpr;menp;mobd;clna ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Mental or Emotional Finding;Drinking History
phv00116107.v2 ::: phs000285.v2.p2 ::: pht001679.v2 ::: C1F39 ::: RAWMG1 ::: URINARY MAGNESIUM (UNADJUSTED):DAY 1 ::: decimal ::: NONE ::: 0 ::: 27 ::: urinary magnesium  unadjusted  day 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine ::: C0428308 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00065989.v1 ::: phs000086.v2.p1 ::: pht000625.v1 ::: EDIC_f0705 ::: GOB5F ::: B5f. Health insurance coverage. If you currently have health insurance, does it provide coverage for blood glucose testing meters ::: byte ::: NONE ::: NONE ::: NONE ::: b5 f  health insurance coverage  if you currently have health insurance, does it provide coverage for blood glucose testing meters ::: NULL ::: NULL ::: NULL ::: NULL ::: fluorides;health insurance;provide (product);blood glucose measurement ::: C0016327;C0021682;C0359589;C0392201 ::: inch,phsu;hlca;food;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding;Healthcare Activity Finding
phv00126817.v1 ::: phs000286.v3.p1 ::: pht001953.v1 ::: DPASS_DIET1_ES ::: lffq_glut ::: LFFQ: glutamic acid (gm) ::: decimal ::: gm ::: 3.067473 ::: 37.20011 ::: lffq  glutamic acid  gm ::: NULL ::: NULL ::: NULL ::: NULL ::: glutamic acid;glutamate measurement ::: C0061472;C0523665 ::: aapp,bacs,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00032831.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL25B08 ::: Pre-breakfast blood glucose at OD 340 (quarterly visit 08) ::: float ::: OD 340 ::: NONE ::: NONE ::: pre breakfast blood glucose at od 340   quarterly visit 08 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00115939.v2 ::: phs000285.v2.p2 ::: pht001674.v2 ::: C1F31B ::: C31B_DO1 ::: WHAT PTT WAS DOING WHEN INJURED -CODE1 ::: integer ::: NONE ::: 1 ::: 88 ::: what ptt was doing when injured code1 ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00027347.v1 ::: phs000086.v2.p1 ::: pht000230.v1 ::: DCCT_cbl2 ::: BCSGLUC3 ::: CBL2: GFR serum glucose - t3 value (mg/dl) ::: byte ::: MG/DL ::: NONE ::: NONE ::: cbl2  glomerular filtration rate serum glucose t3 value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum magnesium finding;glucose;plasma glucose measurement;glucose measurement, serum;glomerular filtration rate finding ::: C0017654;C1826990;C0017725;C0202042;C0202041;C1561549 ::: diap,ortf;fndg;bacs,carb,phsu;lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Diagnostic Procedure
phv00049991.v1 ::: phs000086.v2.p1 ::: pht000332.v1 ::: EDIC_f0422 ::: DBJ6A1 ::: J6a1. Potential contributing factors,  glucose monitoring: self blood glucose ::: byte ::: NONE ::: NONE ::: NONE ::: j6a1   potential contributing factors, glucose monitoring  self blood glucose ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose measurement by monitoring device;blood glucose measurement ::: C0202048;C0392201 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Substance Use History
phv00085604.v2 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: othalc1 ::: OTHER ALCOHOL (FORMER DRINKERS) ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: other alcohol  former drinkers ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement ::: C0001975;C0202304 ::: orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History
phv00021934.v3 ::: phs000007.v18.p7 ::: pht000092.v4 ::: homocys1_2s ::: THC ::: HOMOCYSTEINE ::: NONE ::: NMOL/ML ::: NONE ::: NONE ::: homocysteine ::: NULL ::: NULL ::: NULL ::: NULL ::: homocystine measurement;homocysteine measurement ::: C0919377;C2242817 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00025455.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR28_76 ::: Test r76: difference between year 7  and baseline scores ::: float ::: TEST R76 SCORE DIFFERENCE ::: NONE ::: NONE ::: test r76   difference between year 7 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00007711.v3 ::: phs000007.v18.p7 ::: pht000031.v5 ::: ex1_2s ::: B61 ::: ANTI-CHOLESTEROL AGENT ::: NONE ::: NONE ::: NONE ::: NONE ::: anti cholesterol agent ::: NULL ::: NULL ::: NULL ::: NULL ::: anti-anxiety agents;serum total cholesterol measurement ::: C0040616;C1445957 ::: phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00013027.v1 ::: phs000017.v3.p1 ::: pht000056.v1 ::: EA_DIGS2_Data ::: I14520 ::: N1b. You mentioned earlier your (mood changes/psychotic symptoms), and also that you were using (alcohol drugs) heavily. Think about the first time you had any of these problems. Which came first (mood changes/psychotic symptoms) or (alcohol/drugs)? (IF ALCOHOL/DRUGS OCCURRED FIRST:) For how long were you using (alcohol/drugs)  heavily before your (mood changes/ psychotic symptoms) began? DAYS. (Participants with European ancestry). DIGS2 ::: NONE ::: NONE ::: NONE ::: NONE ::: n1 b  you mentioned earlier your  mood changes psychotic symptoms , and also that you were using  alcohol drugs  heavily  think about the first time you had any of these problems  which came first  mood changes psychotic symptoms  or  alcohol drugs    if alcohol drugs occurred first   for how long were you using  alcohol drugs  heavily before your  mood changes  psychotic symptoms  began  days   participants with european ancestry   digs2 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: n1 category;mood swings;psychotic symptom;pharmaceutical preparations;alcohols;alcohol measurement;thinking, function ::: C0441962;C0085633;C0871189;C0013227;C0001975;C0202304;C0039869 ::: fndg;mobd;sosy;phsu;orch,phsu;lbpr;menp ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Mental or Emotional Finding;Drinking History
phv00032653.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: NLD25_01 ::: Blood glucose profile analysis date (quarterly visit 01) ::: str6 ::: NONE ::: NONE ::: NONE ::: blood glucose profile analysis date  quarterly visit 01 ::: NULL ::: NULL ::: NULL ::: NULL ::: profile (lab procedure);analysis of substances;date fruit;analysis;blood glucose measurement;health care visit ::: C1979963;C0002778;C2348077;C0936012;C0392201;C1512346 ::: lbpr;lbpr;food;resa;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00116637.v2 ::: phs000285.v2.p2 ::: pht001709.v2 ::: D1F05A ::: D05TB1D ::: 13ML RED TUBE, 1 ML SERUM (INSULIN) ::: encoded ::: NONE ::: NONE ::: NONE ::: 13 mesiolingual red tube, 1 mesiolingual serum  insulin ::: NULL ::: NULL ::: NULL ::: NULL ::: redness;serum insulin measurement ::: C0332575;C0428357 ::: fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00121026.v2 ::: phs000285.v2.p2 ::: pht001859.v2 ::: F2HCY ::: FLBVTB6 ::: Y15 VITAMIN B6 (nmol/L) - 2003 RUN ::: decimal ::: nmol/L ::: 0.5 ::: 1496 ::: y15  vitamin b6 nmol  l  2003  run ::: NULL ::: NULL ::: NULL ::: NULL ::: vitamin b6;blood vitamin b6 analysis;running (physical activity);does run (finding) ::: C0087162;C0696232;C0035953;C0600140 ::: orch,phsu,vita;lbpr;dora;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding;Daily or Recreational Activity
phv00026602.v1 ::: phs000086.v2.p1 ::: pht000217.v1 ::: DCCT_f057cmb3 ::: EGB3E2 ::: Percentage of compliance with pre-supper (blood) tests ::: NONE ::: PERCENT - COMPLIANCE ::: NONE ::: NONE ::: percentage of compliance with pre supper  blood  tests ::: NULL ::: NULL ::: NULL ::: NULL ::: compliance behavior;hematologic tests ::: C1321605;C0018941 ::: inbe;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00128745.v1 ::: phs000209.v10.p2 ::: pht001984.v1 ::: MESA_AncilMesaInflammation ::: pcmotfum ::: REASON FOR MISSING DATA: PERCENT OF MONOCYTES THAT ARE TF+ IN UNSTIMULATED EXPRESSION ASSAY ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: reason for missing data  percent of monocytes that are tf+ in unstimulated expression assay ::: NULL ::: NULL ::: NULL ::: NULL ::: monocyte count procedure;expression procedure;biological assay;assay ::: C0200637;C0185117;C0005507;C1510438 ::: lbpr;topp;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00026493.v1 ::: phs000086.v2.p1 ::: pht000215.v1 ::: DCCT_cbl00 ::: BCVOL ::: CBL00: 24-hr urine: volume ::: NONE ::: NONE ::: NONE ::: NONE ::: cbl00   24 heart rate urine  volume ::: NULL ::: NULL ::: NULL ::: NULL ::: urine volume function;urine sample volume measurement;urine volume finding ::: C0232856;C1278293;C1287298 ::: clna;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes;Medical History
phv00032990.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL28A15 ::: Post-lunch blood glucose mg/dl (quarterly visit 15) ::: int ::: MG/DL ::: NONE ::: NONE ::: post lunch blood glucose magnesium distolingual  quarterly visit 15 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00105804.v1 ::: phs000287.v2.p1 ::: pht001490.v1 ::: YR5NEW ::: LIMB27 ::: IS PTT MISSING A LIMB ::: encoded ::: NONE ::: NONE ::: NONE ::: is ptt missing a limb ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00101320.v1 ::: phs000287.v2.p1 ::: pht001473.v1 ::: ULTRAYR5 ::: LOCAT255 ::: BL REREAD PLAQUE EPICENTER, LFT SIDE ::: encoded ::: NONE ::: NONE ::: NONE ::: bleeding on probing reread plaque epicenter, lft side ::: NULL ::: NULL ::: NULL ::: NULL ::: hemorrhage;exploration with a probe;dental plaque;plaque (lesion);senile plaques;liver function tests ::: C0019080;C0419358;C0011389;C0332461;C0333463;C0023901 ::: patf;diap;dsyn;fndg;acab;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure;Medical History
phv00152630.v2 ::: phs000209.v10.p2 ::: pht002109.v2 ::: MESA_MesaFamily_LungCT ::: BC_tot_v ::: BOTH LUNGS, CORE: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: both lungs, core  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00017081.v1 ::: phs000017.v3.p1 ::: pht000058.v1 ::: EA_DIGS4_Data ::: V153 ::: B5a. EEG. EEG/"Brain Wave tests?" (Participants with European ancestry). DIGS4 ::: NONE ::: NONE ::: NONE ::: NONE ::: b5 a  electroencephalogram  electroencephalogram brain wave tests   participants with european ancestry   diagnostic interview for genetic studies ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: electroencephalography;laboratory procedures;diagnosis;genetic study ::: C0013819;C0022885;C0011900;C2827447 ::: diap;lbpr;fndg;resa ::: participant ::: C0679646 ::: popg ::: Demographics;Lab Tests Patient;Research Attributes;Diagnostic Procedure
phv00033408.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL28A34 ::: Post-lunch blood glucose mg/dl (quarterly visit 34) ::: int ::: MG/DL ::: NONE ::: NONE ::: post lunch blood glucose magnesium distolingual  quarterly visit 34 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033362.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL27A32 ::: Pre-lunch blood glucose mg/dl (quarterly visit 32) ::: int ::: MG/DL ::: NONE ::: NONE ::: pre lunch blood glucose magnesium distolingual  quarterly visit 32 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00142328.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: COL4A1_Run4_Plate ::: RNA LEVELS: COL4A1, Run4, Platelet (TaqmanAssayID : Hs01007469_m1) ::: decimal, encoded ::: cycle threshold ::: 14.1462393736348 ::: 26.9289880868452 ::: ribonucleic acid levels  col4a1 , run4, platelet  taqmanassayid   hs01007469_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00066432.v1 ::: phs000092.v1.p1 ::: pht000116.v1 ::: AlcoholDepAdd_Data ::: op_sx1 ::: Tolerance to opiates ::: encoded value ::: NONE ::: 1 ::: 9 ::: tolerance to opiates ::: NULL ::: NULL ::: NULL ::: NULL ::: drug tolerance;immune tolerance;mental tolerance;physiologic tolerance;opioid abuse;opiate assay;opiates ::: C0013220;C0020963;C0220929;C0231197;C0029095;C0242401;C0376196 ::: fndg;patf;menp;phsf;mobd;lbpr;hops,phsu ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Mental or Emotional Finding;Substance Use History;Medical History
phv00007417.v1 ::: phs000007.v18.p7 ::: pht000029.v3 ::: ex0_27s ::: FT385 ::: HAVE YOU FAINTED OR LOST CONSCIOUSNESS IN THE INTERIM? IF DUE TO STROKE SKIP TO SCREEN 11 (IF EVENT IMMEDIATELY PRECEDED BY HEAD INJURY OR ACCIDENT CODE AS NO) ::: NONE ::: NONE ::: NONE ::: NONE ::: have you fainted or lost consciousness in the interim  if due to stroke skip to screen 11  if event immediately preceded by head injury or accident code as no ::: NULL ::: NULL ::: NULL ::: NULL ::: syncope;consciousness related finding;conscious;cerebrovascular accident;does skip;screening procedure;toxicology screen, general (procedure);craniocerebral trauma ::: C0039070;C0009791;C0234421;C0038454;C0560435;C0220908;C0430054;C0018674 ::: sosy;fndg;menp;dsyn;fndg;hlca;lbpr;inpo ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Medical History
phv00031628.v1 ::: phs000086.v2.p1 ::: pht000267.v1 ::: DCCT_f049cmb2 ::: DIB4 ::: How certain (0=Very uncertain; 5=moderately certain; 10=very certain) are you that you will be able to carry out  the following: test for acetone at least once/day ::: NONE ::: NONE ::: NONE ::: NONE ::: how certain 0= very uncertain  5=moderately certain  10=very certain  are you that you will be able to carry out the following  test for acetone at least once day ::: NULL ::: NULL ::: NULL ::: NULL ::: able (finding);does carry;laboratory procedures;acetone ::: C1299581;C0699809;C0022885;C0001002 ::: fndg;fndg;lbpr;orch,phsu ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Medical History
phv00120560.v2 ::: phs000285.v2.p2 ::: pht001840.v2 ::: F1F68 ::: F68STPRS ::: TEXT-OTH REAS FOR PERIODS STOP, 12 MOS. Q 9 ::: string ::: NONE ::: NONE ::: NONE ::: text oth reas for periods stop, 12 mos  q 9 ::: NULL ::: NULL ::: NULL ::: NULL ::: restriction mapping ::: C0035269 ::: lbpr,mbrt ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00112356.v1 ::: phs000096.v4.p1 ::: pht001550.v1 ::: HAPO_European_Phenotypes ::: b_NNA_FLMn ::: Baby's mean flank skinfold ::: decimal, encoded string ::: mm ::: 1.9 ::: 9.05 ::: baby s mean flank skinfold ::: NULL ::: NULL ::: NULL ::: NULL ::: skin fold ::: C1446851 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00029317.v1 ::: phs000086.v2.p1 ::: pht000243.v1 ::: DCCT_ms4exprt ::: ANSCLVIS ::: Quarterly visit number of close-out autonomic nervous system (ANS) tests ::: byte ::: QUARTERLY VISIT ::: NONE ::: NONE ::: quarterly visit number of close out autonomic nervous system  autonomic nervous system  tests ::: NULL ::: NULL ::: NULL ::: NULL ::: health care visit;laboratory procedures ::: C1512346;C0022885 ::: inbe;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00161205.v1 ::: phs000209.v10.p2 ::: pht002195.v2 ::: MESA_Exam1ECGContiWaveform ::: mxstv21 ::: Maximum of STJ,STM, STE Amplitudes, Lead V2 (uV) ::: NUMERIC ::: uV ::: NONE ::: NONE ::: maximum of stj,stm, st elevation amplitudes, lead v2 u v ::: NULL ::: NULL ::: NULL ::: NULL ::: microscopy, scanning tunneling;st segment elevation (finding) ::: C0079837;C0520886 ::: lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00027583.v1 ::: phs000086.v2.p1 ::: pht000231.v1 ::: DCCT_ms5exprt ::: CHOL20 ::: Total cholesterol (mg/dl): quarterly visit 20 ::: int ::: MG/DL ::: NONE ::: NONE ::: total cholesterol  magnesium distolingual   quarterly visit 20 ::: NULL ::: NULL ::: NULL ::: NULL ::: serum total cholesterol measurement;health care visit ::: C1445957;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00110288.v1 ::: phs000287.v2.p1 ::: pht001495.v1 ::: YR9 ::: PRARM27 ::: DOES PTT USE A RIGHT ARM PROTHESIS ::: encoded ::: NONE ::: NONE ::: NONE ::: does ptt use a right arm prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00149226.v1 ::: phs000209.v10.p2 ::: pht002103.v1 ::: MESA_AncilMesaLungExam4CT ::: LUP_tis_v ::: LEFT LUNG UPPER PEEL: TOTAL VOLUME OF TISSUE IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: left lung upper peel  total volume of tissue in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;localized desquamation ::: C2700258;C0520893 ::: lbpr;patf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00142129.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: NPPA_Run2_Plate ::: RNA LEVELS: NPPA, Run2, Platelet (TaqmanAssayID : Hs00383231_m1) ::: decimal, encoded ::: cycle threshold ::: 19.28 ::: 26.97 ::: ribonucleic acid levels  nppa, run2, platelet  taqmanassayid   hs00383231_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: n-propionylprocainamide;platelet count measurement ::: C0068273;C0032181 ::: orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00157789.v1 ::: phs000007.v18.p7 ::: pht002152.v1 ::: ffreq0_21s ::: SCORE18 ::: DERIVED FIELD: NUTRIENT VALUE - VITAMIN B6, (MG) ::: NONE ::: mg ::: NONE ::: NONE ::: derived field  nutrient value vitamin b6,  magnesium ::: NULL ::: NULL ::: NULL ::: NULL ::: nutrients;vitamin b6;blood vitamin b6 analysis ::: C0678695;C0087162;C0696232 ::: food;orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00066107.v1 ::: phs000086.v2.p1 ::: pht000625.v1 ::: EDIC_f0705 ::: GOD4H ::: D4h. Hospitalization and other health care services used. During the past 12 months, have you had any of the following laboratory tests: dilated eye, in past 12 months ::: byte ::: NONE ::: NONE ::: NONE ::: d4 h  hospitalization and other health candidate gene association resource services used  during the past 12 months, have you had any of the following laboratory tests  dilated eye, in past 12 months ::: NULL ::: NULL ::: NULL ::: NULL ::: hospitalization;health services;mental association;used by;laboratory procedures;dilate eye ::: C0019993;C0018747;C0004083;C1273517;C0022885;C0849420 ::: hlca;hlca;menp;fndg;lbpr;topp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Therapeutic or Preventive Procedure
phv00159010.v1 ::: phs000250.v1.p1 ::: pht002188.v1 ::: CALGB_80303_Subject_Phenotypes ::: SUBJID ::: De-identified subject ID.  This variable can be used to merge the phenotype data with the genomic data. ::: NONE ::: NONE ::: NONE ::: NONE ::: deidentified subject identification  this variable can be used to merge the phenotype data with the genomic data ::: NULL ::: NULL ::: NULL ::: NULL ::: identification (psychology);used by;phenotype determination ::: C0020792;C1273517;C1285572 ::: menp;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00002414.v1 ::: phs000007.v18.p7 ::: pht000016.v3 ::: ex0_14s ::: FG310 ::: BLOOD ANALYSIS, HEMATOCRIT ::: NONE ::: PERCENT ::: NONE ::: NONE ::: blood analysis, hematocrit ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;hematocrit procedure ::: C0002778;C0936012;C0018935 ::: lbpr;resa;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00142353.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: IKZF1_Run4_Plate ::: RNA LEVELS: IKZF1, Run4, Platelet (TaqmanAssayID : Hs00172991_m1) ::: decimal, encoded ::: cycle threshold ::: 5.63623043329126 ::: 26.5503049587966 ::: ribonucleic acid levels  ikzf1, run4, platelet  taqmanassayid   hs00172991_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00066340.v1 ::: phs000140.v1.p1 ::: pht000630.v1 ::: T2D_Case_Data ::: Gender ::: Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female ::: continuous integer ::: NONE ::: NONE ::: NONE ::: gender of participant has been confirmed with genotyping  1 = male, 2 = female ::: Gender ::: gender ::: C0079399 ::: orga;orga ::: gender:type:point in time:^patient:nominal;genotype determination;male gender;female ::: C0804628;C1285573;C0024554;C0015780 ::: clna;lbpr;fndg;fndg ::: participant ::: C0679646 ::: popg ::: Demographics;Lab Tests Patient;Medical History
phv00033498.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL29A38 ::: Pre-supper blood glucose mg/dl (quarterly visit 38) ::: int ::: MG/DL ::: NONE ::: NONE ::: pre supper blood glucose magnesium distolingual  quarterly visit 38 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00157788.v1 ::: phs000007.v18.p7 ::: pht002152.v1 ::: ffreq0_21s ::: SCORE17 ::: DERIVED FIELD: NUTRIENT VALUE - NIACIN, (MG) ::: NONE ::: mg ::: NONE ::: NONE ::: derived field  nutrient value niacin,  magnesium ::: NULL ::: NULL ::: NULL ::: NULL ::: nutrients;niacin;vitamin b3 assay ::: C0678695;C0027996;C1142562 ::: food;orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00084532.v2 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: volsp11c ::: SCAN 1: TOTAL VOLUME SCORE, PHANTOM-ADJUSTED ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: scan 1  total volume score, phantom adjusted ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00051852.v2 ::: phs000128.v3.p3 ::: pht000364.v2 ::: gen3 ::: alc1 ::: EQUIVALENT ALCOHOL OZ (PER WEEK), EXAM1 ::: integer ::: ounces ::: 0 ::: 44 ::: equivalent alcohol oz  per week , exam1 ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement ::: C0001975;C0202304 ::: orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History
phv00061913.v2 ::: phs000128.v3.p3 ::: pht000517.v2 ::: simphen118 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00028562.v1 ::: phs000086.v2.p1 ::: pht000239.v1 ::: DCCT_cbl7 ::: BCNLD24 ::: CBL7: Lipid test - 24: collection date ::: str6 ::: NONE ::: NONE ::: NONE ::: cbl7  lipid test 24  collection date ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00025191.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR08_46 ::: Test r46: difference between year 2  and baseline scores ::: byte ::: TEST R46 SCORE ::: NONE ::: NONE ::: test r46   difference between year 2 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00073519.v1 ::: phs000182.v2.p1 ::: pht000795.v1 ::: AMD_MMAP_Phenotype ::: Subject_ID ::: Sample IDs of samples being genotyped ::: integer, string ::: NONE ::: NONE ::: NONE ::: sample ids of samples being genotyped ::: NULL ::: NULL ::: NULL ::: NULL ::: genotype determination ::: C1285573 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142303.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: APOA1_Run4_Plate ::: RNA LEVELS: APOA1, Run4, Platelet (TaqmanAssayID : Hs00163641_m1) ::: decimal, encoded ::: cycle threshold ::: 16.8471688478046 ::: 26.6619450677069 ::: ribonucleic acid levels  apoa1, run4, platelet  taqmanassayid   hs00163641_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: apolipoprotein a1 measurement;platelet count measurement ::: C2698168;C0032181 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00070209.v2 ::: phs000007.v18.p7 ::: pht000680.v3 ::: ffreq1_5s ::: NUT_NIACIN ::: DERIVED FIELD: NUTRIENT VALUE - NIACIN, (MG) ::: NONE ::: mg ::: NONE ::: NONE ::: derived field  nutrient value niacin,  magnesium ::: NULL ::: NULL ::: NULL ::: NULL ::: nutrients;niacin;vitamin b3 assay ::: C0678695;C0027996;C1142562 ::: food;orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00085923.v2 ::: phs000209.v10.p2 ::: pht001118.v5 ::: MESA_Exam2Main ::: hdlcat2c ::: HDL CHOLESTEROL, NCEP CATEGORIES ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: high-density lipoprotein cholesterol, nucleic acid testing categories ::: NULL ::: NULL ::: NULL ::: NULL ::: nucleic acid amplification tests ::: C0200932 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00101693.v1 ::: phs000287.v2.p1 ::: pht001474.v1 ::: YR10 ::: DEVICE27 ::: DOES PTT USE AN ASSISTIVE DEVICE ::: encoded ::: NONE ::: NONE ::: NONE ::: does ptt use an assistive device ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00030736.v1 ::: phs000086.v2.p1 ::: pht000253.v1 ::: DCCT_baseline ::: BCVAL31A ::: T31-blood glucose profile (bgp) 7 - mg/dl ::: int ::: MG/DL ::: NONE ::: NONE ::: t31  blood glucose profile  bgp  7 magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;profile (lab procedure);plasma glucose measurement;blood glucose measurement ::: C0017725;C1979963;C0202042;C0392201 ::: bacs,carb,phsu;lbpr;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00165200.v1 ::: phs000400.v1.p1 ::: pht002536.v1 ::: HeartGO_CHS_LDL_PhenotypeDataFile ::: ESP_AGE_AT_FACTORVII ::: Age in years at Factor VII measurement ::: Numeric ::: Years ::: NONE ::: NONE ::: age in years at factor vii measurement ::: Age ::: age ::: C0001779 ::: orga ::: factor vii measurement ::: C2825856 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Demographics;Lab Tests Patient
phv00007989.v3 ::: phs000007.v18.p7 ::: pht000031.v5 ::: ex1_2s ::: B371 ::: BLOOD ANALYSIS-FASTING LIPIDS: SINKING PRE-BETA BAND ::: NONE ::: NONE ::: NONE ::: NONE ::: blood analysis fasting lipids  sinking pre beta band ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;fasting;analysis ::: C0002778;C0015663;C0936012 ::: lbpr;fndg;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00142126.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: JMJD1C_Run2_Plate ::: RNA LEVELS: JMJD1C, Run2, Platelet (TaqmanAssayID : Hs00405469_m1) ::: decimal, encoded ::: cycle threshold ::: 12.7694443934821 ::: 26.9955748637953 ::: ribonucleic acid levels  jmjd1 c, run2, platelet  taqmanassayid   hs00405469_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00108137.v1 ::: phs000287.v2.p1 ::: pht001492.v1 ::: YR6 ::: PCYRS59 ::: YEARS YOU'VE BEEN TAKING PROGESTIN ::: integer ::: NONE ::: 0 ::: 40 ::: years you expired volume been taking progestin ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;progestins ::: C2700258;C0033306 ::: lbpr;horm,phsu,strd ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00146941.v2 ::: phs000209.v10.p2 ::: pht002102.v2 ::: MESA_AncilMesaLungExam3CT ::: LLC_air_v ::: LEFT LUNG, LOWER CORE: TOTAL VOLUME OF AIR IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: left lung, lower core  total volume of air in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00001383.v1 ::: phs000007.v18.p7 ::: pht000012.v3 ::: ex0_10s ::: FC25 ::: BLOOD ANALYSIS: SERUM PHOSPHOLIPID (MG/100 ML) ::: NONE ::: MG/100ML ::: NONE ::: NONE ::: blood analysis  serum phospholipid  magnesium 100 mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;serum magnesium finding ::: C0002778;C0936012;C1826990 ::: lbpr;resa;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00145659.v1 ::: phs000209.v10.p2 ::: pht002101.v1 ::: MESA_AncilMesaLungExam2CT ::: RLC_tot_v ::: RIGHT LUNG, LOWER CORE: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, lower core  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00108971.v1 ::: phs000287.v2.p1 ::: pht001493.v1 ::: YR7 ::: BRADYC ::: CALCULATED PERSISTENT BRADYCARDIA <40 BE ::: encoded ::: NONE ::: NONE ::: NONE ::: calculated persistent bradycardia <40 be ::: NULL ::: NULL ::: NULL ::: NULL ::: bradycardia;calculated (procedure) ::: C0428977;C1443182 ::: patf;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00025275.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR20_53 ::: Test r53: difference between year 5  and baseline scores ::: byte ::: TEST R53 SCORE ::: NONE ::: NONE ::: test r53   difference between year 5 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00061522.v2 ::: phs000128.v3.p3 ::: pht000505.v2 ::: simphen106 ::: rx1 ::: 1:Rx for high LDL,0:No Rx, visit 1 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0 no rx, visit 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00060889.v2 ::: phs000128.v3.p3 ::: pht000485.v2 ::: simphen086 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00078515.v3 ::: phs000200.v8.p2 ::: pht000999.v3 ::: f30_rel1 ::: HIBLDCA ::: High blood calcium ::: encoded value ::: NONE ::: NONE ::: NONE ::: high blood calcium ::: NULL ::: NULL ::: NULL ::: NULL ::: calcium, increased level;blood calcium measurement ::: C0553702;C0729820 ::: fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00072894.v1 ::: phs000171.v1.p1 ::: pht000760.v1 ::: MS_DATA_LAB ::: BASO_PCT ::: Basophils (%) ::: Decimal ::: % ::: NONE ::: NONE ::: basophils  % ::: NULL ::: NULL ::: NULL ::: NULL ::: total basophil count ::: C1883362 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00169633.v1 ::: phs000200.v8.p2 ::: pht002756.v1 ::: outc_bc_cad_rel2 ::: HIST8522 ::: F130 Breast Histology 8522 Subclass ::: encoded value ::: NONE ::: NONE ::: NONE ::: f130  breast histology 8522  subclass ::: NULL ::: NULL ::: NULL ::: NULL ::: histology procedure ::: C0344441 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032676.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL25B99 ::: Pre-breakfast blood glucose at OD 340 (close-out) ::: float ::: OD 340 ::: NONE ::: NONE ::: pre breakfast blood glucose at od 340   close out ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans ::: C0392201;C0029421 ::: lbpr;dsyn ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00029075.v1 ::: phs000086.v2.p1 ::: pht000242.v1 ::: DCCT_f003cmb2 ::: OCI4 ::: Standard treatment: performs urine glucose monitoring ::: byte ::: NONE ::: NONE ::: NONE ::: standard treatment  performs urine glucose monitoring ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose measurement, urine;preventive monitoring;clinical trials, monitoring;glycosuria;glucose measurement by monitoring device;perform;therapeutic procedure;administration procedure ::: C0004076;C0150369;C1516647;C0017979;C0202048;C2947996;C0087111;C1533734 ::: lbpr;hlca;resa;fndg;lbpr;phsu;topp;topp ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Healthcare Activity Finding;Therapeutic or Preventive Procedure;Research Attributes;Daily or Recreational Activity
phv00151380.v3 ::: phs000209.v10.p2 ::: pht002108.v3 ::: MESA_MesaAirNR_LungCT ::: RC_air_v ::: RIGHT LUNG, CORE: TOTAL VOLUME OF AIR IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, core  total volume of air in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00121021.v2 ::: phs000285.v2.p2 ::: pht001859.v2 ::: F2HCY ::: ALBHCY2 ::: Y0 HOMOCYSTEINE (umol/L) - 2003 RUN ::: decimal ::: umol/L ::: 3.7 ::: 77 ::: y0 homocysteine umol  l  2003  run ::: NULL ::: NULL ::: NULL ::: NULL ::: homocystine measurement;homocysteine measurement;running (physical activity);does run (finding) ::: C0919377;C2242817;C0035953;C0600140 ::: lbpr;lbpr;dora;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Daily or Recreational Activity
phv00031757.v1 ::: phs000086.v2.p1 ::: pht000269.v1 ::: DCCT_cbl5 ::: BCVAL19 ::: CBL5: Renal test - 19: raw clearance value (ml/mn) ::: int ::: ML/MIN ::: NONE ::: NONE ::: cbl5  renal test 19  raw clearance value  mesiolingual mn ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures;renal clearance diagnostic test ::: C0022885;C0699829 ::: lbpr;diap ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure
phv00172226.v1 ::: phs000007.v18.p7 ::: pht002892.v1 ::: l_lppla2_2008_m_0440s ::: placplate ::: ELISA plate number for Lp-PLA2 Mass ::: NONE ::: NONE ::: 1 ::: 51 ::: enzyme-linked immunosorbent assay plate number for lppla2 mass ::: NULL ::: NULL ::: NULL ::: NULL ::: enzyme-linked immunosorbent assay;mass of body structure ::: C0014441;C0577559 ::: lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00063712.v2 ::: phs000128.v3.p3 ::: pht000573.v2 ::: simphen174 ::: rx3 ::: 1:Rx for high LDL, 0:No Rx, visit 3 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 3 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00026660.v1 ::: phs000086.v2.p1 ::: pht000219.v1 ::: DCCT_cbl6 ::: BCSERUM4 ::: CBL6: GFR gamma count serum - t4 ::: int ::: CPM ::: NONE ::: NONE ::: cbl6  glomerular filtration rate gamma count serum t4 ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum thyroxine;glomerular filtration rate finding ::: C0017654;C0036833;C1561549 ::: diap,ortf;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure
phv00024678.v3 ::: phs000007.v18.p7 ::: pht000204.v4 ::: laba1_7s ::: LB_RBC ::: RBC FOLATE (NG OF FOLATE/G HB) ::: NONE ::: ng of folate/g Hb ::: NONE ::: NONE ::: red blood count folate  ng of folate gram hb ::: NULL ::: NULL ::: NULL ::: NULL ::: redness;blood folate measurement;folate ::: C0332575;C0427417;C0178638 ::: fndg;lbpr;orch,phsu,vita ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Medical History
phv00160505.v1 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: nvtrg31c ::: CALCULATED VLDL TRIGLYCERIDES (mg/dL) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS ::: NUMERIC ::: mg/dL ::: NONE ::: NONE ::: calculated very low-density lipoprotein triglycerides magnesium d l  from nuclear magnetic resonance lipoprofile 3 spectral analysis ::: NULL ::: NULL ::: NULL ::: NULL ::: calculated (procedure);magnetic resonance imaging;analysis of substances;analysis ::: C1443182;C0024485;C0002778;C0936012 ::: lbpr;diap;lbpr;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Diagnostic Procedure
phv00024694.v3 ::: phs000007.v18.p7 ::: pht000205.v4 ::: lipids1_5s ::: HDLP4 ::: HDL PARTICLES 9.4+/-0.6 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4 ::: NONE ::: MG/DL ::: NONE ::: NONE ::: high-density lipoprotein particles 9 4+  0 6 nm  expressed as cholesterol concentrations in magnesium distolingual  and determined using nmr, exam 4 ::: NULL ::: NULL ::: NULL ::: NULL ::: mental concentration;serum total cholesterol measurement;magnetic resonance imaging;medical examination ::: C0086045;C1445957;C0024485;C0582103 ::: menp;lbpr;diap;hlca ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Diagnostic Procedure
phv00142340.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: FCER1G_Run4_Plate ::: RNA LEVELS: FCER1G, Run4, Platelet (TaqmanAssayID : Hs00610227_m1) ::: decimal, encoded ::: cycle threshold ::: 4.1639291013504 ::: 25.5405692675511 ::: ribonucleic acid levels  fcer1 g, run4, platelet  taqmanassayid   hs00610227_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163844.v2 ::: phs000159.v4.p2 ::: pht000817.v4 ::: AML_Subject_Phenotypes ::: Differential Count (Peripheral Blood): Myelocytes ::: Differential Count (Peripheral Blood): Myelocytes ::: NONE ::: NONE ::: NONE ::: NONE ::: differential count  peripheral blood   myelocytes ::: NULL ::: NULL ::: NULL ::: NULL ::: myelocyte count procedure ::: C0455284 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00012637.v1 ::: phs000017.v3.p1 ::: pht000056.v1 ::: EA_DIGS2_Data ::: I9010 ::: J17b. Have you ever used any of these drugs to feel good or high, or to feel more active or alert, or when they were not prescribed for you? Or have you ever used a prescribed drugging larger quantities or for longer than prescribed? (IF YES:) INTERVIEWER: For opiates. (Participants with European ancestry). DIGS2 ::: NONE ::: Times ::: NONE ::: NONE ::: j17 b  have you ever used any of these drugs to feel good or high, or to feel more active or alert, or when they were not prescribed for you  or have you ever used a prescribed drugging larger quantities or for longer than prescribed   if yes   interviewer  for opiates   participants with european ancestry   digs2 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: used by;pharmaceutical preparations;emotions;consciousness clear;prescribed;drugged state;pharmacologic substance;opioid abuse;opiate assay;opiates ::: C1273517;C0013227;C0013987;C0239110;C0278329;C0278180;C1254351;C0029095;C0242401;C0376196 ::: fndg;phsu;menp;fndg;hlca;sosy;phsu;mobd;lbpr;hops,phsu ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Mental or Emotional Finding;Substance Use History;Healthcare Activity Finding;Medical History
phv00058880.v2 ::: phs000128.v3.p3 ::: pht000422.v2 ::: simphen023 ::: rx3 ::: 1:Rx for high LDL, 0:No Rx, visit 3 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 3 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00018435.v1 ::: phs000017.v3.p1 ::: pht000058.v1 ::: EA_DIGS4_Data ::: V1407 ::: J42. Opiates.  (Participants with European ancestry). DIGS4 ::: NONE ::: NONE ::: NONE ::: NONE ::: j42   opiates   participants with european ancestry   diagnostic interview for genetic studies ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: opioid abuse;opiate assay;opiates;diagnosis;genetic study ::: C0029095;C0242401;C0376196;C0011900;C2827447 ::: mobd;lbpr;hops,phsu;fndg;resa ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Substance Use History;Research Attributes;Medical History
phv00017335.v1 ::: phs000017.v3.p1 ::: pht000058.v1 ::: EA_DIGS4_Data ::: V307 ::: E6. Effexor. Antidepressants. (Participants with European ancestry). DIGS4 ::: NONE ::: NONE ::: NONE ::: NONE ::: e6  effexor  antidepressants   participants with european ancestry   diagnostic interview for genetic studies ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: effexor;antidepressive agents;antidepressant measurement;diagnosis;genetic study ::: C0591437;C0003289;C2698157;C0011900;C2827447 ::: orch,phsu;phsu;lbpr;fndg;resa ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Research Attributes
phv00061305.v2 ::: phs000128.v3.p3 ::: pht000498.v2 ::: simphen099 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00115292.v2 ::: phs000285.v2.p2 ::: pht001651.v2 ::: C1ECHO ::: LVMASS ::: M-MODE: LEFT VENT. MASS (CoC CALCULATED) ::: decimal ::: NONE ::: 56.94119 ::: 511.549 ::: mmode  left vent  mass  coc calculated ::: NULL ::: NULL ::: NULL ::: NULL ::: mass of body structure;calculated (procedure) ::: C0577559;C1443182 ::: fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00098441.v4 ::: phs000096.v4.p1 ::: pht001424.v4 ::: HAPO_Sample ::: SUBJID ::: GENEVA ID ::: integer ::: NONE ::: NONE ::: NONE ::: gene-environment association studies identification ::: NULL ::: NULL ::: NULL ::: NULL ::: mental association;scientific study;identification (psychology) ::: C0004083;C0947630;C0020792 ::: menp;lbpr;menp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00084456.v2 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: dm031c ::: EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: exam 1 diabetes mellitus by 2003  american diabetes association fasting criteria algorithm ::: NULL ::: NULL ::: NULL ::: NULL ::: medical examination;diabetes mellitus;fasting;observation method - algorithm ::: C0582103;C0011849;C0015663;C1553907 ::: hlca;dsyn;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Healthcare Activity Finding;Medical History
phv00027119.v1 ::: phs000086.v2.p1 ::: pht000225.v1 ::: DCCT_dtfamcls ::: LAER ::: Log of AER ::: float ::: AER-LOG ::: NONE ::: NONE ::: logarithm of albumin-excretion rate ::: NULL ::: NULL ::: NULL ::: NULL ::: albumin excretion rate measurement ::: C0585937 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032993.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL29B15 ::: Pre-supper blood glucose at OD 340 (quarterly visit 15) ::: float ::: OD 340 ::: NONE ::: NONE ::: pre supper blood glucose at od 340   quarterly visit 15 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033032.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL27A17 ::: Pre-lunch blood glucose mg/dl (quarterly visit 17) ::: int ::: MG/DL ::: NONE ::: NONE ::: pre lunch blood glucose magnesium distolingual  quarterly visit 17 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00163883.v2 ::: phs000159.v4.p2 ::: pht000817.v4 ::: AML_Subject_Phenotypes ::: MLL: For FISH tested indicate % ::: :MLL: For FISH tested indicate % ::: :NONE ::: % ::: NONE ::: NONE ::: mixed lineage leukemia  for fluorescent in situ hybridization tested indicate % ::: NULL ::: NULL ::: NULL ::: NULL ::: in situ hybridization;indicated ::: C0162788;C1444656 ::: lbpr,mbrt;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032845.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL32B08 ::: 3:00 a.m. blood glucose at OD 340 (quarterly visit 08) ::: float ::: OD 340 ::: NONE ::: NONE ::: 3 00 a m  blood glucose at od 340   quarterly visit 08 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032632.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL25A00 ::: Pre-breakfast blood glucose mg/dl (quarterly visit 00) ::: int ::: MG/DL ::: NONE ::: NONE ::: pre breakfast blood glucose magnesium distolingual  quarterly visit 00 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00151482.v3 ::: phs000209.v10.p2 ::: pht002108.v3 ::: MESA_MesaAirNR_LungCT ::: RLC_tot_v ::: RIGHT LUNG, LOWER CORE: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, lower core  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032571.v1 ::: phs000086.v2.p1 ::: pht000276.v1 ::: DCCT_cbl10 ::: F0233F ::: CBL10: Form date for 24-hr urine tests ::: NONE ::: NONE ::: NONE ::: NONE ::: cbl10   form date for 24 heart rate urine tests ::: NULL ::: NULL ::: NULL ::: NULL ::: date fruit;laboratory procedures ::: C2348077;C0022885 ::: food;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00062048.v2 ::: phs000128.v3.p3 ::: pht000521.v2 ::: simphen122 ::: rx3 ::: 1:Rx for high LDL, 0:No Rx, visit 3 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 3 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00110289.v1 ::: phs000287.v2.p1 ::: pht001495.v1 ::: YR9 ::: PLLEG27 ::: DOES PTT USE A LEFT LEG PROTHESIS ::: encoded ::: NONE ::: NONE ::: NONE ::: does ptt use a left leg prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00143628.v3 ::: phs000209.v10.p2 ::: pht002100.v3 ::: MESA_AncilMesaLungExam1CT ::: RLC_tot_v ::: RIGHT LUNG, LOWER CORE: TOTAL VOLUME OF THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, lower core  total volume of this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00171036.v1 ::: phs000178.v7.p6 ::: pht002781.v1 ::: TCGA_GBM_Sample_Phenotype ::: pcr_amplification_successful ::: Was PCR amplification successful? ::: string ::: NONE ::: NONE ::: NONE ::: was polymerase chain reaction amplification successful ::: NULL ::: NULL ::: NULL ::: NULL ::: polymerase chain reaction ::: C0032520 ::: lbpr,mbrt ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00126732.v1 ::: phs000286.v3.p1 ::: pht001953.v1 ::: DPASS_DIET1_ES ::: lffq_alc ::: LFFQ: alcohol (gm) ::: decimal ::: gm ::: 0 ::: 194.8651 ::: lffq  alcohol  gm ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement ::: C0001975;C0202304 ::: orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History
phv00142325.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: CHURC1_Run4_Plate ::: RNA LEVELS: CHURC1, Run4, Platelet (TaqmanAssayID : Hs00540886_m1) ::: decimal, encoded ::: cycle threshold ::: 8.6917426138413 ::: 26.9868946011715 ::: ribonucleic acid levels  churc1, run4, platelet  taqmanassayid   hs00540886_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00030371.v1 ::: phs000086.v2.p1 ::: pht000250.v1 ::: DCCT_cbl3 ::: BCSGLUC2 ::: CBL3: GFR serum glucose - t2 value (mg/dl) ::: int ::: MG/DL ::: NONE ::: NONE ::: cbl3  glomerular filtration rate serum glucose t2 value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum magnesium finding;glucose;plasma glucose measurement;glucose measurement, serum;glomerular filtration rate finding ::: C0017654;C1826990;C0017725;C0202042;C0202041;C1561549 ::: diap,ortf;fndg;bacs,carb,phsu;lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Diagnostic Procedure
phv00031078.v1 ::: phs000086.v2.p1 ::: pht000261.v1 ::: DCCT_cbl8 ::: BCUREAN ::: CBL8: 24-hr urine: urea nitrogen (mg/dl) ::: int ::: MG/DL ::: NONE ::: NONE ::: cbl8  24 heart rate urine  urea nitrogen  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine ::: C0428308 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00025174.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR08_29 ::: Test r29: difference between year 2  and baseline scores ::: byte ::: TEST R29 SCORE ::: NONE ::: NONE ::: test r29   difference between year 2 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00084519.v2 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: volsum1c ::: MEAN: TOTAL VOLUME SCORE, UNADJUSTED ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: mean  total volume score, unadjusted ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032794.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL29A06 ::: Pre-supper blood glucose mg/dl (quarterly visit 06) ::: int ::: MG/DL ::: NONE ::: NONE ::: pre supper blood glucose magnesium distolingual  quarterly visit 06 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00100043.v1 ::: phs000287.v2.p1 ::: pht001451.v1 ::: BASE2 ::: LDLUNADJ ::: UNADJUSTED CALCULATED LDL (mg/dl) ::: integer ::: NONE ::: 28 ::: 340 ::: unadjusted calculated low-density lipoprotein  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: calculated (procedure) ::: C1443182 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00126182.v1 ::: phs000286.v3.p1 ::: pht001951.v1 ::: DITA ::: DITA21 ::: Glucose (g) ::: decimal ::: g ::: 0 ::: 275.0591 ::: glucose  gram ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement ::: C0017725;C0202042 ::: bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00155529.v2 ::: phs000200.v8.p2 ::: pht002118.v2 ::: ecg_rel2 ::: STM_V6 ::: M (middle of ST segment) amplitude, lead stm_v6 ::: integer ::: NONE ::: -562 ::: 683 ::: m  middle of subtalar segment  amplitude, lead stm_v6 ::: NULL ::: NULL ::: NULL ::: NULL ::: microscopy, scanning tunneling ::: C0079837 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00058841.v2 ::: phs000128.v3.p3 ::: pht000421.v2 ::: simphen022 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00025422.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR28_43 ::: Test r43: difference between year 7  and baseline scores ::: byte ::: TEST R43 SCORE DIFFERENCE ::: NONE ::: NONE ::: test r43   difference between year 7 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00126449.v1 ::: phs000286.v3.p1 ::: pht001952.v1 ::: DPASS_DIET1 ::: ravg_pro ::: RECALL: total protein ::: decimal ::: NONE ::: 21.71 ::: 202.7624 ::: recall  total protein ::: NULL ::: NULL ::: NULL ::: NULL ::: mental recall;recall:-:point in time:^patient:-;total protein measurement ::: C0034770;C2361119;C0555903 ::: menp;clna;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00142490.v1 ::: phs000306.v3.p1 ::: pht002082.v1 ::: Non_MEC_Prostate_Cancer_AA_Subject_Phenotypes ::: SEVERITY ::: Aggressiveness of disease for prostate cancer cases only: calculated from SEER summary stage and differentiation variables (the latter provides an estimate of gleason grade).  For cases only. ::: encoded integer, encoded string ::: NONE ::: 1 ::: 2 ::: aggressiveness of disease for prostate cancer cases only  calculated from seer summary stage and differentiation variables  the latter provides an estimate of gleason grade   for cases only ::: NULL ::: NULL ::: NULL ::: NULL ::: aggressive behavior;aggressive reaction;disease;malignant neoplasm of prostate;prostate carcinoma;calculated (procedure);histopathologic grade differentiation;provide (product) ::: C0001807;C1457883;C0012634;C0376358;C0600139;C1443182;C1511938;C0359589 ::: mobd;mobd;dsyn;neop;neop;lbpr;clna;food ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Eating or Nutritional Finding;Research Attributes
phv00015020.v1 ::: phs000017.v3.p1 ::: pht000057.v1 ::: EA_DIGS3_Data ::: SINEQUAN ::: E6. Triciclic antidepressants Sinequan, (Participants with European ancestry). DIGS3 ::: NONE ::: NONE ::: NONE ::: NONE ::: e6  triciclic antidepressants sinequan,  participants with european ancestry   digs3 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: antidepressive agents;sinequan;antidepressant measurement ::: C0003289;C0728757;C2698157 ::: phsu;orch,phsu;lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient
phv00109246.v1 ::: phs000287.v2.p1 ::: pht001494.v1 ::: YR8 ::: REASON21 ::: REASONS TEST INCOMPLETE OR NOT DONE ::: encoded ::: NONE ::: NONE ::: NONE ::: reasons test incomplete or not done ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00124228.v1 ::: phs000284.v1.p1 ::: pht001902.v1 ::: CFS_CARe_Subject_Phenotypes ::: losao2r ::: Calculated - min saO2 rem ::: integer ::: NONE ::: 51 ::: 98 ::: calculated minsa o2 rapid eye movement  sleep ::: NULL ::: NULL ::: NULL ::: NULL ::: oxygen;sleep, rem;calculated (procedure) ::: C0030054;C0037322;C1443182 ::: elii,phsu;menp;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Mental or Emotional Finding;Daily or Recreational Activity
phv00010094.v3 ::: phs000007.v18.p7 ::: pht000035.v6 ::: ex1_6s ::: F704 ::: DID YOU EVER HAVE HIGH BLOOD CHOLESTEROL (> 240 MG/DL) ::: NONE ::: NONE ::: NONE ::: NONE ::: did you ever have high blood cholesterol  > 240  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: hypercholesterolemia result;blood cholesterol ::: C1522133;C0518017 ::: fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00098225.v1 ::: phs000280.v1.p1 ::: pht001412.v1 ::: ARIC_CARE_VENBV2C1 ::: VENB09 ::: TIME SPECIMEN TUBES 2-7 SPUN      Q9 ::: string ::: NONE ::: 3660 ::: 45840 ::: time specimen tubes 27 spun q9 ::: NULL ::: NULL ::: NULL ::: NULL ::: spun ::: C1446863 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00157791.v1 ::: phs000007.v18.p7 ::: pht002152.v1 ::: ffreq0_21s ::: SCORE20 ::: DERIVED FIELD: NUTRIENT VALUE - RETINOL, (IU) ::: NONE ::: IU ::: NONE ::: NONE ::: derived field  nutrient value retinol,  international unit ::: NULL ::: NULL ::: NULL ::: NULL ::: nutrients;vitamin a;all-trans-retinol;vitamin a measurement ::: C0678695;C0042839;C0087161;C0373745 ::: food;orch,phsu,vita;orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00009578.v3 ::: phs000007.v18.p7 ::: pht000034.v5 ::: ex1_5s ::: E672 ::: BLOOD ANALYSIS - GLUCOSE - 2 HOUR POST ::: NONE ::: mg/dL ::: NONE ::: NONE ::: blood analysis glucose 2 hour post ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;blood glucose measurement ::: C0002778;C0936012;C0392201 ::: lbpr;resa;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00022565.v3 ::: phs000007.v18.p7 ::: pht000101.v4 ::: pft1_5s ::: RAT_5_1 ::: RATIO FEV1/FVC (CALCULATED VARIABLE) - BEST EFFORT ::: NONE ::: NONE ::: NONE ::: NONE ::: ratio fev1 forced vital capacity  calculated variable  best effort ::: NULL ::: NULL ::: NULL ::: NULL ::: forced expiratory volume in 1 second finding;vital capacity test;capacity.vital.forced:volume:point in time:respiratory system:quantitative;volume^at 1.0 s post forced expiration:volume:point in time:respiratory system:quantitative;pulmonary function test/forced expiratory volume 1;calculated (procedure);exertion ::: C0429706;C0430511;C0802685;C0802965;C0849974;C1443182;C0015264 ::: fndg;diap;clna;clna;diap;lbpr;orgf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure;Medical History
phv00112339.v1 ::: phs000096.v4.p1 ::: pht001550.v1 ::: HAPO_European_Phenotypes ::: b_CordPGC_mg ::: Baby's cord glucose ::: decimal, encoded string ::: mg/dL ::: 37.8 ::: 185.4 ::: baby s cord glucose ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement ::: C0017725;C0202042 ::: bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00109271.v1 ::: phs000287.v2.p1 ::: pht001494.v1 ::: YR8 ::: MLLEG27 ::: IS PTT MISSING LEFT LEG ::: encoded ::: NONE ::: NONE ::: NONE ::: is ptt missing left leg ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00025208.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR08_63 ::: Test r63: difference between year 2  and baseline scores ::: byte ::: TEST R63 SCORE ::: NONE ::: NONE ::: test r63   difference between year 2 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00085016.v2 ::: phs000209.v10.p2 ::: pht001116.v7 ::: MESA_Exam1Main ::: crp1t ::: NATURAL LOG TRANSFORMED C-REACTIVE PROTEIN (CRP) ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: natural logarithm transformed creactive protein  c-reactive protein ::: NULL ::: NULL ::: NULL ::: NULL ::: metaplastic cell transformation;c-reactive protein measurement ::: C1510411;C0201657 ::: patf;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00063673.v2 ::: phs000128.v3.p3 ::: pht000572.v2 ::: simphen173 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00146007.v1 ::: phs000209.v10.p2 ::: pht002101.v1 ::: MESA_AncilMesaLungExam2CT ::: RUC_air_v ::: RIGHT LUNG, UPPER CORE: TOTAL VOLUME OF AIR IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, upper core  total volume of air in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032705.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL28B02 ::: Post-lunch blood glucose at OD 340 (quarterly visit 02) ::: float ::: OD 340 ::: NONE ::: NONE ::: post lunch blood glucose at od 340   quarterly visit 02 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00082414.v1 ::: phs000219.v1.p1 ::: pht001098.v1 ::: d_prevtest_other_trans ::: OTH_EIS_RAWSCORE ::: EMORY IMPAIRMENT SCREEN: Other - Raw Score ::: NONE ::: NONE ::: NONE ::: NONE ::: emory impairment screen  other raw score ::: NULL ::: NULL ::: NULL ::: NULL ::: impaired health;screening procedure;toxicology screen, general (procedure) ::: C0684336;C0220908;C0430054 ::: fndg;hlca;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Healthcare Activity Finding;Medical History
phv00119612.v2 ::: phs000285.v2.p2 ::: pht001802.v2 ::: E1LIP ::: EL1CHOL ::: TOTAL PLASMA CHOLESTEROL (mg/dL) ::: integer ::: mg/dL ::: 58 ::: 368 ::: total plasma cholesterol magnesium d l ::: NULL ::: NULL ::: NULL ::: NULL ::: serum total cholesterol measurement;plasma cholesterol ::: C1445957;C0858034 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00025182.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR08_37 ::: Test r37: difference between year 2  and baseline scores ::: float ::: TEST R37 SCORE ::: NONE ::: NONE ::: test r37   difference between year 2 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00171663.v1 ::: phs000462.v1.p1 ::: pht002844.v1 ::: T2D_GENES_Subject_Phenotypes ::: LEPTIN_NUM ::: Number of study visits for which we have Leptin concentration ::: integer ::: NONE ::: 0 ::: 5 ::: number of study visits for which we have leptin concentration ::: NULL ::: NULL ::: NULL ::: NULL ::: clinical trials;study;mental concentration;leptin measurement ::: C0008976;C2603343;C0086045;C1295176 ::: resa;resa;menp;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Research Attributes
phv00113508.v2 ::: phs000285.v2.p2 ::: pht001577.v2 ::: A4F14 ::: A14CARE ::: HOW OFTEN PTT FEELS THAT OTHERS CARE? Q 8 ::: encoded ::: NONE ::: NONE ::: NONE ::: how often ptt feels that others candidate gene association resource  q 8 ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement;emotions;mental association ::: C0030605;C0013987;C0004083 ::: lbpr;menp;menp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00030416.v1 ::: phs000086.v2.p1 ::: pht000250.v1 ::: DCCT_cbl3 ::: BCLDT21 ::: CBL3: Lipid test - 21: collection date ::: str6 ::: NONE ::: NONE ::: NONE ::: cbl3  lipid test 21  collection date ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00085827.v2 ::: phs000209.v10.p2 ::: pht001118.v5 ::: MESA_Exam2Main ::: VOLP12C ::: SCAN 1:  TOTAL CALCIUM VOLUME, PHANTOM ADJUSTED ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: scan 1  total calcium volume, phantom adjusted ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement;calcium volume ::: C2700258;C1562777 ::: lbpr;clna ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00165264.v1 ::: phs000400.v1.p1 ::: pht002536.v1 ::: HeartGO_CHS_LDL_PhenotypeDataFile ::: ESP_AGE_AT_URINARY_CREATININE ::: Age in years at urinary creatinine measurement ::: Numeric ::: Years ::: NONE ::: NONE ::: age in years at urinary creatinine measurement ::: Age ::: age ::: C0001779 ::: orga ::: urine creatinine measurement ::: C1318439 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Demographics;Lab Tests Patient
phv00104711.v1 ::: phs000287.v2.p1 ::: pht001489.v1 ::: YR4 ::: PLARM27 ::: DOES PTT USE A LEFT ARM PROTHESIS ::: encoded ::: NONE ::: NONE ::: NONE ::: does ptt use a left arm prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00084391.v2 ::: phs000209.v10.p2 ::: pht001115.v3 ::: MESA_Exam1Diet ::: alcbeer1c ::: TOTAL INTAKE OF ALCOHOL FROM BEER PER DAY (G) ::: NUMERIC ::: g ::: NONE ::: NONE ::: total intake of alcohol from beer per day  gram ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement;beer ::: C0001975;C0202304;C0004922 ::: orch,phsu;lbpr;food ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History;Eating or Nutritional Finding
phv00111878.v3 ::: phs000200.v8.p2 ::: pht001517.v3 ::: f60_item_rel1 ::: GRAINS ::: Computed food group: Grains, med serv/day ::: decimal ::: servings ::: 0 ::: 65 ::: computed food group  grains, med serv day ::: NULL ::: NULL ::: NULL ::: NULL ::: computed (procedure);food;cereals ::: C1441526;C0016452;C0007757 ::: lbpr;food;food ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Eating or Nutritional Finding
phv00080752.v1 ::: phs000007.v18.p7 ::: pht001039.v2 ::: cortisol1_6s ::: ucre24hr ::: Urine creatinine 24 hour total ::: integer, encoded ::: mg/24 hours ::: 84 ::: 3711 ::: urine creatinine 24 hour total ::: NULL ::: NULL ::: NULL ::: NULL ::: urine creatinine measurement ::: C1318439 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00143976.v3 ::: phs000209.v10.p2 ::: pht002100.v3 ::: MESA_AncilMesaLungExam1CT ::: RUC_air_v ::: RIGHT LUNG, UPPER CORE: TOTAL VOLUME OF AIR IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, upper core  total volume of air in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00001404.v1 ::: phs000007.v18.p7 ::: pht000012.v3 ::: ex0_10s ::: FC48 ::: BLOOD ANALYSIS, FASTING: VLDL BETA BAND ::: NONE ::: NONE ::: NONE ::: NONE ::: blood analysis, fasting  very low-density lipoprotein beta band ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;fasting ::: C0002778;C0936012;C0015663 ::: lbpr;resa;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00124088.v1 ::: phs000284.v1.p1 ::: pht001902.v1 ::: CFS_CARe_Subject_Phenotypes ::: vtdna_total ::: Vermont DNA Total Volume (ug) ::: decimal ::: NONE ::: 0 ::: 3705 ::: vermont deoxyribonucleic acid total volume  ug ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00033082.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL30A19 ::: Post-supper blood glucose mg/dl (quarterly visit 19) ::: int ::: MG/DL ::: NONE ::: NONE ::: post supper blood glucose magnesium distolingual  quarterly visit 19 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00093980.v1 ::: phs000280.v1.p1 ::: pht001322.v1 ::: ARIC_CARE_FTRAV1C1 ::: FTRA42 ::: NOTIFICATION OF TEST RESULTS      Q42 ::: encoded ::: NONE ::: NONE ::: NONE ::: notification of test results q42 ::: NULL ::: NULL ::: NULL ::: NULL ::: notifications;laboratory procedures ::: C0422202;C0022885 ::: hlca;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Healthcare Activity Finding
phv00149526.v1 ::: phs000209.v10.p2 ::: pht002103.v1 ::: MESA_AncilMesaLungExam4CT ::: RM_tis_v ::: RIGHT LUNG, MIDDLE: TOTAL VOLUME OF TISSUE IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, middle  total volume of tissue in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00025546.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR36_12 ::: Test r12: difference between year 9  and baseline scores ::: byte ::: TEST R12 score difference ::: NONE ::: NONE ::: test r12   difference between year 9 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00035192.v1 ::: phs000017.v3.p1 ::: pht000292.v1 ::: EA_GAIN_phenotype_controls_questionnaire_subset ::: H1_1 ::: The next questions are about your use of drugs on your own.  By "on your own" we mean either without a doctor's prescription, in larger amounts than prescribed, or for longer than prescribed.  With this definition in mind, did you ever use any of the following drugs on your own? Sedatives, including either barbiturates or sleeping pills? (Seconal, Halcion, Methaqualone, etc.).  (Participants with European ancestry) ::: numbers (see key to right): 1, 2, -1, -2 ::: NONE ::: NONE ::: NONE ::: the next questions are about your use of drugs on your own  by on your own we mean either without a doctor s prescription, in larger amounts than prescribed, or for longer than prescribed  with this definition in mind, did you ever use any of the following drugs on your own  sedatives, including either barbiturates or sleeping pills   seconal, halcion, methaqualone, etc     participants with european ancestry ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: pharmaceutical preparations;prescription procedure;prescribed;psyche structure;sedatives;barbiturates;seconal;halcion;methaqualone;methaqualone measurement ::: C0013227;C0033080;C0278329;C0229992;C0036557;C0004745;C0733450;C0733624;C0025627;C0025628 ::: phsu;hlca;hlca;menp;phsu;orch,phsu;orch,phsu;orch,phsu;orch,phsu;lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Daily or Recreational Activity
phv00116357.v2 ::: phs000285.v2.p2 ::: pht001693.v2 ::: C1GMP ::: C39VOL2 ::: 2ND COLLN:TOTAL VOLUME IN DL ::: decimal ::: dl ::: 2.510457 ::: 48.0996 ::: 2nd colln total volume in distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00125068.v1 ::: phs000286.v3.p1 ::: pht001931.v1 ::: AFUA2 ::: AFUA1Y ::: (Year only) 1. Date of status determination ::: string ::: NONE ::: NONE ::: NONE ::: year only  1  date of status determination ::: NULL ::: NULL ::: NULL ::: NULL ::: date fruit;determination aspects ::: C2348077;C1148554 ::: food;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00029348.v1 ::: phs000086.v2.p1 ::: pht000243.v1 ::: DCCT_ms4exprt ::: PT2_00 ::: Peroneal nerve - post-test temperature (celsius): baseline - Note: There may be instances of errors in recording some body temperatures values.  Body temperature values outside reasonable ranges (e.g., 30-40 degrees celsius) might be treated as recording or measurement errors. ::: float ::: DEGREES (CELSIUS) ::: NONE ::: NONE ::: peroneal nerve post test temperature  celsius   baseline note  there may be instances of errors in recording some body temperatures values  body temperature values outside reasonable ranges  e gram , 3040  degrees celsius  might be treated as recording or measurement errors ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures;treated with ::: C0022885;C0332293 ::: lbpr;topp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Clinical Attributes
phv00156660.v2 ::: phs000007.v18.p7 ::: pht002144.v2 ::: l_opg_2005_m_0462s ::: raw2 ::: Osteoprotegerin raw OD reading for second well ::: decimal, encoded ::: NONE ::: 0.145 ::: 2.868 ::: osteoprotegerin raw od reading for second well ::: NULL ::: NULL ::: NULL ::: NULL ::: osteochondritis dissecans;reading (activity);reading (datum presentation);osteoprotegerin test ::: C0029421;C0034754;C1705179;C1262886 ::: dsyn;dora;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Daily or Recreational Activity
phv00007955.v3 ::: phs000007.v18.p7 ::: pht000031.v5 ::: ex1_2s ::: B337 ::: BLOOD ANALYSIS: SERUM POTASSIUM ::: NONE ::: NONE ::: NONE ::: NONE ::: blood analysis  serum potassium ::: NULL ::: NULL ::: NULL ::: NULL ::: blood potassium;analysis of substances;analysis;dietary potassium;serum potassium measurement ::: C0853173;C0002778;C0936012;C0162800;C0302353 ::: lbpr;lbpr;resa;food,inch;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Substance Use History;Eating or Nutritional Finding;Research Attributes
phv00063897.v2 ::: phs000128.v3.p3 ::: pht000579.v2 ::: simphen180 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00100036.v1 ::: phs000287.v2.p1 ::: pht001451.v1 ::: BASE2 ::: STRTDT45 ::: RECORDING START DATE (COMPUTED JULIAN) ::: integer ::: NONE ::: 147956 ::: 149326 ::: recording start date  computed julian ::: NULL ::: NULL ::: NULL ::: NULL ::: computed (procedure) ::: C1441526 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00162828.v1 ::: phs000404.v1.p1 ::: pht002368.v1 ::: GENEVA_Smoking_Cessation_Subject_Phenotypes_COGEND ::: age_first_drink ::: Age when had first drink of alcohol ::: integer, encoded integer,  encoded string ::: Years ::: 0 ::: 39 ::: age when had first drink of alcohol ::: Age ::: age ::: C0001779 ::: orga ::: drink (dietary substance);alcohols;alcohol measurement ::: C0452428;C0001975;C0202304 ::: food;orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Demographics;Medication Patient;Lab Tests Patient;Drinking History;Eating or Nutritional Finding
phv00032779.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL32B05 ::: 3:00 a.m. blood glucose at OD 340 (quarterly visit 05) ::: float ::: OD 340 ::: NONE ::: NONE ::: 3 00 a m  blood glucose at od 340   quarterly visit 05 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00007628.v3 ::: phs000007.v18.p7 ::: pht000030.v5 ::: ex1_1s ::: A115 ::: AMOUNT OF ALCOHOL ::: NONE ::: NONE ::: NONE ::: NONE ::: amount of alcohol ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohols;alcohol measurement ::: C0001975;C0202304 ::: orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Drinking History
phv00071177.v2 ::: phs000166.v2.p1 ::: pht000704.v2 ::: ACRN_CData ::: pred_bursts_event2_month ::: Number of months from Baseline to second prednisone burst.  This is calculated by dividing the number of days between Baseline and the second prednisone burst by 30.25. ::: decimal ::: month ::: 0 ::: 14.21 ::: number of months from baseline to second prednisone burst  this is calculated by dividing the number of days between baseline and the second prednisone burst by 30 25 ::: NULL ::: NULL ::: NULL ::: NULL ::: prednisone;calculated (procedure) ::: C0032952;C1443182 ::: horm,phsu,strd;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00050912.v1 ::: phs000086.v2.p1 ::: pht000340.v1 ::: EDIC_f0704 ::: GOD4D ::: D4d. Hospitalization and other health care services used. During the past 12months, have you had any of the following laboratory tests: fasting lipid test ::: byte ::: NONE ::: NONE ::: NONE ::: d4 d  hospitalization and other health candidate gene association resource services used  during the past 12 months, have you had any of the following laboratory tests  fasting lipid test ::: NULL ::: NULL ::: NULL ::: NULL ::: hospitalization;health services;mental association;used by;laboratory procedures;fasting ::: C0019993;C0018747;C0004083;C1273517;C0022885;C0015663 ::: hlca;hlca;menp;fndg;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Medical History
phv00161934.v2 ::: phs000007.v18.p7 ::: pht002344.v2 ::: l_rnatrans2_ex08_1_0619s ::: DB129663_Run3_Plate ::: RNA levels (cycle threshold): DB129663, run3, Platelet (AssaySequences:[forward primer: CAGAGGAGCAGATAAGGAAGCAA; reverse primer: TCATTTCCTTGCCATCCACAGT; probe: ATAGCTCCCGACAAATC]) ::: NONE ::: cycle threshold ::: 19.2710255 ::: 26.28204 ::: ribonucleic acid levels  cycle threshold   db129663 , run3, platelet  assaysequences  forward primer  cagaggagcagataaggaagcaa  reverse primer  tcatttccttgccatccacagt  probe  atagctcccgacaaatc ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement;dna probe method ::: C0032181;C1442917 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00033197.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL32B24 ::: 3:00 a.m. blood glucose at OD 340 (quarterly visit 24) ::: byte ::: OD 340 ::: NONE ::: NONE ::: 3 00 a m  blood glucose at od 340   quarterly visit 24 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00167008.v2 ::: phs000007.v18.p7 ::: pht002572.v2 ::: t_echo_2008_m_0549s ::: SQCOLDOP ::: STUDY QUALITY - Qualitative: Color Doppler ::: NONE ::: NONE ::: NONE ::: NONE ::: study quality qualitative  color doppler ::: NULL ::: NULL ::: NULL ::: NULL ::: clinical trials;doppler studies;coloring excipient;color assessment;study ::: C0008976;C0554756;C1705245;C1880121;C2603343 ::: resa;diap;phsu;lbpr;resa ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Research Attributes;Diagnostic Procedure
phv00126992.v1 ::: phs000286.v3.p1 ::: pht001953.v1 ::: DPASS_DIET1_ES ::: sffq_pro ::: SFFQ: total protein (gm) ::: decimal ::: gm ::: 1.952365 ::: 379.313 ::: sffq  total protein  gm ::: NULL ::: NULL ::: NULL ::: NULL ::: total protein measurement ::: C0555903 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00172169.v1 ::: phs000007.v18.p7 ::: pht002889.v1 ::: l_fhslab_2011_m_0656s ::: GGT ::: Gamma glutamyltransferase (sample type: serum) ::: NONE ::: U/L ::: 3 ::: 718 ::: gamma glutamyltransferase  sample type  serum ::: NULL ::: NULL ::: NULL ::: NULL ::: gamma glutamyl transferase measurement ::: C0202035 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142372.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: MYB_Run4_Plate ::: RNA LEVELS: MYB, Run4, Platelet (TaqmanAssayID : Hs00193527_m1) ::: decimal, encoded ::: cycle threshold ::: 10.6323319709621 ::: 26.7793397304577 ::: ribonucleic acid levels  myb, run4, platelet  taqmanassayid   hs00193527_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00063993.v2 ::: phs000128.v3.p3 ::: pht000582.v2 ::: simphen183 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00121281.v2 ::: phs000285.v2.p2 ::: pht001869.v2 ::: Y1MORB06 ::: Y01LDH12 ::: LDH1 & LDH2 AVAILABLE ::: encoded ::: NONE ::: NONE ::: NONE ::: ldh1 & ldh2 available ::: NULL ::: NULL ::: NULL ::: NULL ::: lactate dehydrogenase isoenzyme 2 measurement;lactate dehydrogenase isoenzyme 1 measurement ::: C2697873;C2697872 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00053760.v2 ::: phs000001.v3.p1 ::: pht000371.v2 ::: amdlensphenotype ::: RCOR ::: FINAL CORTICAL OPACITY PHENOTYPE - RIGHT EYE (ALL PARTICIPANTS) ::: enumerated integer ::: NONE ::: NONE ::: NONE ::: final cortical opacity phenotype right eye  all participants ::: NULL ::: NULL ::: NULL ::: NULL ::: decreased translucency;phenotype determination;abnormally opaque structure (morphologic abnormality) ::: C0029053;C1285572;C1265876 ::: fndg;lbpr;patf ::: participant ::: C0679646 ::: popg ::: Lab Tests Patient;Medical History
phv00161200.v1 ::: phs000209.v10.p2 ::: pht002195.v2 ::: MESA_Exam1ECGContiWaveform ::: mxstavf1 ::: Maximum of STJ,STM, STE Amplitudes, Lead AVF (uV) ::: NUMERIC ::: uV ::: NONE ::: NONE ::: maximum of stj,stm, st elevation amplitudes, lead exploring electrode located at the left foot u v ::: NULL ::: NULL ::: NULL ::: NULL ::: microscopy, scanning tunneling;st segment elevation (finding);lead;plumbum metallicum, homeopathic preparation ::: C0079837;C0520886;C0023175;C1442948 ::: lbpr;fndg;elii,hops;inch,phsu ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Substance Use History;Medical History
phv00128734.v1 ::: phs000209.v10.p2 ::: pht001984.v1 ::: MESA_AncilMesaInflammation ::: pccd4a ::: PERCENT LYMPHOCYTES IN WHOLE BLOOD THAT ARE CD4+ ::: NUMERIC ::: NONE ::: NONE ::: NONE ::: percent lymphocytes in whole blood that are cd4+ ::: NULL ::: NULL ::: NULL ::: NULL ::: lymphocyte count measurement ::: C0200635 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00164625.v1 ::: phs000401.v1.p1 ::: pht002476.v1 ::: HeartGO_FHS_LDLandEOMI_PhenotypeDataFile ::: ESP_MEAN_CORPUSCULAR_VOLUME ::: Mean corpuscular volume in femtoliters at designated visit (may not be baseline) ::: Numeric ::: NONE ::: NONE ::: NONE ::: mean corpuscular volume in femtoliters at designated visit  may not be baseline ::: NULL ::: NULL ::: NULL ::: NULL ::: mean corpuscular volume analyses;erythrocyte mean corpuscular volume measurement;health care visit ::: C0863148;C1948043;C1512346 ::: lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00026011.v1 ::: phs000086.v2.p1 ::: pht000214.v1 ::: DCCT_f0034 ::: OCDM1UDS ::: Diabetes monitoring (one or two daily injection[s]): urine test(s) should have done before dinner ::: int ::: URINE GLUCOSE TESTS ::: NONE ::: NONE ::: diabetes monitoring  one or two daily injection s    urine test s  should have done before dinner ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetes monitoring check done;injection of therapeutic agent;urinalysis;injection procedure ::: C0422587;C0021485;C0042014;C1533685 ::: fndg;topp;lbpr;topp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00090350.v2 ::: phs000007.v18.p7 ::: pht001225.v3 ::: ctpaof3_2005s ::: TAT_VOL ::: Thoracic Aortic Fat Volume ::: decimal, encoded ::: cm3 ::: 0.43 ::: 49.55 ::: thoracic aortic fat volume ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032635.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL26B00 ::: Post-breakfast blood glucose at OD 340 (quarterly visit 00) ::: float ::: OD 340 ::: NONE ::: NONE ::: post breakfast blood glucose at od 340   quarterly visit 00 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00118398.v2 ::: phs000285.v2.p2 ::: pht001759.v2 ::: E1F05 ::: E05030A ::: 3ML GRAY TUBE, 1ML SERUM(2 HR GLUCOSE). Q 28 ::: encoded ::: NONE ::: NONE ::: NONE ::: 3ml gray tube, 1ml serum 2 heart rate glucose   q 28 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose measurement, serum ::: C0202041 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00044915.v1 ::: phs000125.v1.p1 ::: pht000320.v1 ::: COGA_SSAGA ::: AL7A_6 ::: While drinking has one or two drinks of alcohol ever caused you to - have heart palpitations during which your heart beat so hard you could feel it?  -  NOTE: The data values for this variable represent harmonized values; they were derived from information obtained with Sections A and E of the SSAGAI and SSAGAII questionnaires. ::: integer ::: NONE ::: NONE ::: NONE ::: while drinking has one or two drinks of alcohol ever caused you to have heart palpitations during which your heart beat so hard you could feel it  note  the data values for this variable represent harmonized values  they were derived from information obtained with sections a and e of the ssagai and ssagaii questionnaires ::: NULL ::: NULL ::: NULL ::: NULL ::: alcohol consumption;drinking function;drink (dietary substance);alcohols;alcohol measurement;palpitations;emotions;division (surgical procedure) ::: C0001948;C0684271;C0452428;C0001975;C0202304;C0030252;C0013987;C1293097 ::: inbe;orgf;food;orch,phsu;lbpr;fndg;menp;topp ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Mental or Emotional Finding;Drinking History;Eating or Nutritional Finding;Therapeutic or Preventive Procedure
phv00001391.v1 ::: phs000007.v18.p7 ::: pht000012.v3 ::: ex0_10s ::: FC35 ::: GLUCOSE CHALLENGE: TIME OF LAST EATING, AM OR PM ::: NONE ::: NONE ::: NONE ::: NONE ::: glucose challenge  time of last eating, am or pm ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;challenge:type:point in time:^patient:nominal;challenge;plasma glucose measurement;eating ::: C0017725;C0798503;C0805586;C0202042;C0013470 ::: bacs,carb,phsu;clna;hlca;lbpr;orgf ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Self-care Status;Healthcare Activity Finding;Medical History
phv00126892.v1 ::: phs000286.v3.p1 ::: pht001953.v1 ::: DPASS_DIET1_ES ::: ravg_nia ::: RECALL: niacin ::: decimal ::: NONE ::: 5.66 ::: 53.4575 ::: recall  niacin ::: NULL ::: NULL ::: NULL ::: NULL ::: mental recall;niacin;vitamin b3 assay;recall:-:point in time:^patient:- ::: C0034770;C0027996;C1142562;C2361119 ::: menp;orch,phsu,vita;lbpr;clna ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Mental or Emotional Finding
phv00032931.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL31B12 ::: Bedtime blood glucose at OD 340 (quarterly visit 12) ::: float ::: OD 340 ::: NONE ::: NONE ::: bedtime blood glucose at od 340   quarterly visit 12 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00015339.v1 ::: phs000017.v3.p1 ::: pht000057.v1 ::: EA_DIGS3_Data ::: OTH_DEP_DECR_ALCOHOL ::: F68.a. Oth Dep Decr Alcohol, (Participants with European ancestry). DIGS3 ::: NONE ::: NONE ::: NONE ::: NONE ::: f68  a  oth dep decr alcohol,  participants with european ancestry   digs3 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: 1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride;alcohols;alcohol measurement ::: C0057472;C0001975;C0202304 ::: orch,phsu;orch,phsu;lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Drinking History
phv00152828.v2 ::: phs000209.v10.p2 ::: pht002109.v2 ::: MESA_MesaFamily_LungCT ::: LL_air_v ::: LEFT LUNG, LOWER: TOTAL VOLUME OF AIR IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: left lung, lower  total volume of air in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00167575.v2 ::: phs000218.v6.p1 ::: pht002622.v2 ::: TARGET_ALLP1_Subject_Phenotypes ::: BCR_ABL_STATUS ::: Presence or absence of BCR-ABL1 fusion detected by FISH, PCR or cytogenetics ::: string ::: NONE ::: NONE ::: NONE ::: presence or absence of bcr abl1 fusion detected by fish, polymerase chain reaction or cytogenetics ::: NULL ::: NULL ::: NULL ::: NULL ::: presence;absence (morphologic abnormality);fusion procedure;detected (finding);detection;fish (food);polymerase chain reaction ::: C0392148;C1689985;C1293131;C0442726;C1511790;C2349190;C0032520 ::: topp;anab;topp;fndg;topp;food;lbpr,mbrt ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Eating or Nutritional Finding;Therapeutic or Preventive Procedure
phv00013698.v1 ::: phs000017.v3.p1 ::: pht000056.v1 ::: EA_DIGS2_Data ::: I13280 ::: K53. Have you had many days in a row when you were not up to getting dressed or would start  things but would not finish them (except during depression)? Alcohol. (Participants with European ancestry). DIGS2 ::: NONE ::: NONE ::: NONE ::: NONE ::: k53   have you had many days in a row when you were not up to getting dressed or would start things but would not finish them  except during depression   alcohol   participants with european ancestry   digs2 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: dressing of skin or wound;dressing self-care;dressing- activity of daily living;mental depression;alcohols;alcohol measurement;depressive disorder;depressed mood ::: C0278286;C0518459;C1305428;C0011570;C0001975;C0202304;C0011581;C0344315 ::: topp;fndg;dora;mobd;orch,phsu;lbpr;mobd;fndg ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Drinking History;Therapeutic or Preventive Procedure;Daily or Recreational Activity
phv00063001.v2 ::: phs000128.v3.p3 ::: pht000551.v2 ::: simphen152 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00163478.v1 ::: phs000007.v18.p7 ::: pht002429.v1 ::: t_pwaved_1975_m_0644s ::: lead_V5_1 ::: Lead V5 measurement 1 ::: integer ::: ms ::: 47 ::: 133 ::: lead v5 measurement 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: lead measurement ::: C0524167 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00018394.v1 ::: phs000017.v3.p1 ::: pht000058.v1 ::: EA_DIGS4_Data ::: V1366 ::: J35. Opiates.  (Participants with European ancestry). DIGS4 ::: NONE ::: NONE ::: NONE ::: NONE ::: j35   opiates   participants with european ancestry   diagnostic interview for genetic studies ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: opioid abuse;opiate assay;opiates;diagnosis;genetic study ::: C0029095;C0242401;C0376196;C0011900;C2827447 ::: mobd;lbpr;hops,phsu;fndg;resa ::: participant ::: C0679646 ::: popg ::: Demographics;Medication Patient;Lab Tests Patient;Substance Use History;Research Attributes;Medical History
phv00115942.v2 ::: phs000285.v2.p2 ::: pht001674.v2 ::: C1F31B ::: C31B_DO4 ::: WHAT PTT WAS DOING WHEN INJURED -CODE4 ::: encoded ::: NONE ::: NONE ::: NONE ::: what ptt was doing when injured code4 ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00050919.v1 ::: phs000086.v2.p1 ::: pht000340.v1 ::: EDIC_f0704 ::: GOD4G1 ::: D4g1. Hospitalization and other health care services used. During the past 12months, have you had any of the following laboratory tests: stress test -number of times ::: byte ::: Times ::: NONE ::: NONE ::: d4g1   hospitalization and other health candidate gene association resource services used  during the past 12 months, have you had any of the following laboratory tests  stress test number of times ::: NULL ::: NULL ::: NULL ::: NULL ::: hospitalization;health services;mental association;used by;laboratory procedures;exercise stress test ::: C0019993;C0018747;C0004083;C1273517;C0022885;C0015260 ::: hlca;hlca;menp;fndg;lbpr;diap ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Diagnostic Procedure
phv00100051.v1 ::: phs000287.v2.p1 ::: pht001451.v1 ::: BASE2 ::: GLU244 ::: 2 HR GLUCOSE (mg/dl) ::: integer ::: NONE ::: 38 ::: 691 ::: 2 heart rate glucose  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement ::: C0017725;C0202042 ::: bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Clinical Attributes
phv00094122.v1 ::: phs000280.v1.p1 ::: pht001324.v1 ::: ARIC_CARE_GW000605A ::: LIPC4A ::: GLUCOSE (VALUE IN MG/DL)          Q4A ::: integer ::: NONE ::: 52 ::: 685 ::: glucose  value in magnesium distolingual  q4 a ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement ::: C0017725;C0202042 ::: bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00163940.v1 ::: phs000398.v1.p1 ::: pht002467.v1 ::: HeartGO_ARIC_LDLandEOMI_PhenotypeDataFile ::: ESP_PHENOTYPE ::: Values: EOMI_Case (Early MI case); EOMI_Control (Early MI control); LDL_High; LDL_Low ::: String ::: NONE ::: NONE ::: NONE ::: values  eomi_case  early myocardial infarction case   eomi_control  early myocardial infarction control   ldl_high  ldl_low ::: NULL ::: NULL ::: NULL ::: NULL ::: case control;myocardial infarction;serum ldl cholesterol measurement;myocardial infarction:finding:point in time:^patient:ordinal ::: C0872128;C0027051;C0428474;C2926063 ::: hlca;dsyn;lbpr;clna ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Healthcare Activity Finding;Research Attributes;Medical History
phv00095349.v1 ::: phs000280.v1.p1 ::: pht001350.v1 ::: ARIC_CARE_NUT1V3C1 ::: RETI ::: Retinol (IU) ::: decimal ::: NONE ::: 11.75 ::: 20131.77 ::: retinol  international unit ::: NULL ::: NULL ::: NULL ::: NULL ::: vitamin a;all-trans-retinol;vitamin a measurement ::: C0042839;C0087161;C0373745 ::: orch,phsu,vita;orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00030392.v1 ::: phs000086.v2.p1 ::: pht000250.v1 ::: DCCT_cbl3 ::: BCSPCR ::: CBL3: 24-hr urine: creatinine/specimen value (mg/spec) ::: int ::: MG/SPEC ::: NONE ::: NONE ::: cbl3  24 heart rate urine  creatinine specimen value  magnesium spec ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine;creatinine finding;urine creatinine measurement ::: C0428308;C1561535;C1318439 ::: lbpr;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00161927.v2 ::: phs000007.v18.p7 ::: pht002344.v2 ::: l_rnatrans2_ex08_1_0619s ::: HMOX1_Run3_Plate ::: RNA levels (cycle threshold): HMOX1, run3, Platelet (TaqmanAssayID: Hs01110250_m1) ::: NONE ::: cycle threshold ::: 7.921224 ::: 26.9637596 ::: ribonucleic acid levels  cycle threshold   hmox1, run3, platelet  taqmanassayid  hs01110250_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00127638.v1 ::: phs000286.v3.p1 ::: pht001959.v1 ::: LOCA ::: uacid_cresult ::: Uric acid character result ::: string ::: NONE ::: NONE ::: NONE ::: uric acid character result ::: NULL ::: NULL ::: NULL ::: NULL ::: personality character;experimental result;uric acid measurement (procedure) ::: C0007952;C2825142;C0202239 ::: menp;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00142381.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: PRKAG2_Run4_Plate ::: RNA LEVELS: PRKAG2, Run4, Platelet (TaqmanAssayID : Hs00211903_m1) ::: decimal, encoded ::: cycle threshold ::: 2.5 ::: 26.8949392591767 ::: ribonucleic acid levels  prkag2, run4, platelet  taqmanassayid   hs00211903_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00068732.v2 ::: phs000007.v18.p7 ::: pht000682.v3 ::: ffreq1_7s ::: NUT_B6 ::: DERIVED FIELD: NUTRIENT VALUE - VITAMIN B6, (MG) ::: NONE ::: mg ::: NONE ::: NONE ::: derived field  nutrient value vitamin b6,  magnesium ::: NULL ::: NULL ::: NULL ::: NULL ::: nutrients;vitamin b6;blood vitamin b6 analysis ::: C0678695;C0087162;C0696232 ::: food;orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00123010.v1 ::: phs000284.v1.p1 ::: pht001902.v1 ::: CFS_CARe_Subject_Phenotypes ::: ENDMID_time ::: Calculated mid-point of sleep period during weekend ::: integer ::: NONE ::: 0 ::: 85500 ::: calculated mid point of sleep period during weekend ::: NULL ::: NULL ::: NULL ::: NULL ::: calculated (procedure);sleep ::: C1443182;C0037313 ::: lbpr;orgf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Daily or Recreational Activity
phv00077611.v3 ::: phs000200.v8.p2 ::: pht000990.v3 ::: f143_rel1 ::: ETDUR_3 ::: Used Estrogen and Testosterone pills - how many months ::: encoded value ::: NONE ::: NONE ::: NONE ::: used estrogen and testosterone pills how many months ::: NULL ::: NULL ::: NULL ::: NULL ::: estrogen use;testosterone;total testosterone measurement ::: C0239301;C0039601;C0202227 ::: fndg;horm,phsu,strd;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00145607.v1 ::: phs000209.v10.p2 ::: pht002101.v1 ::: MESA_AncilMesaLungExam2CT ::: RL_air_v ::: RIGHT LUNG, LOWER: TOTAL VOLUME OF AIR IN THIS LUNG REGION (ml) ::: Numeric ::: ml ::: NONE ::: NONE ::: right lung, lower  total volume of air in this lung region  mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: volume measurement ::: C2700258 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142106.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: APOC1_Run2_Plate ::: RNA LEVELS: APOC1, Run2, Platelet (TaqmanAssayID : Hs03037377_m1) ::: decimal, encoded ::: cycle threshold ::: 19.13 ::: 26.99 ::: ribonucleic acid levels  apoc1, run2, platelet  taqmanassayid   hs03037377_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00025100.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: QV20_R17 ::: Category test - subtest 7 - errors (quarterly visit 20) ::: byte ::: ERRORS/SUBTEST 7 ::: NONE ::: NONE ::: category test subtest 7 errors  quarterly visit 20 ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures;health care visit ::: C0022885;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142225.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: CDKN2BAS_L_Run4_Leuk ::: RNA LEVELS: CDKN2BAS, L, Run4, Leukocyte(AssaySequences:[forward primer: ACACAGTGCTCAAATCCATGATCT;reverse primer: CAAATTCCTGCCACTTCCTCTACT; probe: CATAGGTGGAGAACTTC]) ::: decimal, encoded ::: cycle threshold ::: 11.8710323755052 ::: 26.4050650756928 ::: ribonucleic acid levels  cdkn2 bas, l, run4, leukocyte assaysequences  forward primer  acacagtgctcaaatccatgatct reverse primer  caaattcctgccacttcctctact  probe  cataggtggagaacttc ::: NULL ::: NULL ::: NULL ::: NULL ::: beta-adrenergic stimulation, response to;dna probe method ::: C1862288;C1442917 ::: clna;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00031575.v1 ::: phs000086.v2.p1 ::: pht000266.v1 ::: DCCT_cbl4 ::: BCSERUM4 ::: CBL4: GFR gamma count serum - t4 ::: int ::: CPM ::: NONE ::: NONE ::: cbl4  glomerular filtration rate gamma count serum t4 ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum thyroxine;glomerular filtration rate finding ::: C0017654;C0036833;C1561549 ::: diap,ortf;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure
phv00107482.v1 ::: phs000287.v2.p1 ::: pht001492.v1 ::: YR6 ::: PLLEG27 ::: DOES PTT USE A LEFT LEG PROTHESIS ::: encoded ::: NONE ::: NONE ::: NONE ::: does ptt use a left leg prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00050930.v1 ::: phs000086.v2.p1 ::: pht000340.v1 ::: EDIC_f0704 ::: GOD4M ::: D4m. Hospitalization and other health care services used. During the past 12months, have you had any of the following laboratory tests: other urine tests ::: byte ::: NONE ::: NONE ::: NONE ::: d4 m  hospitalization and other health candidate gene association resource services used  during the past 12 months, have you had any of the following laboratory tests  other urine tests ::: NULL ::: NULL ::: NULL ::: NULL ::: hospitalization;health services;mental association;used by;laboratory procedures;others ::: C0019993;C0018747;C0004083;C1273517;C0022885;C1955473 ::: hlca;hlca;menp;fndg;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding
phv00171972.v1 ::: phs000495.v1.p1 ::: pht002866.v1 ::: TGP_Subject_Phenotypes ::: CARDIO_STRUCTURE_&_CONDUCTION_DX ::: ICD9 code representing phenotype of participant: Cardio Structure and Conduction Dx ::: decimal, encoded ::: NONE ::: NONE ::: NONE ::: icd9 code representing phenotype of participant  cardio structure and conduction diagnosis ::: NULL ::: NULL ::: NULL ::: NULL ::: phenotype determination;diagnosis;diagnosis study ::: C1285572;C0011900;C1704656 ::: lbpr;fndg;resa ::: participant ::: C0679646 ::: popg ::: Lab Tests Patient;Research Attributes
phv00030986.v1 ::: phs000086.v2.p1 ::: pht000260.v1 ::: DCCT_cbl9 ::: BCSGLUC1 ::: CBL9: GFR serum glucose - t1 value (mg/dl) ::: int ::: MG/DL ::: NONE ::: NONE ::: cbl9  glomerular filtration rate serum glucose t1 value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum magnesium finding;glucose;plasma glucose measurement;glucose measurement, serum;glomerular filtration rate finding ::: C0017654;C1826990;C0017725;C0202042;C0202041;C1561549 ::: diap,ortf;fndg;bacs,carb,phsu;lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Diagnostic Procedure
phv00111160.v2 ::: phs000200.v8.p2 ::: pht001503.v2 ::: outc_bc_cad_rel1 ::: ERDY ::: F130 Days to Estrogen Assay ::: integer ::: NONE ::: 366 ::: 5410 ::: f130  days to estrogen assay ::: NULL ::: NULL ::: NULL ::: NULL ::: estrogens;biological assay;assay ::: C0014939;C0005507;C1510438 ::: horm,phsu,strd;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00027384.v1 ::: phs000086.v2.p1 ::: pht000230.v1 ::: DCCT_cbl2 ::: BCVAL18 ::: CBL2: Renal test - 18: patient's weight in kg ::: float ::: KG ::: NONE ::: NONE ::: cbl2  renal test 18  patient s weight in kg ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures;weighing patient ::: C0022885;C1305866 ::: lbpr;diap ::: patients ::: C0030705 ::: podg ::: Lab Tests Patient;Clinical Attributes
phv00061497.v2 ::: phs000128.v3.p3 ::: pht000504.v2 ::: simphen105 ::: rx2 ::: 1:Rx for high LDL, 0:No Rx, visit 2 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 2 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00159437.v2 ::: phs000254.v2.p1 ::: pht002227.v2 ::: ESP_LungGO_CF_PA_Culture_Data ::: culture_number ::: 1st, 2nd, 3rd, etc. culture taken for a particular subject. ::: integer ::: NONE ::: NONE ::: NONE ::: 1st, 2nd, 3rd, etc  culture taken for a particular subject ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory culture;microbial culture (procedure) ::: C0430400;C2242979 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00116266.v2 ::: phs000285.v2.p2 ::: pht001685.v2 ::: C1F42A ::: C42AEAS1 ::: END OF TEST -ABM SYSTOLIC- 1ST READ ::: integer ::: NONE ::: 74 ::: 208 ::: end of test abm systolic 1st read ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures;reading (activity) ::: C0022885;C0034754 ::: lbpr;dora ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00165217.v1 ::: phs000400.v1.p1 ::: pht002536.v1 ::: HeartGO_CHS_LDL_PhenotypeDataFile ::: ESP_HEMATOCRIT ::: Hematocrit at designated visit (may not be baseline) in % ::: Numeric ::: % ::: NONE ::: NONE ::: hematocrit at designated visit  may not be baseline  in % ::: NULL ::: NULL ::: NULL ::: NULL ::: hematocrit procedure;health care visit ::: C0018935;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00025576.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR36_42 ::: Test r42: difference between year 9  and baseline scores ::: byte ::: TEST R42 score difference ::: NONE ::: NONE ::: test r42   difference between year 9 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00126016.v1 ::: phs000286.v3.p1 ::: pht001949.v1 ::: DERIVE05 ::: GLF01ST ::: Glucose fasting status ::: encoded ::: NONE ::: NONE ::: NONE ::: glucose fasting status ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;fasting status;plasma glucose measurement ::: C0017725;C1976106;C0202042 ::: bacs,carb,phsu;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00061760.v2 ::: phs000128.v3.p3 ::: pht000512.v2 ::: simphen113 ::: rx3 ::: 1:Rx for high LDL, 0:No Rx, visit 3 ::: integer ::: NONE ::: NONE ::: NONE ::: 1  rx for high ldl,0  no rx, visit 3 ::: NULL ::: NULL ::: NULL ::: NULL ::: rx therapy;serum ldl cholesterol measurement;health care visit ::: C2709207;C0428474;C1512346 ::: topp;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00173148.v1 ::: phs000488.v1.p1 ::: pht002911.v1 ::: LUAD_CIP_Subject_Phenotypes ::: Data Freeze Included ::: Sample was included in final Imielinski et al analysis [TRUE, FALSE, NA] ::: NONE ::: NONE ::: NONE ::: NONE ::: sample was included in final imielinski et attatchment loss analysis  true, false, na ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis ::: C0002778;C0936012 ::: lbpr;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00032570.v1 ::: phs000086.v2.p1 ::: pht000276.v1 ::: DCCT_cbl10 ::: BCVOL ::: CBL10: 24-hr: urine volume ::: NONE ::: ML ::: NONE ::: NONE ::: cbl10   24 heart rate  urine volume ::: NULL ::: NULL ::: NULL ::: NULL ::: urine volume function;urine sample volume measurement;urine volume finding ::: C0232856;C1278293;C1287298 ::: clna;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes;Medical History
phv00068821.v2 ::: phs000007.v18.p7 ::: pht000682.v3 ::: ffreq1_7s ::: B6DUR ::: FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION ::: NONE ::: NONE ::: NONE ::: NONE ::: food frequency questionnaire  vitamin b6 supplement years of duration ::: NULL ::: NULL ::: NULL ::: NULL ::: food, supplemented;vitamin b6;blood vitamin b6 analysis;duration ::: C0524813;C0087162;C0696232;C2926735 ::: food;orch,phsu,vita;lbpr;phsu ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding
phv00033414.v1 ::: phs000086.v2.p1 ::: pht000278.v1 ::: DCCT_bgpdat ::: VAL31A34 ::: Bedtime blood glucose mg/dl (quarterly visit 34) ::: int ::: MG/DL ::: NONE ::: NONE ::: bedtime blood glucose magnesium distolingual  quarterly visit 34 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00126616.v1 ::: phs000286.v3.p1 ::: pht001952.v1 ::: DPASS_DIET1 ::: sffq_nia ::: SFFQ: niacin (mg) ::: decimal ::: mg ::: 0.909827 ::: 119.3288 ::: sffq  niacin  magnesium ::: NULL ::: NULL ::: NULL ::: NULL ::: niacin;vitamin b3 assay ::: C0027996;C1142562 ::: orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00142349.v2 ::: phs000007.v18.p7 ::: pht002077.v3 ::: l_rnatrans_ex08_1_0552s ::: HK1_Run4_Plate ::: RNA LEVELS: HK1, Run4, Platelet (TaqmanAssayID : Hs00175976_m1) ::: decimal, encoded ::: cycle threshold ::: 5.90428171523163 ::: 26.8675310857833 ::: ribonucleic acid levels  hk1, run4, platelet  taqmanassayid   hs00175976_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00025244.v1 ::: phs000086.v2.p1 ::: pht000212.v1 ::: DCCT_ms7exf10 ::: DR20_22 ::: Test r22: difference between year 5  and baseline scores ::: float ::: TEST R22 SCORE ::: NONE ::: NONE ::: test r22   difference between year 5 and baseline scores ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00024660.v3 ::: phs000007.v18.p7 ::: pht000203.v4 ::: laba1_6s ::: HCYST1 ::: HOMOCYSTEINE (UMOL/L) ::: NONE ::: UMOL/L ::: NONE ::: NONE ::: homocysteine  umol l ::: NULL ::: NULL ::: NULL ::: NULL ::: homocystine measurement;homocysteine measurement ::: C0919377;C2242817 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
